# Orange Book - Lists of Scheduling Actions, Controlled Substances, and Regulated Chemicals

- **Original-PDF (den gällande versionen):** https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf
- **Licens och upphov:** Licens: se originalet. Författare: se originalet.
- **Citera som:** Orange Book - Lists of Scheduling Actions, Controlled Substances, and Regulated Chemicals.
- **Den här kopian:** webbsida https://kmr.clearagency.ai/docs/orangebook · PDF https://kmr.clearagency.ai/docs/orangebook.pdf (140 sidor)

> Omvandlad till Markdown för tillgänglighetens skull; originalet är den gällande versionen. Original: https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf

# Orange Book - Lists of Scheduling Actions, Controlled Substances, and Regulated Chemicals

## U.S. Department of Justice

Drug Enforcement Administration Diversion Control Division Drug & Chemical Evaluation Section

## Lists of:

Scheduling Actions Controlled Substances Regulated Chemicals

## November 2026

## Foreword

The first three sections of this booklet list the names of the substances which are described in the Code of Federal Regulations (CFR) as well as some of those which generate frequent inquiries. The substances are first arranged alphabetically, then by Drug Enforcement Administration (DEA) drug code number, and finally by Controlled Substances Act (21 U.S.C. §801 et seq.) (CSA) schedule. These lists describe the basic or parent chemical and do not describe the salts, isomers, salts of isomers, esters, ethers, and derivatives which may be controlled substances. These are not comprehensive lists so please note that a substance need not be listed as a controlled substance to be treated as a scheduled substance for criminal prosecution. The “Other Names” column, provides some examples of alternate names for certain compounds, and in some instances provides examples of “positional isomers”. If outside parties want to ensure that a compound is not considered a scheduled substance or listed chemical, they should write the DEA, Drug and Chemical Evaluation Section (DRE), Diversion Control Division, 8701 Morrissette Drive, Springfield, Virginia 22152, for an official determination. A substance (not included on these lists) may also be regulated as a controlled substance analogue. A controlled substance analogue is a substance which is intended for human consumption, is structurally substantially similar to a schedule I or schedule II substance, is pharmacologically substantially similar to a schedule I or schedule II substance, or is represented as being similar to a schedule I or schedule II substance and is not an approved medication in the United States. See 21 U.S.C. § 802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. § 813 for the schedule. The next two sections of this booklet list the Federal Register notices through which the DEA has directed substances to be added, deleted or transferred between schedules of the CSA. The scheduling changes are listed first in alphabetical order by substance and then in chronological order by effective date. With the exception of anabolic steroids, section 812 of the CSA lists only those substances which were controlled in 1970 when the law was enacted. Since then, numerous substances have been added, removed, or transferred from one schedule to another. The current official list of controlled substances can be found in section 1308 of the most recent issue of Title 21 Code of Federal Regulations Part 1300 to end (21 CFR § 1308) and the final rules which have been published in the Federal Register subsequent to the issuance of the CFR. The CFR and the Federal Register are available on the U.S. Government Printing Office web site at https://www.gpo.gov/fdsys/. This information is accessible, also, on the Diversion Control Division’s website at https://www.deadiversion.usdoj.gov/. The last section of this booklet identifies the “List I” and “List II” chemicals. Certain commercial transactions involving these chemicals are regulated by the CSA. See 21 CFR §§ 1309, 1310 and 1313 for details.

### These lists are intended as general references and are not comprehensive listings of all controlled substances and

regulated chemicals.

Drug and Chemical Evaluation Section Diversion Control Division Drug Enforcement Administration

### November 2026

## Abbreviations

2C-B = 4-Bromo-2,5-dimethoxyphenethylamine 2C-T-7 = 2,5-Dimethoxy-4(n)-propylthiophenethylamine BZP = N-Benzylpiperazine DMT = Dimethyltryptamine

| DOM | = 4-Methyl-2,5-dimethoxyamphetamine |
|---|---|
| GBL | = Gamma butyrolactone |
| GHB | = Gamma hydroxybutyric acid, gamma hydroxybutyrate, |

4-hydroxybutanoic acid, sodium oxybate LAAM = Levo-alphacetylmethadol LSD = Lysergic acid diethylamide, lysergide

| MDA | = 3,4-Methylenedioxyamphetamine |
|---|---|
| MDE | = 3,4-Methylenedioxy-N-ethylamphetamine |

MDMA = 3,4-Methylenedioxymethamphetamine MPPP = 1-Methyl-4-phenyl-4-propionoxypiperidine

| P2P | = Phenyl-2-propanone, phenylacetone |
|---|---|
| PCC | = 1-Piperidinocyclohexanecarbonitrile |
| PCE | = N-Ethyl-1-phenylcyclohexylamine |
| PCH | = 1-Phenylcyclohexylamine |
| PCP | = 1-(1-Phenylcyclohexyl)piperidine, phencyclidine |

PEPAP = 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine

| PHP | = 1-(1-Phenylcyclohexyl)pyrrolidine |
|---|---|
| SPA | = (-)-1-Dimethylamino-1,2-diphenylethane |
| TCP | = 1-[1-(2-Thienyl)cyclohexyl]piperidine |
| TCPy | = 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine |
| THC | = Tetrahydrocannabinols |
| THG | = Tetrahydrogestrinone |

## Alphabetical OrderScheduling Actions

## Scheduling Actions

## - Alphabetical Order -

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (AM–1220)

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 04-16-19 84 FR 15505 4/16/2019 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) *

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 03-31-21 86 FR 16669 4/16/2021 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) **

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 04-07-22 87 FR 20318 4/7/2022 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144)

(1-(5-FLUOROPENTYL)-1H-INDOL-3-YL)(4- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLNAPHTHALEN-1-YL)METHANONE (MAM–2201)

(1-HEXYL-5-PHENYL-1H-PYRROL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–147)

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) *

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-15-15 80 FR 27854 5/15/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) **

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)

(2-IODOPHENYL)(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (AM–2233)

(2-METHYL-1-PENTYL-1H-INDOL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–007)

(4-ETHYLNAPHTHALEN-1-YL)(1-(5-FLUOROPENTYL)-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (EAM–2201)

(4-ETHYLNAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–210)

(4-FLUORONAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–412)

(4-METHOXYNAPHTHALEN-1-YL)(2-METHYL-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (JWH–098)

(4-METHYLNAPHTHALEN-1-YL)(1-(2-MORPHOLINOETHYL)- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1H-INDOL-3-YL)METHANONE (JWH–193)

(5-(2-FLUOROPHENYL)-1-PENTYL-1H-PYRROL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (JWH–307)

(5-METHYL-3-(MORPHOLINOMETHYL)-2,3-DIHYDRO- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I [1,4]OXAZINO[2,3,4-HI]INDOL-6-YL)(NAPHTHALEN-1- YL)METHANONE (WIN 55,212– 2)

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1- 01-30-15 80 FR 5042 1/30/2015 I YL)METHANONE (THJ-2201) *

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1- 10-16-17 82 FR 47971 10/16/2017 I YL)METHANONE (THJ-2201)

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR- 144; XLR11) *

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-15-15 80 FR 27854 5/5/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR- 144; XLR11) **

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO-UR- 144; XLR11)

| [123I]IOFLUPANE | 06-03-15 | 09-11-15 | 80 FR 54715 | 9/11/2015 | II → NC |
|---|---|---|---|---|---|
| [18F]FP-CIT | 11-04-21 | 11-21-22 | 87 FR 70715 | 12/21/2022 II → NC |  |
| 1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3- | 03-01-21 | 86 FR 11862 | 3/1/2021 | I |  |

DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE) *

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3- 03-06-23 88 FR 13692 4/5/2023 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE)

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-5,6- 08-27-26 91 FR 55252 8/27/2026 I DICHLORO-1,3-DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6- DICHLORO BRORPHINE, SR–14968) *

1-(1,3-BENZODIOXOL-5-YL)-2-(DIMETHYLAMINO)PENTAN-1- 08-08-25 90 FR 38396 8/8/2025 I ONE (N,N-DIMETHYLPENTYLONE; DIPENTYLONE) (Prior control as a positional isomer of N-ETHYLPENTYLONE: See 90 FR 38396 08/31/2018)

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-31-18 83 FR 44474 8/31/2018 I ONE (N-ETHYLPENTYLONE; EPHYLONE) *

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-27-20 85 FR 52915 8/31/2020 I ONE (N-ETHYLPENTYLONE; EPHYLONE) **

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 06-14-21 86 FR 31427 6/14/2021 I ONE (N-ETHYLPENTYLONE; EPHYLONE)

| 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) * | 09-20-02 | 67 FR 59161 | 9/20/2002 | I |  |
|---|---|---|---|---|---|
| 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) ** | 09-10-03 | 68 FR 53289 | 9/20/2003 | I |  |
| 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) | 09-08-03 | 03-18-04 | 69 FR 12794 | 3/19/2004 | I → NC |
| 1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- | 07-10-18 | 83 FR 31877 | 7/10/2018 | I |  |

INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) *

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) **

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 06-10-21 86 FR 30775 6/10/2021 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA)

1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE (AM2201) 04-13-23 01-20-26 91 FR 2297 2/19/2026 I (Prior control under SDAPA: See 78 FR 664 01/04/2013)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-16-19 84 FR 15505 4/16/2019 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 03-31-21 86 FR 16669 4/16/2021 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-07-22 87 FR 20318 4/7/2022 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-10-18 83 FR 31877 7/10/2018 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 06-10-21 86 FR 30775 6/10/2021 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA)

| 1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE | 03-20-89 | 07-06-89 | 54 FR 28414 | 7/6/1989 | I |
|---|---|---|---|---|---|
| 19-NOR-4,9(10)-ANDROSTADIENEDIONE (ESTRA-4,9(10)- | 04-25-08 | 12-04-09 | 74 FR 63603 | 1/4/2010 | III |

DIENE-3,17-DIONE)

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(2-((2,3-DIHYDROBENZOFURAN-5-YL)METHYL)-5-NITRO- 10-15-25 90 FR 48259 10/15/2025 I 1H-BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (ETHYLENEOXYNITAZENE) *

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 04-12-22 87 FR 21556 4/12/2022 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) *

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 04-11-24 89 FR 25517 4/12/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) **

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-25-24 89 FR 85047 10/25/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE)

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-12-22 87 FR 21556 4/12/2022 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE) *

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-11-24 89 FR 25514 4/11/2024 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE)

2-(2-(4-ETHOXYBENZYL)-5-METHYL-1H-BENZIMIDAZOL-1- 10-15-25 90 FR 48259 10/15/2025 I YL)-N,N-DIETHYLETHAN-1-AMINE (5-METHYL ETODESNITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N,N-DIMETHYLETHAN-1-AMINE (N,N-DIMETHYLAMINO ETONITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N-ETHYLETHAN-1-AMINE (N-DESETHYL ETONITAZENE) *

2-(2-(BENZODIOXOL-5-YLMETHYL)-5-NITRO-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (METHYLENEDIOXYNITAZENE; 3′,4′- METHYLENEDIOXYNITAZENE) *

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLDECAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C9 HOMOLOG)

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLHEPTAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C6 HOMOLOG)

2-(3-METHOXYPHENYL)-1-(1-PENTYL-1H-INDOL-3-YL)ETHAN-04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1-ONE (JWH–302)

2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL)ETHANAMINE (25B-NBOMe) *

2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL)ETHANAMINE (25C-NBOMe) *

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1-YL)ETHYL)- 07-29-24 89 FR 60817 7/29/2024 I 1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE) *

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1-YL)ETHYL)- 12-23-25 90 FR 59969 1/22/2026 I 1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-12-22 87 FR 21556 4/12/2022 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE) *

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-11-24 89 FR 25514 4/11/2024 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE)

2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) 11-15-13 78 FR 68716 11/15/2013 I ETHANAMINE (25I-NBOMe) *

2-(4-ISOPROPOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 10-15-25 90 FR 48259 10/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ISOTONITAZENE) *

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE) *

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE)

2-(5-HYDROXY-2-(3-HYDROXYPROPYL)CYCLOHEXYL)-5-(2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLOCTAN-2-YL)PHENOL (CP–55,940)

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-T- 09-20-02 67 FR 59163 9/20/2002 I 7) *

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-T- 09-10-03 68 FR 53289 9/20/2003 I 7) **

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-T-09-08-03 03-18-04 69 FR 12794 3/18/2004 I 7)

| 2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC) | 04-11-22 | 04-11-22 | 87 FR 21069 | I |
|---|---|---|---|---|
| 2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC) | 04-11-22 | 08-29-22 | 87 FR 52712 | I Withdrew |

2022 proposed rule

| 2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET) | 10-30-87 | 01-14-93 | 58 FR 4316 | 2/16/1993 | I |
|---|---|---|---|---|---|
| 2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI) | 04-11-22 | 04-11-22 | 87 FR 21069 | I |  |
| 2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI) | 04-11-22 | 08-29-22 | 87 FR 52712 | I Withdrew |  |

2022 proposed rule

| 2,5-DIMETHOXYAMPHETAMINE (DMA) | 05-31-73 | 09-21-73 | 38 FR 26447 | 9/21/1973 | I |
|---|---|---|---|---|---|
| 2',5'-DIMETHOXYFENTANYL (N-(1-(2,5- | 12-07-23 | 88 FR 85104 | 12/7/2023 | I |  |

DIMETHOXYPHENETHYL)PIPERIDINE-4-YL)-N- PHENYLPROPIONAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

2'-FLUORO ORTHO-FLUOROFENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

2-FLUORODESCHLOROKETAMINE (2-(2-FLUOROPHENYL)-2- 05-22-26 91 FR 30204 5/22/2026 I (METHYLAMINO)CYCLOHEXAN-1-ONE; 2-FDCK) *

2-METHYL AP-237 (1-(2-METHYL-4-(3-PHENYLPROP-2-EN-1- 03-15-24 89 FR 18793 4/15/2024 I YL)PIPERAZIN-1-YL)BUTAN-1-ONE)

3-((4-METHYLNAPHTHALEN-1-YL)METHYL)-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOLE (JWH–184)

3-(3-(1-(1-(4-CHLOROPHENYL)ETHYL)PIPERIDIN-4-YL)-2- 08-27-26 91 FR 55252 8/27/2026 I OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-1- YL)PROPANENITRILE (N-PROPIONITRILE CHLORPHINE, CYCHLORPHINE) *

3,4-DICHLORO-N-[(1- 04-14-16 81 FR 22023 5/15/2016 I DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE (AH- 7921)

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 11-14-16 81 FR 79389 11/14/2016 I METHYLBENZAMIDE (U-47700) *

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 04-20-18 83 FR 17486 4/20/2018 I METHYLBENZAMIDE (U-47700)

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; 10-15-87 52 FR 38225 10/15/1987 I MDEA) *

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; 10-13-88 53 FR 40061 10/13/1988 I MDEA) **

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; 10-14-88 04-13-89 54 FR 14797 4/13/1989 I MDEA)

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 76 FR 65371 10/21/2011 I (METHYLONE) *

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 04-12-13 78 FR 21818 4/12/2013 I (METHYLONE)

| 3,4-METHYLENEDIOXYPYROVALERONE (MDPV) * | 10-21-11 | 76 FR 65371 | 10/21/2011 | I |
|---|---|---|---|---|
| 3-CHLOROMETHCATHINONE (3-CMC; 1-(3- | 11-06-26 | 91 FR 70009 | 11/6/2026 | I |

CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

| 3-FLUORO-N-METHYLCATHINONE (3-FMC) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
|---|---|---|---|---|---|
| 3-FLUORO-N-METHYLCATHINONE (3-FMC) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| 3-FLUORO-N-METHYLCATHINONE (3-FMC) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| 3-FURANYL FENTANYL (N-(1-PHENTHYLPIPERIDIN-4-YL)-N- | 12-07-23 | 88 FR 85104 | 12/7/2023 | I |  |

PHENYLFURAN-3-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

3-METHOXYPHENCYCLIDINE (1-(1-(3- 03-23-26 91 FR 13733 4/22/2026 I METHOXYPHENYL)CYCLOHEXYL)PIPERIDINE; 3-MEO–PCP)

| 3-METHYLFENTANYL * | 03-25-85 | 50 FR 11690 | 4/25/1985 | I |  |
|---|---|---|---|---|---|
| 3-METHYLFENTANYL ** | 04-24-86 | 51 FR 15474 | 4/25/1986 | I |  |
| 3-METHYLFENTANYL | 04-24-86 | 09-22-86 | 51 FR 33592 | 9/22/1986 | I |
| 3-METHYLTHIOFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
| 3-METHYLTHIOFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| 3-METHYLTHIOFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| 3-MMC (2-(METHYLAMINO)-1-(3-METHYLPHENYL)PROPAN-1- | 12-13-23 | 88 FR 86266 | 12/13/2023 | I |  |

ONE) (Prior control as a positional isomer of MEPHEDRONE: See 88 FR 86266 07/09/2012)

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-26-23 88 FR 48112 7/26/2023 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) *

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-25-25 90 FR 35236 7/26/2025 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) **

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM)

4,4′-DIMETHYLAMINOREX (4,4′-DMAR; 4,5-DIHYDRO-4- 04-07-20 08-12-21 86 FR 44270 9/13/2021 I METHYL-5-(4-METHYLPHENYL)-2-OXAZOLAMINE)

| 4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |  |
|---|---|---|---|---|---|
| 4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) ** | 07-18-21 | 86 FR 37672 | 7/18/2021 | I |  |
| 4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |  |
| 4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP) | 04-09-08 | 06-29-10 | 75 FR 37296 | 8/30/2010 | II |
| 4-BROMO-2,5-DIMETHOXYAMPHETAMINE | 07-02-73 | 09-21-73 | 38 FR 26447 | 9/21/1973 | I |
| 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE * | 01-06-94 | 59 FR 00671 | 1/6/1994 | I |  |
| 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE ** | 12-21-94 | 59 FR 65710 | 1/6/1995 | I |  |
| 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE | 12-20-94 | 06-02-95 | 60 FR 28718 | 6/2/1995 | I |
| 4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |  |

CHLORO-α-PVP) *

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- 07-18-21 86 FR 37672 7/18/2021 I CHLORO-α-PVP) **

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- 06-01-22 87 FR 32996 6/1/2022 I CHLORO-α-PVP)

4-CHLOROMETHCATHINONE (4-CMC, 1-(4- 11-17-25 90 FR 51102 12/17/2025 I CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

4-FLUOROAMPHETAMINE (4–FA, 1-(4- 06-03-25 01-15-26 91 FR 1692 2/17/2026 I FLUOROPHENYL)PROPAN-2-AMINE, PARA- FLUOROAMPHETAMINE)

| 4-FLUORO-N-METHYLCATHINONE (4-FMC) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
|---|---|---|---|---|---|
| 4-FLUORO-N-METHYLCATHINONE (4-FMC) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| 4-FLUORO-N-METHYLCATHINONE (4-FMC) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| 4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- | 12-12-23 | 88 FR 86040 | 12/12/2023 | I |  |

3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

| 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
|---|---|---|---|---|
| 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT) | 01-14-22 | 07-27-22 | 87 FR 45076 | I Withdrew |

2022 proposed rule

| 4-METHOXYAMPHETAMINE (PMA) | 07-02-73 | 09-21-73 | 38 FR 26447 | 9/21/1973 | I |
|---|---|---|---|---|---|
| 4'-METHYL ACETYL FENTANYL (Prior control under Temporary | 04-27-21 | 86 FR 22113 | 4/27/2021 | I |  |

Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-19 84 FR 34291 7/18/2019 I *

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-21 86 FR 37672 7/18/2021 I **

| 4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |
|---|---|---|---|---|
| 4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |

MePPP) *

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- 03-04-16 81 FR 11429 3/4/2016 I MePPP) **

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- 03-04-16 03-01-17 82 FR 12171 3/1/2017 I MePPP)

| 4-METHYLAMINOREX * | 10-15-87 | 52 FR 38225 | 10/15/1987 | I |  |
|---|---|---|---|---|---|
| 4-METHYLAMINOREX ** | 10-13-88 | 53 FR 40061 | 10/13/1988 | I |  |
| 4-METHYLAMINOREX | 10-14-88 | 04-13-89 | 54 FR 14799 | 4/13/1989 | I |
| 4-METHYL-N-ETHYLCATHINONE (4-MEC) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
| 4-METHYL-N-ETHYLCATHINONE (4-MEC) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| 4-METHYL-N-ETHYLCATHINONE (4-MEC) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| 4-METHYL-N-METHYLCATHINONE (MEPHEDRONE) * | 10-21-11 | 76 FR 65371 | 10/21/2011 | I |  |
| 5,6-DICHLORO-1-(1-(4-CHLOROBENZYL)PIPERIDIN-4-YL)-1,3- | 08-27-26 | 91 FR 55252 | 8/27/2026 | I |  |

DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6-DICHLORO DESMETHYLCHLORPHINE,SR–17018) *

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-12-23 88 FR 86040 12/12/2023 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-16-25 90 FR 58149 12/12/2025 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

| 5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
|---|---|---|---|---|
| 5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT) | 01-14-22 | 07-27-22 | 87 FR 45076 | I Withdrew |

2022 proposed rule

| 5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
|---|---|---|---|---|
| 5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET) | 01-14-22 | 07-27-22 | 87 FR 45076 | I Withdrew |

2022 proposed rule

| 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) * | 04-04-03 | 68 FR 16427 | 4/4/2003 | I |  |
|---|---|---|---|---|---|
| 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) ** | 04-01-04 | 69 FR 17034 | 4/1/2004 | I |  |
| 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) | 09-29-04 | 69 FR 58050 | 9/29/2004 | I |  |
| 5-METHOXY-N,N-DIMETHYLTRYPTAMINE | 08-21-09 | 12-20-10 | 75 FR 79296 | 1/19/2011 | I |
| 5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO- | 01-14-22 | 01-14-22 | 87 FR 2376 | I |  |

MiPT)

| 5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO- | 01-14-22 | 07-27-22 | 87 FR 45076 | I Withdrew |
|---|---|---|---|---|
| MiPT) | 2022 |  |  |  |

proposed rule

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE) *

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE)

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-12-23 88 FR 86040 12/12/2023 I 1-ONE (CUMYL-PEGACLONE, SGT-151) *

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-11-25 90 FR 57542 12/12/2025 I 1-ONE (CUMYL-PEGACLONE, SGT-151) **

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-11-25 05-13-26 91 FR 26913 5/13/2026 I 1-ONE (CUMYL-PEGACLONE, SGT-151)

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) *

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) **

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM)

6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,9,10,10A-HEXAHYDRO- 05-04-26 91 FR 23913 5/4/2026 I 6H-BENZO[C]CHROMEN-1-OL (HEXAHYDROCANNABINOL, HHC)

6β-NALTREXOL ((5a,6β)-17-(CYCLOPROPYLMETHYL)-4,5- 01-24-20 85 FR 4215 1/24/2020 II → NC EPOXYMORPHINAN-3,6,14-TRIOL)

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-26-23 88 FR 48112 7/26/2023 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) *

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-25-25 90 FR 35236 7/26/2025 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) **

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM)

8-(1-(4-CHLOROPHENYL)ETHYL)-1-PHENYL-1,3,8- 08-27-26 91 FR 55252 8/27/2026 I TRIAZASPIRO[4.5]DECAN-4-ONE (SPIROCHLORPHINE, R–6890) *

8-BROMO-1-METHYL-6-PHENYL-4H- 03-16-26 91 FR 12504 3/16/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (BROMAZOLAM) *

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) *

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) **

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM)

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) *

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) **

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM)

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-17-15 80 FR 42381 7/17/2015 I PHENYLACETAMIDE) *

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 06-07-17 82 FR 26349 6/7/2017 I PHENYLACETAMIDE)

| ACETYL-ALPHA-METHYLFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
|---|---|---|---|---|---|
| ACETYL-ALPHA-METHYLFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| ACETYL-ALPHA-METHYLFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- | 07-14-17 | 82 FR 32453 | 7/14/2017 | I |  |

PHENYLACRYLAMIDE) *

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-29-18 83 FR 61320 11/29/2018 I PHENYLACRYLAMIDE)

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-12-23 88 FR 86040 12/12/2023 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) *

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-16-25 90 FR 58149 12/12/2025 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) **

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE)

ADB-BUTINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2- 12-13-23 88 FR 86266 12/13/2023 I YL)-1-BUTYL-1H-INDAZOLE-3-CARBOXAMIDE) (Prior control as a positional isomer of AB-PINACA: See 88 FR 86266 01/30/2015)

| ALFAXALONE (5α-PREGNAN-3α-OL-11,20-DIONE) | 03-25-13 | 02-27-14 | 79 FR 10985 | 3/31/2014 | IV |
|---|---|---|---|---|---|
| ALFENTANIL | 06-25-84 | 49 FR 25849 | 8/24/1984 | I |  |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| ALFENTANIL | 04-17-86 | 01-23-87 | 52 FR 2516 | 1/23/1987 | I → II |
|---|---|---|---|---|---|
| ALPHA-ETHYLTRYPTAMINE * | 03-12-93 | 58 FR 13533 | 3/12/1993 | I |  |
| ALPHA-ETHYLTRYPTAMINE ** | 03-07-94 | 59 FR 10720 | 3/12/1994 | I |  |
| ALPHA-ETHYLTRYPTAMINE | 03-07-94 | 09-12-94 | 59 FR 46757 | 9/12/1994 | I |
| ALPHA'-METHYL BUTYRYL FENTANYL (2-METHYL-N-(1- | 12-07-23 | 88 FR 85104 | 12/7/2023 | I |  |

PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| ALPHA-METHYLFENTANYL | 08-05-81 | 09-22-81 | 46 FR 46799 | 9/22/1981 | I |
|---|---|---|---|---|---|
| ALPHA-METHYLTHIOFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
| ALPHA-METHYLTHIOFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| ALPHA-METHYLTHIOFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| ALPHA-METHYLTRYPTAMINE (AMT) * | 04-04-03 | 68 FR 16427 | 4/4/2003 | I |  |
| ALPHA-METHYLTRYPTAMINE (AMT) ** | 04-01-04 | 69 FR 17034 | 4/1/2004 | I |  |
| ALPHA-METHYLTRYPTAMINE (AMT) | 09-29-04 | 69 FR 58050 | 9/29/2004 | I |  |
| ALPHA-PIHP (4-METHYL-1-PHENYL-2-(PYRROLIDIN-1- | 12-13-23 | 88 FR 86266 | 12/13/2023 | I |  |

YL)PENTAN-1-ONE) (Prior control as a positional isomer of A- PHP: See 88 FR 86266 07/18/2019)

| ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
|---|---|---|---|---|---|
| ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |  |
| ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) ** | 07-18-21 | 86 FR 37672 | 7/18/2021 | I |  |
| ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |  |
| ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |  |
| ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) ** | 07-18-21 | 86 FR 37672 | 7/18/2021 | I |  |
| ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |  |
| ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
| ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| ALPRAZOLAM | 04-29-81 | 11-12-81 | 46 FR 55688 | 11/12/1981 | IV |
| AMINEPTINE (7-[(10,11-DIHYDRO-5H- | 07-22-22 | 11-17-22 | 87 FR 68895 | 12/19/2022 | I |

DIBENZO[A,D]CYCLOHEPTEN-5-YL)AMINO]HEPTANOIC ACID)

| AMINOREX * | 09-21-92 | 57 FR 43399 | 9/21/1992 | I |  |
|---|---|---|---|---|---|
| AMINOREX ** | 08-24-93 | 58 FR 44611 | 9/21/1993 | I |  |
| AMINOREX | 08-20-93 | 03-18-94 | 59 FR 12828 | 3/18/1994 | I |
| AMOBARBITAL | 05-31-73 | 11-13-73 | 38 FR 31310 | 11/13/1973 | III → II |
| AMPHETAMINE | 05-26-71 | 07-07-71 | 36 FR 12734 | 7/7/1971 | III → II |
| ANABOLIC STEROIDS | PL 101-647 | 02-13-91 | 56 FR 5753 | 2/27/1991 | III |
| ANABOLIC STEROIDS | PL 108-358 | 12-16-05 | 70 FR 74653 | 1/17/2006 | III |
| ANABOLIC STEROIDS (amended regulations consistent with | 08-01-23 | 88 FR 50036 | 8/1/2023 | III |  |

DASCA; updated and moved specific listing to 21 CFR 1308.13(f))

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| APOMORPHINE | 04-08-76 | 06-28-76 | 41 FR 26568 | 6/28/1976 | II → NC |
|---|---|---|---|---|---|
| APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD | 09-28-18 | 83 FR 48953 | 9/28/2018 | V |  |

AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD 08-21-20 85 FR 51639 8/21/2020 V → NC AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

| BENZPHETAMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
|---|---|---|---|---|---|
| BENZYLFENTANYL* | 10-29-85 | 50 FR 43698 | 11/29/1985 I Expired |  |  |

11/29/86

| BETA-HYDROXY-3-METHYLFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |
|---|---|---|---|---|
| BETA-HYDROXY-3-METHYLFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 I Expired |  |

5/29/87

| BETA-HYDROXY-3-METHYLFENTANYL | 11-28-86 | 01-08-88 | 53 FR 500 | 1/8/1988 | I |
|---|---|---|---|---|---|
| BETA-HYDROXYFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
| BETA-HYDROXYFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| BETA-HYDROXYFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| BETA-HYDROXYTHIOFENTANYL * | 05-12-16 | 81 FR 29492 | 5/12/2016 | I |  |
| BETA-HYDROXYTHIOFENTANYL | 05-08-19 | 84 FR 20023 | 5/8/2019 | I |  |
| BETA-METHYL FENTANYL (Prior control under Temporary | 04-27-21 | 86 FR 22113 | 4/27/2021 | I |  |

Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 12-30-24 89 FR 106311 12/31/2024 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 09-18-25 90 FR 44979 9/18/2025 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA'-PHENYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| BIPHETAMINE & BIPHETAMINE-T | 05-26-71 | 07-23-71 | 36 FR 13686 | 7/23/1971 | III → II |
|---|---|---|---|---|---|
| BOLDIONE (ANDROSTA-1,4-DIENE-3,17-DIONE) | 04-25-08 | 12-04-09 | 74 FR 63603 | 1/4/2010 | III |
| BREXANOLONE (3α-HYDROXY-5α-PREGNAN-20-ONE), | 06-17-19 | 84 FR 27938 | 6/17/2019 | IV |  |

ALLOPREGNANOLONE

| BRIVARACETAM (BRV; UCB-34714; BRIVIACT) | 05-12-16 | 81 FR 29487 | 5/12/2016 | V |  |
|---|---|---|---|---|---|
| BROMAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| BUPRENORPHINE | 09-20-82 | 02-28-85 | 50 FR 8104 | 4/1/1985 | II → V |
| BUPRENORPHINE | 03-21-02 | 10-07-02 | 67 FR 62354 | 10/7/2002 | V → III |
| BUTORPHANOL | 07-10-97 | 10-01-97 | 62 FR 51370 | 10/31/1997 | IV |
| BUTORPHANOL, THEBAINE DERIVED | 04-03-92 | 07-14-92 | 57 FR 31126 | 7/14/1992 | II → NC |

Superseded 10/97

| BUTYLONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
|---|---|---|---|---|---|
| BUTYLONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| BUTYLONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| BUTYRYL FENTANYL* | 05-12-16 | 81 FR 29492 | 5/12/2016 | I |  |
|---|---|---|---|---|---|
| CAMAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CANNABIMIMETIC AGENTS (as defined in 21 CFR § | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |

1308.11(g))

| CARFENTANIL | 01-12-88 | 10-28-88 | 53 FR 43684 | 10/28/1988 | II |
|---|---|---|---|---|---|
| CARISOPRODOL | 11-17-09 | 12-12-11 | 76 FR 77330 | 1/11/2012 | IV |
| CATHINE | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| CATHINONE | 10-30-87 | 01-14-93 | 58 FR 4316 | 2/16/1993 | I |
| CENOBAMATE [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2- | 03-10-20 | 85 FR 13741 | 3/10/2020 | V |  |

YL)ETHYL]CARBAMATE

| CENTANAFADINE | 10-30-26 | 91 FR 68470 | 10/30/2026 | III |  |
|---|---|---|---|---|---|
| CHLORDIAZEPOXIDE | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| CHLORPHENTERMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| CIPEPOFOL | 08-27-26 | 91 FR 55259 | 8/27/2026 | IV |  |
| CLOBAZAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CLONAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| CLORAZEPATE | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| CLORTERMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| CLOTIAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CLOXAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CONCENTRATE OF POPPY STRAW | 12-20-74 | 02-14-75 | 40 FR 6779 | 2/14/1975 | II |
| CP-47,497 C8 HOMOLOGUE * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
| CP-47,497 C8 HOMOLOGUE ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| CP-47,497 C8 HOMOLOGUE (Consolidated under | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |

"CANNABIMIMETIC AGENTS" as defined in 21 CFR § 1308.11(g))

| CP-47,497 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
|---|---|---|---|---|---|
| CP-47,497 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| CP-47,497 (Consolidated under "CANNABIMIMETIC AGENTS" | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |

as defined in 21 CFR § 1308.11(g))

CROTONYL FENTANYL ((E)-N-(1-PHENETHYLPIPERIDIN-4- 10-02-20 85 FR 62215 10/2/2020 I YL)-N-PHENYLBUT-2-ENAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- 01-04-18 83 FR 469 1/4/2018 I YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE) *

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- 10-25-19 84 FR 57323 10/25/2019 I YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)

| DARIDOREXANT (QUVIVIQ) | 04-07-22 | 87 FR 20313 | 4/7/2022 | IV |  |
|---|---|---|---|---|---|
| DELORAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| DESOXYMETHYLTESTOSTERONE (17α-METHYL-5α- | 04-25-08 | 12-04-09 | 74 FR 63603 | 1/4/2010 | III |

ANDROST-2-EN-17-OL; MADOL)

| DEXTROPROPOXYPHENE | 09-29-76 | 02-11-77 | 42 FR 8636 | 3/14/1977 | IV |
|---|---|---|---|---|---|
| DEXTROPROPOXYPHENE | 01-21-80 | 06-24-80 | 45 FR 42264 | 7/24/1980 | IV |
| DEXTROPROPOXYPHENE (BULK) | 07-22-80 | 45 FR 48881 | 9/22/1980 | IV → II |  |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| DEXTRORPHAN | 04-19-76 | 10-01-76 | 41 FR 43401 | 10/1/1976 | I → NC |
|---|---|---|---|---|---|
| DIAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| DICHLORALPHENAZONE (chloral hydrate compound) | 12-11-00 | 08-16-01 | 66 FR 42943 | 8/16/2001 clarification |  |

of CIV control

| DIETHYLPROPION | 05-10-73 | 07-06-73 | 38 FR 18013 | 7/6/1973 | IV |
|---|---|---|---|---|---|
| DIFENOXIN | 05-07-75 | 40 FR 19813 | 6/1/1975 | I |  |
| DIFENOXIN 1 MG WITH ATROPINE | 06-26-78 | 08-28-78 | 43 FR 38382 | 9/27/1978 | I → IV |
| DIFENOXIN 1/2 MG WITH ATROPINE | 06-26-78 | 08-28-78 | 43 FR 38382 | 9/27/1978 | I → V |
| DIHYDROETORPHINE (thebaine derivative) | 11-17-00 | 65 FR 69442 | 11/17/2000 clarification |  |  |

of CII control

| DIPHENIDINE (1-(1,2-DIPHENYLETHYL)PIPERIDINE) | 05-26-26 | 09-21-26 | 91 FR 59695 | 10/21/2026 | I |
|---|---|---|---|---|---|
| DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCT | 03-23-17 | 82 FR 14815 | 3/23/2017 | II |  |

APPROVED FOR MARKETING BY U.S. FOOD AND DRUG ADMINISTRATION

| DRONABINOL PRODUCT (MARINOL) | 10-18-85 | 05-13-86 | 51 FR 17476 | 5/13/1986 | I → II |
|---|---|---|---|---|---|
| DRONABINOL PRODUCT (MARINOL) | 11-05-98 | 07-02-99 | 64 FR 35928 | 7/2/1999 | II → III |
| DROTEBANOL | 07-03-73 | 38 FR 17717 | 8/6/1973 | I |  |
| ELUXADOLINE | 08-11-15 | 11-12-15 | 80 FR 69861 | 12/17/2015 | IV |
| EMBUTRAMIDE | 07-29-05 | 08-29-06 | 71 FR 51115 | 9/28/2006 | III |
| ESKATROL | 05-26-71 | 08-18-71 | 36 FR 15744 | 8/18/1971 | III → II |
| ESTAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- | 04-16-19 | 84 FR 15505 | 4/16/2019 | I |  |

CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) *

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) **

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-07-22 87 FR 20318 4/7/2022 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA)

| ETHYL LOFLAZEPATE | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
|---|---|---|---|---|---|
| ETHYLONE (Prior control as a positional isomer of BUTYLONE: | 06-08-20 | 85 FR 34607 | 6/8/2020 | I |  |

See 85 FR 34967 03/07/2014)

ETHYLPHENIDATE (ETHYL 2-PHENYL-2-(PIPERIDIN-2- 09-22-23 10-22-24 89 FR 84281 11/21/2024 I YL)ACETATE)

| ETORPHINE HYDROCHLORIDE | 11-23-73 | 03-29-74 | 39 FR 11535 | 4/19/1974 | I → II |
|---|---|---|---|---|---|
| EUTYLONE (1-(1,3-BENZODIOXOL-5-YL)-2- | 04-10-23 | 88 FR 21101 | 4/10/2023 | I |  |

(ETHYLAMINO)BUTAN-1-ONE) (Prior control as a positional isomer of PENTYLONE: See 88 FR 21101 03/07/2014)

| EZOGABINE | 10-21-11 | 12-15-11 | 76 FR 77895 | 12/15/2011 | V |
|---|---|---|---|---|---|
| FENCAMFAMIN | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| FENETHYLLINE | 05-01-81 | 07-21-81 | 46 FR 37503 | 8/20/1981 | I |
| FENFLURAMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | IV |
| FENFLURAMINE | 05-06-97 | 05-06-97 | 62 FR 24620 | IV → NC |  |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

FENFLURAMINE 05-06-97 05-15-03 68 FR 26247 IV Withdrew 97 proposed rule

| FENFLURAMINE | 07-19-22 | 12-23-22 | 87 FR 78857 | 12/23/2022 IV → NC |  |
|---|---|---|---|---|---|
| FENPROPOREX | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| FENTANYL CARBAMATE (Prior control under Temporary Order | 05-04-21 | 86 FR 23602 | 5/4/2021 | I |  |

for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

FENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21 CFR 02-06-18 83 FR 5188 2/6/2018 I 1308.11(h)*

| FETAMIN | 05-26-71 | 07-23-71 | 36 FR 13686 | 7/23/1971 | III → II |
|---|---|---|---|---|---|
| FLUDIAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| FLUNITRAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| FLURAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| FOSPROPOFOL | 07-23-09 | 10-06-09 | 74 FR 51234 | 11/5/2009 | IV |
| FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- | 11-03-17 | 82 FR 51154 | 11/3/2017 | I |  |

FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) *

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 03-30-20 85 FR 17494 3/30/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE)

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 10-30-19 84 FR 58045 11/3/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) **

| GAMMA HYDROXYBUTYRIC ACID (GHB) | PL 106-172 | 03-13-00 | 65 FR 13235 | 3/13/2000 | I |
|---|---|---|---|---|---|
| GAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drug | PL 106-172 | 03-13-00 | 65 FR 13235 | 3/13/2000 | III |

products

GANAXOLONE (3α-HYDROXY-3β-METHYL-5α-PREGNAN-20- 06-01-22 87 FR 32991 6/1/2022 V ONE)

| GLUTETHIMIDE | 07-26-90 | 03-21-91 | 56 FR 11930 | 3/21/1991 | III → II |
|---|---|---|---|---|---|
| HALAZEPAM | 04-29-81 | 10-29-81 | 46 FR 53407 | 10/29/1981 | IV |
| HALOXAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| HYDROCODONE COMBINATION PRODUCTS | 02-27-14 | 08-22-14 | 79 FR 49661 | 10/6/2014 | III → II |
| INDIPLON | 01-31-08 | 01-31-08 | 1/31/2008 | IV |  |
| ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 | 08-20-20 | 85 FR 51342 | 8/20/2020 | I |  |

ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE) *

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 11-04-21 86 FR 60761 12/6/2021 I ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE)

ISOVALERY FENTANYL (3-METHYL-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| JWH–018 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
|---|---|---|---|---|---|
| JWH–018 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| JWH–018 | 01-04-13 | 78 FR 664 | 1/4/2013 | I |  |
| JWH–018 (Reclassified under 21 CFR § 1308.11(d)) | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| JWH–073 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
|---|---|---|---|---|---|
| JWH–073 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| JWH–073 (Consolidated under "CANNABIMIMETIC AGENTS" | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |

as defined in 21 CFR § 1308.11(g))

| JWH–200 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
|---|---|---|---|---|---|
| JWH–200 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| JWH–200 (Consolidated under "CANNABIMIMETIC AGENTS" | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |

as defined in 21 CFR § 1308.11(g))

| KETAMINE | 04-09-99 | 07-13-99 | 64 FR 37673 | 8/12/1999 | III |
|---|---|---|---|---|---|
| KETAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| LACOSAMIDE | 03-10-09 | 05-21-09 | 74 FR 23789 | 6/22/2009 | V |
| LASMIDITAN [2,4,6-TRIFLUORO-N-(6-(1-METHYLPIPERIDINE- | 01-31-20 | 85 FR 5557 | 1/31/2020 | V |  |

4-CARBONYL)PYRIDINE-2-YL-BENZAMIDE]

| LEMBOREXANT | 04-07-20 | 85 FR 19387 | 4/7/2020 | IV |  |
|---|---|---|---|---|---|
| LEVO-ALPHACETYLMETHADOL (LAAM) | 04-28-93 | 08-18-93 | 58 FR 43795 | 8/18/1993 | I → II |
| LIBRAX | 06-05-75 | 11-11-75 | 40 FR 52609 | 11/28/1975 Exempted |  |

RX

| LISDEXAMFETAMINE | 02-22-07 | 05-03-07 | 72 FR 24532 | 6/4/2007 | II |
|---|---|---|---|---|---|
| LOPERAMIDE | 07-29-76 | 05-18-77 | 42 FR 25498 | 6/17/1977 | V |
| LOPERAMIDE | 07-28-82 | 11-03-82 | 47 FR 49840 | 11/3/1982 | V → NC |
| LOPRAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| LORAZEPAM | 06-28-77 | 10-07-77 | 42 FR 54546 | 10/3/1977 | IV |
| LORCASERIN | 12-19-12 | 05-08-13 | 78 FR 26701 | 6/7/2013 | IV |
| LORMETAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| MARIJUANA EXTRACT, AS DEFINED IN 21 CFR | 04-28-26 | 91 FR 22714 | 4/28/2026 | III |  |

1308.11(D)(58), IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

MARIJUANA, AS DEFINED IN 21 U.S.C. 802(16), IN A U.S. 04-28-26 91 FR 22714 4/28/2026 III FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

| MAZINDOL | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
|---|---|---|---|---|---|
| MAZINDOL | 04-17-81 | 10-27-81 | 46 FR 52333 | 11/27/1981 | III → IV |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) * | 05-31-85 | 50 FR 23118 | 7/1/1985 | I |  |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) ** | 06-17-86 | 51 FR 21911 | 7/1/1986 | I |  |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) | 07-27-84 | 10-14-86 | 51 FR 36552 | 11/13/1986 | I |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) | 01-27-88 | 53 FR 2225 | 1/27/1988 | I → NC |  |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) | 02-22-88 | 53 FR 5156 | 3/23/1988 | I |  |
| MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- | 12-12-23 | 88 FR 86040 | 12/12/2023 | I |  |

EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) *

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 12-11-25 90 FR 57356 12/12/2025 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) **

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 10-02-25 04-24-26 91 FR 21958 4/27/2026 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE)

| MEBUTAMATE | 12-13-74 | 01-30-75 | 40 FR 4418 | 1/30/1975 | IV |
|---|---|---|---|---|---|
| MECLOQUALONE | 05-29-75 | 07-08-75 | 40 FR 28611 | 7/10/1975 | I |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| MEDAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
|---|---|---|---|---|---|
| MEFENOREX | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| MENRIUM | 06-05-75 | 11-11-75 | 40 FR 52609 | 11/28/1975 Exempted |  |

RX

MESOCARB (N-PHENYL-N'-(3-(1-PHENYLPROPAN-2-YL)- 08-11-21 11-22-22 87 FR 71247 12/22/2022 I 1,2,3-OXADIAZOL-3-IUM-5-YL)CARBAMIMIDATE)

META-FLUOROFENTANYL (N-(3-FLUORPHENYL)-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 12-30-24 89 FR 106311 12/31/2024 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2-CARBOXAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 09-18-25 90 FR 44979 9/18/2025 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2- CARBOXAMIDE (Prior control under Temporary Order Fentanyl- Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROISOBUTYRYL FENTANYL (N-(3- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| METHAMPHETAMINE | 05-26-71 | 07-07-71 | 36 FR 12734 | 7/7/1971 | III → II |
|---|---|---|---|---|---|
| METHAQUALONE | 04-11-73 | 10-04-73 | 38 FR 27516 | 10/4/1973 | II |
| METHAQUALONE | 08-27-84 | 49 FR 33870 | 8/27/1984 | II → I |  |
| METHASTERONE (2α,17α-DIMETHYL-5α-ANDROSTAN-17β- | 11-23-11 | 07-30-12 | 77 FR 44456 | 8/29/2012 | III |

OL-3-ONE)

| METHCATHINONE * | 05-01-92 | 57 FR 18824 | 5/1/1992 | I |  |
|---|---|---|---|---|---|
| METHCATHINONE ** | 04-29-93 | 58 FR 25934 | 5/1/1993 | I |  |
| METHCATHINONE | 04-28-93 | 10-15-93 | 58 FR 53404 | 10/15/1993 | I |
| METHIOPROPAMINE (N-METHYL-1-(THIOPHEN-2- | 09-02-21 | 12-09-22 | 87 FR 75470 | 1/9/2023 | I |

YL)PROPANE-2-AMINE)

| METHOXETAMINE | 12-07-21 | 06-07-22 | 87 FR 34166 | 7/6/2022 | I |
|---|---|---|---|---|---|
| METHOXYACETYL FENTANYL (2-METHOXY-N-(1- | 10-26-17 | 82 FR 49504 | 10/26/2017 | I |  |

PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE) *

METHOXYACETYL FENTANYL (2-METHOXY-N-(1- 10-25-19 84 FR 57323 10/25/2019 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)

METHYL (E)-2-((1′S,6′S,7′S)-6′-ETHYL-4-METHOXY-3-OXO- 08-26-26 91 FR 54948 8/26/2026 I 3′,5′,6′,7′,8′,8A′-HEXAHYDRO-2′H-SPIRO[INDOLINE-2,1′- INDOLIZINE]-7′-YL)-3-METHOXYACRYLATE (MITRAGYNINE PSEUDOINDOXYL) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-7A- 08-26-26 91 FR 54948 8/26/2026 I HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–15, DIHYDRO-7- HYDROXYMITRAGYNINE) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-9-FLUORO- 08-26-26 91 FR 54948 8/26/2026 I 7A-HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–16) *

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB–FUBINACA) *

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA) **

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA)

METHYL 2-(1-(4-FLUOROBUTYL)-1H-INDAZOLE-3- 06-22-21 86 FR 32633 6/22/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (4F-MDMB- BINACA) (Prior control as a positional isomer of 5F-AMB: See 86 FR 32633 04/10/2017)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-16-19 84 FR 15505 4/16/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-07-22 87 FR 20318 4/7/2022 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-10-18 83 FR 31877 7/10/2018 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA)

| METHYLPHENIDATE | 09-17-71 | 10-28-71 | 36 FR 20686 | 10/28/1971 | III → II |
|---|---|---|---|---|---|
| MIDAZOLAM | 02-07-86 | 03-25-86 | 51 FR 10190 | 3/25/1986 | IV |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-12-23 88 FR 86040 12/12/2023 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) *

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) **

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE)

| MODAFINIL | 04-14-98 | 01-27-99 | 64 FR 4050 | 1/27/1999 | IV |
|---|---|---|---|---|---|
| MPPP * | 07-10-85 | 50 FR 28098 | 8/12/1985 | I |  |
| MPPP ** | 08-11-86 | 51 FR 28695 | 8/12/1986 | I |  |
| MPPP | 08-11-86 | 01-23-87 | 52 FR 2515 | 1/23/1987 | I |
| MT-45 (1-CYCLOHEXYL-4-(1,2- | 12-13-17 | 82 FR 58557 | 1/12/2018 | I |  |

DIPHENYLETHYL)PIPERAZINE))

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-16-13 78 FR 28735 5/16/2013 I CARBOXAMIDE (APINACA, AKB48) *

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-15-15 80 FR 27854 5/15/2015 I CARBOXAMIDE (APINACA; AKB48) **

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-11-16 81 FR 29142 5/11/2016 I CARBOXAMIDE (APINACA; AKB48)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-10-17 82 FR 17119 4/10/2017 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-08-19 84 FR 13796 4/8/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 01-24-20 85 FR 4211 1/24/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB- FUBINACA)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 02-05-16 81 FR 6171 2/5/2016 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-30-18 83 FR 4411 1/30/2018 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-29-19 84 FR 444 1/29/2019 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-10-14 79 FR 7577 2/10/2014 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-05-16 81 FR 6175 2/5/2016 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 09-06-16 81 FR 61130 9/6/2016 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-10-14 79 FR 7577 2/10/2014 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-05-16 81 FR 6175 2/5/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 09-06-16 81 FR 61130 9/6/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA)

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-10-18 83 FR 31877 7/10/2018 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-13-20 85 FR 42296 7/10/2020 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 06-10-21 86 FR 30775 6/10/2021 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 01-30-15 80 FR 5042 1/30/2015 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 10-16-17 82 FR 47971 10/16/2017 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 01-30-15 80 FR 5042 1/30/2015 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 10-16-17 82 FR 47971 10/16/2017 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE 04-20-18 83 FR 17486 4/20/2018 I (BUTYRYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-25-20 85 FR 75231 11/25/2020 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-16 81 FR 85873 11/29/2016 I CARBOXAMIDE (FURANYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-18 83 FR 61320 11/29/2018 I CARBOXAMIDE (FURANYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-25-20 85 FR 75231 11/25/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 02-01-18 83 FR 4580 2/1/2018 I (VALERYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 01-30-20 85 FR 5321 2/1/2020 I (VALERYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 11-25-20 85 FR 75231 11/25/2020 I (VALERYL FENTANYL)

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 02-01-18 83 FR 4580 2/1/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL) *

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) *

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) **

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 10-25-19 84 FR 57323 10/25/2019 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 05-03-17 82 FR 20544 5/3/2017 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-29-18 83 FR 61320 11/29/2018 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) *

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) **

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-16-19 84 FR 15505 4/16/2019 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) *

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 03-31-21 86 FR 16669 4/16/2021 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) **

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-07-22 87 FR 20318 4/7/2022 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA)

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-10-17 82 FR 17119 4/10/2017 I 3-CARBOXAMIDE (5F–APINACA; 5F–AKB48) *

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-08-19 84 FR 13796 4/8/2019 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48) **

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 01-24-20 85 FR 4211 1/24/2020 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48)

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) *

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-11-24 89 FR 25517 4/12/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) **

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 10-25-24 89 FR 85047 10/25/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE)

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-12-22 87 FR 21556 4/12/2022 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-11-24 89 FR 25517 4/12/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) **

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 10-25-24 89 FR 85047 10/25/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE)

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 08-18-23 88 FR 56466 9/18/2023 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE)

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE) *

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-11-24 89 FR 25514 4/11/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE)

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| N,N-DIISOPROPYLTRYPTAMINE (DiPT) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
|---|---|---|---|---|
| N,N-DIISOPROPYLTRYPTAMINE (DiPT) | 01-14-22 | 07-27-22 | 87 FR 45076 | I Withdrew |

2022 proposed rule

| N,N-DIMETHYLAMPHETAMINE * | 08-03-88 | 53 FR 29232 | 8/3/1988 | I |  |
|---|---|---|---|---|---|
| N,N-DIMETHYLAMPHETAMINE ** | 08-02-89 | 54 FR 31815 | 8/2/1989 | I |  |
| N,N-DIMETHYLAMPHETAMINE | 08-02-89 | 02-02-90 | 55 FR 3586 | 2/2/1990 | I |
| NABILONE | 06-18-86 | 04-07-87 | 52 FR 11042 | 4/7/1987 | II |
| NALBUPHINE | 05-11-76 | 10-01-76 | 41 FR 43401 | 10/1/1976 | II → NC |
| NALMEFENE | 05-31-85 | 11-04-85 | 50 FR 45815 | 11/4/1985 | II → NC |
| NALOXEGEL | 10-29-14 | 01-23-15 | 80 FR 3468 | 1/23/2015 | II → NC |
| NALOXONE | 07-10-74 | 12-24-74 | 39 FR 44392 | 12/24/1974 II → NC |  |
| NALOXONE HYDROCHLORIDE | 08-19-71 | 09-29-71 | 36 FR 19116 | 9/29/1971 | II → NC |
| NALTREXONE | 12-09-74 | 03-06-75 | 40 FR 10455 | 3/6/1975 | II → NC |
| NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- | 07-10-18 | 83 FR 31877 | 7/10/2018 | I |  |

CARBOXYLATE (NM2201; CBL2201) *

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXYLATE (NM2201; CBL2201) **

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXYLATE (NM2201; CBL2201)

NAPHTHALEN-1-YL(1-(PENT-4-EN-1-YL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–022)

| NAPHYRONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
|---|---|---|---|---|---|
| NAPHYRONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| NAPHYRONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| NATURALLY DERIVED DELTA-9- | 04-28-26 | 91 FR 22714 | 4/28/2026 | III |  |

TETRAHYDROCANNABINOLS IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR IN MARIJUANA SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

| N-BENZYLPIPERAZINE (BZP) * | 09-20-02 | 67 FR 59161 | 9/20/2002 | I |  |
|---|---|---|---|---|---|
| N-BENZYLPIPERAZINE (BZP) ** | 09-10-03 | 68 FR 53289 | 9/20/2003 | I |  |
| N-BENZYLPIPERAZINE (BZP) | 09-08-03 | 03-18-04 | 69 FR 12794 | 3/18/2004 | I |
| N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- | 07-29-24 | 89 FR 60817 | 7/29/2024 | I |  |

BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE) *

N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- 12-23-25 90 FR 59969 1/22/2026 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE)

N-ETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL PROTONITAZENE) *

| N-ETHYLAMPHETAMINE | 09-10-81 | 12-08-81 | 46 FR 59969 | 1/7/1982 | I |
|---|---|---|---|---|---|
| N-ETHYLHEXEDRONE * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |  |
| N-ETHYLHEXEDRONE ** | 07-18-21 | 86 FR 37672 | 7/18/2021 | I |  |
| N-ETHYLHEXEDRONE | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |  |
| N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE * | 10-15-87 | 52 FR 38225 | 10/15/1987 | I |  |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE ** | 10-13-88 | 53 FR 40061 | 10/13/1988 | I |  |
|---|---|---|---|---|---|
| N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE | 10-14-88 | 04-13-89 | 54 FR 14797 | 4/13/1989 | I |
| NIMETAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| NITRAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| NORDIAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| NORFENTANYL (N-PHENYL-N-(PIPERIDIN-4- | 09-17-19 | 04-17-20 | 85 FR 21320 | 5/18/2020 | II |

YL)PROPIONAMIDE)

O-DESMETHYLTRAMADOL (O-DSMT; DESMETRAMADOL; 3- 08-12-26 91 FR 52013 8/12/2026 I [(1R,2R)-2-[(DIMETHYLAMINO)METHYL]-1- HYDROXYCYCLOHEXYL]PHENOL) *

| OLICERIDINE | 10-30-20 | 85 FR 68749 | 10/30/2020 | II |
|---|---|---|---|---|
| ORIPAVINE | 09-24-07 | 72 FR 54208 | 9/24/2007 | II |
| ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1- | 12-30-24 | 89 FR 106311 12/31/2024 | I |  |

PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROACRYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROBUTYRYL FENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-26-17 82 FR 49504 10/26/2017 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)) *

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-25-19 84 FR 57323 10/25/2019 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))

ORTHO-FLUOROFURANYL FENTANYL (N-(2- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)FURAN- 2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROISOBUTYRYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL ACETYLFENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL METHOXYACETYL FENTANYL (Prior control 04-27-21 86 FR 22113 4/27/2021 I under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 12-30-24 89 FR 106311 12/31/2024 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 09-18-25 90 FR 44979 9/18/2025 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| OVEPOREXTON | 11-12-26 | 91 FR 72775 | 11/12/2026 | IV |  |
|---|---|---|---|---|---|
| OXAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| OXAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1- | 12-30-24 | 89 FR 106311 12/31/2024 | I |  |  |

PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO FURANYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 12-30-24 89 FR 106311 12/31/2024 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 09-18-25 90 FR 44979 9/18/2025 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| PARA-FLUOROFENTANYL * | 02-07-86 | 51 FR 4722 | 3/10/1986 | I |  |
|---|---|---|---|---|---|
| PARA-FLUOROFENTANYL ** | 03-10-87 | 52 FR 7270 | 3/10/1987 | I |  |
| PARA-FLUOROFENTANYL | 03-10-87 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| PARAHEXYL | 08-05-82 | 11-22-82 | 47 FR 52432 | 12/22/1982 | I |
| PARA-METHOXYFURANYL FENTANYL (N-(4- | 12-07-23 | 88 FR 85104 | 12/7/2023 | I |  |

METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)FURAN-2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHOXYMETHAMPHETAMINE (PMMA), 1-(4- 05-15-20 06-25-21 86 FR 33508 7/26/2021 I METHOXYPHENYL)-N-METHYLPROPAN-2-AMINE

PARA-METHYLCYCLOPROPYL FENTANYL (N-(4- 12-07-23 88 FR 85104 12/7/2023 I METHYLPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)CYCLOPROPANECARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHYLFENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| PCC (PCP PRECURSOR) | 03-20-78 | 05-17-78 | 43 FR 21324 | 6/16/1978 | II |
|---|---|---|---|---|---|
| PCE (PCP ANALOG) | 08-11-78 | 09-25-78 | 43 FR 43295 | 10/25/1978 | I |
| PCH (PCP PRECURSOR) | 03-20-78 | 05-17-78 | 43 FR 21324 | 6/16/1978 | II |
| PEMOLINE | 11-07-74 | 01-28-75 | 40 FR 4150 | 1/28/1975 | IV |
| PENTAZOCINE | 09-13-78 | 01-10-79 | 44 FR 2169 | 2/9/1979 | IV |
| PENTEDRONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
| PENTEDRONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
| PENTEDRONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| PENTOBARBITAL | 05-31-73 | 11-13-73 | 38 FR 31310 | 11/13/1973 | III → II |
| PENTYLONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| PENTYLONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |  |
|---|---|---|---|---|---|
| PENTYLONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| PEPAP * | 07-10-85 | 50 FR 28098 | 8/12/1985 | I |  |
| PEPAP ** | 08-11-86 | 51 FR 28695 | 8/12/1986 | I |  |
| PEPAP | 08-11-86 | 01-23-87 | 52 FR 2515 | 1/23/1987 | I |
| PERAMPANEL [2-(2-OXO-1-PHENYL-5-PYRIDIN-2-YL-l ,2- | 10-22-13 | 12-02-13 | 78 FR 72013 | 1/2/2014 | III |

DIHYDROPYRIDIN-3-YL)BENZONITRILE]

| PHENCYCLIDINE (PCP) | 12-19-77 | 01-25-78 | 43 FR 3359 | 2/24/1978 | III → II |
|---|---|---|---|---|---|
| PHENDIMETRAZINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| PHENMETRAZINE | 09-17-71 | 10-28-71 | 36 FR 20686 | 10/28/1971 | III → II |
| PHENTERMINE | 05-09-73 | 07-06-73 | 38 FR 18013 | 7/6/1973 | IV |
| PHENYL FENTANYL (Prior control under Temporary Order for | 04-27-21 | 86 FR 22113 | 4/27/2021 | I |  |

Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| PHENYLACETONE (P2P) | 12-12-79 | 44 FR 71822 | 2/11/1980 | II |  |
|---|---|---|---|---|---|
| PHP (PCP ANALOG) | 08-11-78 | 09-25-78 | 43 FR 43295 | 10/25/1978 | I |
| PINAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| PIPRADROL | 09-30-80 | 45 FR 64570 | 12/1/1980 | IV |  |
| PRAZEPAM | 07-29-76 | 12-17-76 | 41 FR 55176 | 12/17/1976 | IV |
| PREGABALIN | 05-12-05 | 07-28-05 | 70 FR 43633 | 7/28/2005 | V |
| PROPIRAM | 01-29-72 | 37 FR 1468 | 1/29/1972 | I |  |
| PROPYLHEXEDRINE | 10-30-87 | 04-04-88 | 53 FR 10869 | 5/4/1988 | V |
| PROPYLHEXEDRINE | 12-03-91 | 56 FR 61372 | 12/3/1991 | V → NC |  |
| PROSTANOZOL (17β-HYDROXY-5α-ANDROSTANO[3,2- | 11-23-11 | 07-30-12 | 77 FR 44456 | 8/29/2012 | III |

C]PRYAZOLE)

| PYROVALERONE | 10-30-87 | 04-04-88 | 53 FR 10869 | 5/4/1988 | V |
|---|---|---|---|---|---|
| QUAZEPAM | 02-07-86 | 03-25-86 | 51 FR 10190 | 3/25/1986 | IV |
| QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- | 02-10-14 | 79 FR 7577 | 2/10/2014 | I |  |

CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) *

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-05-16 81 FR 6175 2/5/2016 I CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) **

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 09-06-16 81 FR 61130 9/6/2016 I CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22)

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-10-14 79 FR 7577 2/10/2014 I (PB–22; QUPIC) *

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-05-16 81 FR 6175 2/5/2016 I (PB–22; QUPIC) **

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB- 09-06-16 81 FR 61130 9/6/2016 I 22; QUPIC)

| REMIFENTANIL | 09-16-96 | 11-05-96 | 61 FR 56893 | 11/5/1996 | II |
|---|---|---|---|---|---|
| REMIMAZOLAM (4H-IMIDAZOL[1,2-A][1,4]BENZODIAZEPINE-4- | 10-06-20 | 85 FR 63014 | 10/6/2020 | IV |  |

PROPIONIC ACID)

| SAMIDORPHAN | 04-19-21 | 86 FR 20284 | 4/19/2021 | II → NC |  |
|---|---|---|---|---|---|
| SECOBARBITAL | 05-31-73 | 11-13-73 | 38 FR 31310 | 11/13/1973 | III → II |
| SERDEXMETHYLPHENIDATE | 05-07-21 | 86 FR 24487 | 5/7/2021 | IV |  |
| SIBUTRAMINE | 12-08-97 | 02-11-98 | 63 FR 6862 | 2/11/1998 | IV |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

SOLRIAMFETOL (2-AMINO-3-PHENYLPROPYL CAR-BAMATE; 06-17-19 84 FR 27943 6/17/2019 IV BENZENEPROPANOL,BETA-AMINO-, CARBAMATE (ESTER))

| SPA (LEFETAMINE) | 09-30-80 | 45 FR 64570 | 12/1/1980 | IV |  |
|---|---|---|---|---|---|
| SUFENTANIL | 09-30-80 | 45 FR 64571 | 12/1/1980 | I |  |
| SUFENTANIL | 03-20-84 | 05-25-84 | 49 FR 22074 | 5/25/1984 | I → II |
| SUVOREXANT | 02-13-14 | 08-28-14 | 79 FR 52143 | 9/29/2014 | IV |
| Synthetic Drug Abuse Prevention Act of 2012 (SDAPA) | 01-04-13 | 78 FR 664 | 1/4/2013 | I |  |

Establishment of Drug Codes for 26 Substances (amended regulations consistent with SDAPA; updated 21 CFR 1308)

| TAPENTADOL | 02-17-09 | 05-21-09 | 74 FR 23790 | 6/22/2009 | II |
|---|---|---|---|---|---|
| TCP (PCP ANALOG) | 05-29-75 | 07-08-75 | 40 FR 28611 | 8/11/1975 | I |
| TEMAZEPAM | 01-05-81 | 04-07-81 | 45 FR 20671 | 4/7/1981 | IV |
| TETRAHYDROFURANYL FENTANYL (N-(1- | 10-26-17 | 82 FR 49504 | 10/26/2017 | I |  |

PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE) *

TETRAHYDROFURANYL FENTANYL (N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| TETRAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
|---|---|---|---|---|---|
| THENYLFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 I Expired |  |  |

11/29/86

| THIAFENTANIL | 08-26-16 | 81 FR 58834 | 8/26/2016 | II |  |
|---|---|---|---|---|---|
| THIOFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
| THIOFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| THIOFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| THIOFURANYL FENTANYL (Prior control under Temporary | 04-27-21 | 86 FR 22113 | 4/27/2021 | I |  |

Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| TILETAMINE/ZOLAZEPAM (TELAZOL) | 08-11-86 | 01-21-87 | 52 FR 2221 | 2/20/1987 | III |
|---|---|---|---|---|---|
| TILIDINE | 09-30-80 | 45 FR 64571 | 1/12/1980 | I |  |
| TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3- | 11-04-13 | 07-02-14 | 79 FR 37623 | 8/18/2014 | IV |

METHOXYPHENYL)CYCLOHEXANOL)

| TRIAZOLAM | 04-29-81 | 12-28-82 | 47 FR 57694 | 12/28/1982 | IV |
|---|---|---|---|---|---|
| ZALEPLON | 05-05-99 | 09-15-99 | 64 FR 49982 | 9/15/1999 | IV |
| ZIPEPROL (1-METHOXY-3-[4-(2-METHOXY-2- | 05-14-20 | 11-21-22 | 87 FR 70717 | 12/21/2022 | I |

PHENYLETHYL)PIPERAZIN-1-YL]-1-PHENYLPROPAN-2-OL)

| ZOLPIDEM | 11-24-92 | 02-05-93 | 58 FR 7186 | 2/5/1993 | IV |
|---|---|---|---|---|---|
| ZOPICLONE | 02-14-05 | 04-04-05 | 70 FR 16935 | 4/4/2005 | IV |
| ZURANOLONE | 10-31-23 | 88 FR 74347 | 10/31/2023 | IV |  |

Scheduling Actions - Alphabetical Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

Scheduling Actions - Alphabetical Order

## Chronological OrderScheduling Actions

## - Chronological Order -

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| AMPHETAMINE | 05-26-71 | 07-07-71 | 36 FR 12734 | 7/7/1971 | III → II |
|---|---|---|---|---|---|
| METHAMPHETAMINE | 05-26-71 | 07-07-71 | 36 FR 12734 | 7/7/1971 | III → II |
| BIPHETAMINE & BIPHETAMINE-T | 05-26-71 | 07-23-71 | 36 FR 13686 | 7/23/1971 | III → II |
| FETAMIN | 05-26-71 | 07-23-71 | 36 FR 13686 | 7/23/1971 | III → II |
| ESKATROL | 05-26-71 | 08-18-71 | 36 FR 15744 | 8/18/1971 | III → II |
| NALOXONE HYDROCHLORIDE | 08-19-71 | 09-29-71 | 36 FR 19116 | 9/29/1971 | II → NC |
| METHYLPHENIDATE | 09-17-71 | 10-28-71 | 36 FR 20686 | 10/28/1971 | III → II |
| PHENMETRAZINE | 09-17-71 | 10-28-71 | 36 FR 20686 | 10/28/1971 | III → II |
| PROPIRAM | 01-29-72 | 37 FR 1468 | 1/29/1972 | I |  |
| BENZPHETAMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| CHLORPHENTERMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| CLORTERMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| FENFLURAMINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | IV |
| MAZINDOL | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| PHENDIMETRAZINE | 05-09-73 | 06-15-73 | 38 FR 15719 | 6/15/1973 | III |
| DIETHYLPROPION | 05-10-73 | 07-06-73 | 38 FR 18013 | 7/6/1973 | IV |
| PHENTERMINE | 05-09-73 | 07-06-73 | 38 FR 18013 | 7/6/1973 | IV |
| DROTEBANOL | 07-03-73 | 38 FR 17717 | 8/6/1973 | I |  |
| 2,5-DIMETHOXYAMPHETAMINE (DMA) | 05-31-73 | 09-21-73 | 38 FR 26447 | 9/21/1973 | I |
| 4-BROMO-2,5-DIMETHOXYAMPHETAMINE | 07-02-73 | 09-21-73 | 38 FR 26447 | 9/21/1973 | I |
| 4-METHOXYAMPHETAMINE (PMA) | 07-02-73 | 09-21-73 | 38 FR 26447 | 9/21/1973 | I |
| METHAQUALONE | 04-11-73 | 10-04-73 | 38 FR 27516 | 10/4/1973 | II |
| AMOBARBITAL | 05-31-73 | 11-13-73 | 38 FR 31310 | 11/13/1973 | III → II |
| PENTOBARBITAL | 05-31-73 | 11-13-73 | 38 FR 31310 | 11/13/1973 | III → II |
| SECOBARBITAL | 05-31-73 | 11-13-73 | 38 FR 31310 | 11/13/1973 | III → II |
| ETORPHINE HYDROCHLORIDE | 11-23-73 | 03-29-74 | 39 FR 11535 | 4/19/1974 | I → II |
| NALOXONE | 07-10-74 | 12-24-74 | 39 FR 44392 | 12/24/1974 II → NC |  |
| PEMOLINE | 11-07-74 | 01-28-75 | 40 FR 4150 | 1/28/1975 | IV |
| MEBUTAMATE | 12-13-74 | 01-30-75 | 40 FR 4418 | 1/30/1975 | IV |
| CONCENTRATE OF POPPY STRAW | 12-20-74 | 02-14-75 | 40 FR 6779 | 2/14/1975 | II |
| NALTREXONE | 12-09-74 | 03-06-75 | 40 FR 10455 | 3/6/1975 | II → NC |
| DIFENOXIN | 05-07-75 | 40 FR 19813 | 6/1/1975 | I |  |
| CHLORDIAZEPOXIDE | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| CLONAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
|---|---|---|---|---|---|
| CLORAZEPATE | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| DIAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| FLURAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| OXAZEPAM | 01-27-75 | 06-04-75 | 40 FR 23998 | 7/2/1975 | IV |
| MECLOQUALONE | 05-29-75 | 07-08-75 | 40 FR 28611 | 7/10/1975 | I |
| TCP (PCP ANALOG) | 05-29-75 | 07-08-75 | 40 FR 28611 | 8/11/1975 | I |
| LIBRAX | 06-05-75 | 11-11-75 | 40 FR 52609 | 11/28/1975 Exempted |  |

RX

MENRIUM 06-05-75 11-11-75 40 FR 52609 11/28/1975 Exempted RX

| APOMORPHINE | 04-08-76 | 06-28-76 | 41 FR 26568 | 6/28/1976 | II → NC |
|---|---|---|---|---|---|
| DEXTRORPHAN | 04-19-76 | 10-01-76 | 41 FR 43401 | 10/1/1976 | I → NC |
| NALBUPHINE | 05-11-76 | 10-01-76 | 41 FR 43401 | 10/1/1976 | II → NC |
| PRAZEPAM | 07-29-76 | 12-17-76 | 41 FR 55176 | 12/17/1976 | IV |
| DEXTROPROPOXYPHENE | 09-29-76 | 02-11-77 | 42 FR 8636 | 3/14/1977 | IV |
| LOPERAMIDE | 07-29-76 | 05-18-77 | 42 FR 25498 | 6/17/1977 | V |
| LORAZEPAM | 06-28-77 | 10-07-77 | 42 FR 54546 | 10/3/1977 | IV |
| PHENCYCLIDINE (PCP) | 12-19-77 | 01-25-78 | 43 FR 3359 | 2/24/1978 | III → II |
| PCC (PCP PRECURSOR) | 03-20-78 | 05-17-78 | 43 FR 21324 | 6/16/1978 | II |
| PCH (PCP PRECURSOR) | 03-20-78 | 05-17-78 | 43 FR 21324 | 6/16/1978 | II |
| DIFENOXIN 1 MG WITH ATROPINE | 06-26-78 | 08-28-78 | 43 FR 38382 | 9/27/1978 | I→ IV |
| DIFENOXIN 1/2 MG WITH ATROPINE | 06-26-78 | 08-28-78 | 43 FR 38382 | 9/27/1978 | I→V |
| PCE (PCP ANALOG) | 08-11-78 | 09-25-78 | 43 FR 43295 | 10/25/1978 | I |
| PHP (PCP ANALOG) | 08-11-78 | 09-25-78 | 43 FR 43295 | 10/25/1978 | I |
| PENTAZOCINE | 09-13-78 | 01-10-79 | 44 FR 2169 | 2/9/1979 | IV |
| TILIDINE | 09-30-80 | 45 FR 64571 | 1/12/1980 | I |  |
| PHENYLACETONE (P2P) | 12-12-79 | 44 FR 71822 | 2/11/1980 | II |  |
| DEXTROPROPOXYPHENE | 01-21-80 | 06-24-80 | 45 FR 42264 | 7/24/1980 | IV |
| DEXTROPROPOXYPHENE (BULK) | 07-22-80 | 45 FR 48881 | 9/22/1980 | IV → II |  |
| PIPRADROL | 09-30-80 | 45 FR 64570 | 12/1/1980 | IV |  |
| SPA (LEFETAMINE) | 09-30-80 | 45 FR 64570 | 12/1/1980 | IV |  |
| SUFENTANIL | 09-30-80 | 45 FR 64571 | 12/1/1980 | I |  |
| TEMAZEPAM | 01-05-81 | 04-07-81 | 45 FR 20671 | 4/7/1981 | IV |
| FENETHYLLINE | 05-01-81 | 07-21-81 | 46 FR 37503 | 8/20/1981 | I |
| ALPHA-METHYLFENTANYL | 08-05-81 | 09-22-81 | 46 FR 46799 | 9/22/1981 | I |
| HALAZEPAM | 04-29-81 | 10-29-81 | 46 FR 53407 | 10/29/1981 | IV |
| ALPRAZOLAM | 04-29-81 | 11-12-81 | 46 FR 55688 | 11/12/1981 | IV |
| MAZINDOL | 04-17-81 | 10-27-81 | 46 FR 52333 | 11/27/1981 | III → IV |

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| N-ETHYLAMPHETAMINE | 09-10-81 | 12-08-81 | 46 FR 59969 | 1/7/1982 | I |
|---|---|---|---|---|---|
| LOPERAMIDE | 07-28-82 | 11-03-82 | 47 FR 49840 | 11/3/1982 | V → NC |
| PARAHEXYL | 08-05-82 | 11-22-82 | 47 FR 52432 | 12/22/1982 | I |
| TRIAZOLAM | 04-29-81 | 12-28-82 | 47 FR 57694 | 12/28/1982 | IV |
| SUFENTANIL | 03-20-84 | 05-25-84 | 49 FR 22074 | 5/25/1984 | I → II |
| ALFENTANIL | 06-25-84 | 49 FR 25849 | 8/24/1984 | I |  |
| METHAQUALONE | 08-27-84 | 49 FR 33870 | 8/27/1984 | II → I |  |
| BROMAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CAMAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CLOBAZAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CLOTIAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| CLOXAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| DELORAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| ESTAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| ETHYL LOFLAZEPATE | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| FLUDIAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| FLUNITRAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| HALOXAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| KETAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| LOPRAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| LORMETAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| MEDAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| NIMETAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| NITRAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| NORDIAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| OXAZOLAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| PINAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| TETRAZEPAM | 08-01-84 | 10-05-84 | 49 FR 39307 | 11/5/1984 | IV |
| BUPRENORPHINE | 09-20-82 | 02-28-85 | 50 FR 8104 | 4/1/1985 | II → V |
| 3-METHYLFENTANYL * | 03-25-85 | 50 FR 11690 | 4/25/1985 | I |  |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) * | 05-31-85 | 50 FR 23118 | 7/1/1985 | I |  |
| MPPP * | 07-10-85 | 50 FR 28098 | 8/12/1985 | I |  |
| PEPAP * | 07-10-85 | 50 FR 28098 | 8/12/1985 | I |  |
| NALMEFENE | 05-31-85 | 11-04-85 | 50 FR 45815 | 11/4/1985 | II → NC |
| 3-METHYLTHIOFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
| ACETYL-ALPHA-METHYLFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
| ALPHA-METHYLTHIOFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

BENZYLFENTANYL* 10-29-85 50 FR 43698 11/29/1985 I Expired 11/29/86

| BETA-HYDROXY-3-METHYLFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |
|---|---|---|---|---|
| BETA-HYDROXYFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |
| THENYLFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 I Expired |  |

11/29/86

| THIOFENTANYL * | 10-29-85 | 50 FR 43698 | 11/29/1985 | I |  |
|---|---|---|---|---|---|
| PARA-FLUOROFENTANYL * | 02-07-86 | 51 FR 4722 | 3/10/1986 | I |  |
| MIDAZOLAM | 02-07-86 | 03-25-86 | 51 FR 10190 | 3/25/1986 | IV |
| QUAZEPAM | 02-07-86 | 03-25-86 | 51 FR 10190 | 3/25/1986 | IV |
| 3-METHYLFENTANYL ** | 04-24-86 | 51 FR 15474 | 4/25/1986 | I |  |
| DRONABINOL PRODUCT (MARINOL) | 10-18-85 | 05-13-86 | 51 FR 17476 | 5/13/1986 | I → II |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) ** | 06-17-86 | 51 FR 21911 | 7/1/1986 | I |  |
| MPPP ** | 08-11-86 | 51 FR 28695 | 8/12/1986 | I |  |
| PEPAP ** | 08-11-86 | 51 FR 28695 | 8/12/1986 | I |  |
| 3-METHYLFENTANYL | 04-24-86 | 09-22-86 | 51 FR 33592 | 9/22/1986 | I |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) | 07-27-84 | 10-14-86 | 51 FR 36552 | 11/13/1986 | I |
| 3-METHYLTHIOFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| ACETYL-ALPHA-METHYLFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| ALPHA-METHYLTHIOFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| BETA-HYDROXY-3-METHYLFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 I Expired |  |  |

5/29/87

| BETA-HYDROXYFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
|---|---|---|---|---|---|
| THIOFENTANYL ** | 11-26-86 | 51 FR 42834 | 11/29/1986 | I |  |
| ALFENTANIL | 04-17-86 | 01-23-87 | 52 FR 2516 | 1/23/1987 | I → II |
| MPPP | 08-11-86 | 01-23-87 | 52 FR 2515 | 1/23/1987 | I |
| PEPAP | 08-11-86 | 01-23-87 | 52 FR 2515 | 1/23/1987 | I |
| TILETAMINE/ZOLAZEPAM (TELAZOL) | 08-11-86 | 01-21-87 | 52 FR 2221 | 2/20/1987 | III |
| PARA-FLUOROFENTANYL ** | 03-10-87 | 52 FR 7270 | 3/10/1987 | I |  |
| NABILONE | 06-18-86 | 04-07-87 | 52 FR 11042 | 4/7/1987 | II |
| 3-METHYLTHIOFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| ACETYL-ALPHA-METHYLFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| ALPHA-METHYLTHIOFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| BETA-HYDROXYFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| PARA-FLUOROFENTANYL | 03-10-87 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| THIOFENTANYL | 11-28-86 | 05-29-87 | 52 FR 20070 | 5/29/1987 | I |
| 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; | 10-15-87 | 52 FR 38225 | 10/15/1987 | I |  |

MDEA) *

4-METHYLAMINOREX * 10-15-87 52 FR 38225 10/15/1987 I

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE * | 10-15-87 | 52 FR 38225 | 10/15/1987 | I |  |
|---|---|---|---|---|---|
| BETA-HYDROXY-3-METHYLFENTANYL | 11-28-86 | 01-08-88 | 53 FR 500 | 1/8/1988 | I |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) | 01-27-88 | 53 FR 2225 | 1/27/1988 | I→ NC |  |
| MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) | 02-22-88 | 53 FR 5156 | 3/23/1988 | I |  |
| PROPYLHEXEDRINE | 10-30-87 | 04-04-88 | 53 FR 10869 | 5/4/1988 | V |
| PYROVALERONE | 10-30-87 | 04-04-88 | 53 FR 10869 | 5/4/1988 | V |
| CATHINE | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| FENCAMFAMIN | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| FENPROPOREX | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| MEFENOREX | 10-30-87 | 05-17-88 | 53 FR 17459 | 6/16/1988 | IV |
| N,N-DIMETHYLAMPHETAMINE * | 08-03-88 | 53 FR 29232 | 8/3/1988 | I |  |
| 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; | 10-13-88 | 53 FR 40061 | 10/13/1988 | I |  |

MDEA) **

| 4-METHYLAMINOREX ** | 10-13-88 | 53 FR 40061 | 10/13/1988 | I |  |
|---|---|---|---|---|---|
| N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE ** | 10-13-88 | 53 FR 40061 | 10/13/1988 | I |  |
| CARFENTANIL | 01-12-88 | 10-28-88 | 53 FR 43684 | 10/28/1988 | II |
| 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE; | 10-14-88 | 04-13-89 | 54 FR 14797 | 4/13/1989 | I |

MDEA)

| 4-METHYLAMINOREX | 10-14-88 | 04-13-89 | 54 FR 14799 | 4/13/1989 | I |
|---|---|---|---|---|---|
| N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE | 10-14-88 | 04-13-89 | 54 FR 14797 | 4/13/1989 | I |
| 1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE | 03-20-89 | 07-06-89 | 54 FR 28414 | 7/6/1989 | I |
| N,N-DIMETHYLAMPHETAMINE ** | 08-02-89 | 54 FR 31815 | 8/2/1989 | I |  |
| N,N-DIMETHYLAMPHETAMINE | 08-02-89 | 02-02-90 | 55 FR 3586 | 2/2/1990 | I |
| ANABOLIC STEROIDS | PL 101-647 | 02-13-91 | 56 FR 5753 | 2/27/1991 | III |
| GLUTETHIMIDE | 07-26-90 | 03-21-91 | 56 FR 11930 | 3/21/1991 | III → II |
| PROPYLHEXEDRINE | 12-03-91 | 56 FR 61372 | 12/3/1991 | V → NC |  |
| METHCATHINONE * | 05-01-92 | 57 FR 18824 | 5/1/1992 | I |  |
| BUTORPHANOL, THEBAINE DERIVED | 04-03-92 | 07-14-92 | 57 FR 31126 | 7/14/1992 | II → NC |

Superseded 10/97

| AMINOREX * | 09-21-92 | 57 FR 43399 | 9/21/1992 | I |  |
|---|---|---|---|---|---|
| ZOLPIDEM | 11-24-92 | 02-05-93 | 58 FR 7186 | 2/5/1993 | IV |
| 2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET) | 10-30-87 | 01-14-93 | 58 FR 4316 | 2/16/1993 | I |
| CATHINONE | 10-30-87 | 01-14-93 | 58 FR 4316 | 2/16/1993 | I |
| ALPHA-ETHYLTRYPTAMINE * | 03-12-93 | 58 FR 13533 | 3/12/1993 | I |  |
| METHCATHINONE ** | 04-29-93 | 58 FR 25934 | 5/1/1993 | I |  |
| LEVO-ALPHACETYLMETHADOL (LAAM) | 04-28-93 | 08-18-93 | 58 FR 43795 | 8/18/1993 | I → II |
| AMINOREX ** | 08-24-93 | 58 FR 44611 | 9/21/1993 | I |  |
| METHCATHINONE | 04-28-93 | 10-15-93 | 58 FR 53404 | 10/15/1993 | I |

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

| 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE * | 01-06-94 | 59 FR 00671 | 1/6/1994 | I |  |
|---|---|---|---|---|---|
| ALPHA-ETHYLTRYPTAMINE ** | 03-07-94 | 59 FR 10720 | 3/12/1994 | I |  |
| AMINOREX | 08-20-93 | 03-18-94 | 59 FR 12828 | 3/18/1994 | I |
| ALPHA-ETHYLTRYPTAMINE | 03-07-94 | 09-12-94 | 59 FR 46757 | 9/12/1994 | I |
| 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE ** | 12-21-94 | 59 FR 65710 | 1/6/1995 | I |  |
| 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE | 12-20-94 | 06-02-95 | 60 FR 28718 | 6/2/1995 | I |
| REMIFENTANIL | 09-16-96 | 11-05-96 | 61 FR 56893 | 11/5/1996 | II |
| FENFLURAMINE | 05-06-97 | 05-06-97 | 62 FR 24620 | IV → NC |  |
| BUTORPHANOL | 07-10-97 | 10-01-97 | 62 FR 51370 | 10/31/1997 | IV |
| SIBUTRAMINE | 12-08-97 | 02-11-98 | 63 FR 6862 | 2/11/1998 | IV |
| MODAFINIL | 04-14-98 | 01-27-99 | 64 FR 4050 | 1/27/1999 | IV |
| DRONABINOL PRODUCT (MARINOL) | 11-05-98 | 07-02-99 | 64 FR 35928 | 7/2/1999 | II → III |
| KETAMINE | 04-09-99 | 07-13-99 | 64 FR 37673 | 8/12/1999 | III |
| ZALEPLON | 05-05-99 | 09-15-99 | 64 FR 49982 | 9/15/1999 | IV |
| GAMMA HYDROXYBUTYRIC ACID (GHB) | PL 106-172 | 03-13-00 | 65 FR 13235 | 3/13/2000 | I |
| GAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drug PL 106-172 | 03-13-00 | 65 FR 13235 | 3/13/2000 | III |  |

products

DIHYDROETORPHINE (thebaine derivative) 11-17-00 65 FR 69442 11/17/2000 clarification of CII control

DICHLORALPHENAZONE (chloral hydrate compound) 12-11-00 08-16-01 66 FR 42943 8/16/2001 clarification of CIV control

| 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) * | 09-20-02 | 67 FR 59161 | 9/20/2002 | I |
|---|---|---|---|---|
| 2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- | 09-20-02 | 67 FR 59163 | 9/20/2002 | I |

T-7) *

| N-BENZYLPIPERAZINE (BZP) * | 09-20-02 | 67 FR 59161 | 9/20/2002 | I |  |
|---|---|---|---|---|---|
| BUPRENORPHINE | 03-21-02 | 10-07-02 | 67 FR 62354 | 10/7/2002 | V → III |
| 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) * | 04-04-03 | 68 FR 16427 | 4/4/2003 | I |  |
| ALPHA-METHYLTRYPTAMINE (AMT) * | 04-04-03 | 68 FR 16427 | 4/4/2003 | I |  |
| FENFLURAMINE | 05-06-97 | 05-15-03 | 68 FR 26247 | IV |  |

Withdrew 97 proposed rule

| 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) ** | 09-10-03 | 68 FR 53289 | 9/20/2003 | I |
|---|---|---|---|---|
| 2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C- | 09-10-03 | 68 FR 53289 | 9/20/2003 | I |

T-7) **

| N-BENZYLPIPERAZINE (BZP) ** | 09-10-03 | 68 FR 53289 | 9/20/2003 | I |
|---|---|---|---|---|
| 2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2C-09-08-03 | 03-18-04 | 69 FR 12794 | 3/18/2004 | I |

T-7)

| N-BENZYLPIPERAZINE (BZP) | 09-08-03 | 03-18-04 | 69 FR 12794 | 3/18/2004 | I |
|---|---|---|---|---|---|
| 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) | 09-08-03 | 03-18-04 | 69 FR 12794 | 3/19/2004 | I → NC |

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) 04-01-04 69 FR 17034 4/1/2004 I **

| ALPHA-METHYLTRYPTAMINE (AMT) ** | 04-01-04 | 69 FR 17034 | 4/1/2004 | I |  |
|---|---|---|---|---|---|
| 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) | 09-29-04 | 69 FR 58050 | 9/29/2004 | I |  |
| ALPHA-METHYLTRYPTAMINE (AMT) | 09-29-04 | 69 FR 58050 | 9/29/2004 | I |  |
| ZOPICLONE | 02-14-05 | 04-04-05 | 70 FR 16935 | 4/4/2005 | IV |
| PREGABALIN | 05-12-05 | 07-28-05 | 70 FR 43633 | 7/28/2005 | V |
| ANABOLIC STEROIDS | PL 108-358 | 12-16-05 | 70 FR 74653 | 1/17/2006 | III |
| EMBUTRAMIDE | 07-29-05 | 08-29-06 | 71 FR 51115 | 9/28/2006 | III |
| LISDEXAMFETAMINE | 02-22-07 | 05-03-07 | 72 FR 24532 | 6/4/2007 | II |
| ORIPAVINE | 09-24-07 | 72 FR 54208 | 9/24/2007 | II |  |
| INDIPLON | 01-31-08 | 01-31-08 | 1/31/2008 | IV |  |
| LACOSAMIDE | 03-10-09 | 05-21-09 | 74 FR 23789 | 6/22/2009 | V |
| TAPENTADOL | 02-17-09 | 05-21-09 | 74 FR 23790 | 6/22/2009 | II |
| FOSPROPOFOL | 07-23-09 | 10-06-09 | 74 FR 51234 | 11/5/2009 | IV |
| 19-NOR-4,9(10)-ANDROSTADIENEDIONE (ESTRA-4,9(10)- | 04-25-08 | 12-04-09 | 74 FR 63603 | 1/4/2010 | III |

DIENE-3,17-DIONE)

| BOLDIONE (ANDROSTA-1,4-DIENE-3,17-DIONE) | 04-25-08 | 12-04-09 | 74 FR 63603 | 1/4/2010 | III |
|---|---|---|---|---|---|
| DESOXYMETHYLTESTOSTERONE (17α-METHYL-5α- | 04-25-08 | 12-04-09 | 74 FR 63603 | 1/4/2010 | III |

ANDROST-2-EN-17-OL; MADOL)

| 4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP) | 04-09-08 | 06-29-10 | 75 FR 37296 | 8/30/2010 | II |
|---|---|---|---|---|---|
| 5-METHOXY-N,N-DIMETHYLTRYPTAMINE | 08-21-09 | 12-20-10 | 75 FR 79296 | 1/19/2011 | I |
| CP-47,497 C8 HOMOLOGUE * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
| CP-47,497 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
| JWH–018 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
| JWH–073 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
| JWH–200 * | 03-01-11 | 76 FR 11075 | 3/1/2011 | I |  |
| 3,4-METHYLENEDIOXY-N-METHYLCATHINONE | 10-21-11 | 76 FR 65371 | 10/21/2011 | I |  |

(METHYLONE) *

| 3,4-METHYLENEDIOXYPYROVALERONE (MDPV) * | 10-21-11 | 76 FR 65371 | 10/21/2011 | I |  |
|---|---|---|---|---|---|
| 4-METHYL-N-METHYLCATHINONE (MEPHEDRONE) * | 10-21-11 | 76 FR 65371 | 10/21/2011 | I |  |
| EZOGABINE | 10-21-11 | 12-15-11 | 76 FR 77895 | 12/15/2011 | V |
| CARISOPRODOL | 11-17-09 | 12-12-11 | 76 FR 77330 | 1/11/2012 | IV |
| CP-47,497 C8 HOMOLOGUE ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| CP-47,497 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| JWH–018 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| JWH–073 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| JWH–200 ** | 02-29-12 | 77 FR 12201 | 2/29/2012 | I |  |
| METHASTERONE (2α,17α-DIMETHYL-5α-ANDROSTAN-17β- | 11-23-11 | 07-30-12 | 77 FR 44456 | 8/29/2012 | III |

OL-3-ONE)

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

PROSTANOZOL (17β-HYDROXY-5α-ANDROSTANO[3,2- 11-23-11 07-30-12 77 FR 44456 8/29/2012 III C]PRYAZOLE)

| JWH–018 | 01-04-13 | 78 FR 664 | 1/4/2013 | I |
|---|---|---|---|---|
| Synthetic Drug Abuse Prevention Act of 2012 (SDAPA) | 01-04-13 | 78 FR 664 | 1/4/2013 | I |

Establishment of Drug Codes for 26 Substances (amended regulations consistent with SDAPA; updated 21 CFR 1308)

3,4-METHYLENEDIOXY-N-METHYLCATHINONE 10-21-11 04-12-13 78 FR 21818 4/12/2013 I (METHYLONE)

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) *

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-16-13 78 FR 28735 5/16/2013 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO- UR-144; XLR11) *

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-16-13 78 FR 28735 5/16/2013 I CARBOXAMIDE (APINACA, AKB48) *

| LORCASERIN | 12-19-12 | 05-08-13 | 78 FR 26701 | 6/7/2013 | IV |
|---|---|---|---|---|---|
| 2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2- | 11-15-13 | 78 FR 68716 | 11/15/2013 | I |  |

METHOXYBENZYL)ETHANAMINE (25B-NBOMe) *

2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2- 11-15-13 78 FR 68716 11/15/2013 I METHOXYBENZYL)ETHANAMINE (25C-NBOMe) *

2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL) 11-15-13 78 FR 68716 11/15/2013 I ETHANAMINE (25I-NBOMe) *

PERAMPANEL [2-(2-OXO-1-PHENYL-5-PYRIDIN-2-YL-l ,2- 10-22-13 12-02-13 78 FR 72013 1/2/2014 III DIHYDROPYRIDIN-3-YL)BENZONITRILE]

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-10-14 79 FR 7577 2/10/2014 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-10-14 79 FR 7577 2/10/2014 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) *

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-10-14 79 FR 7577 2/10/2014 I CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) *

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-10-14 79 FR 7577 2/10/2014 I (PB–22; QUPIC) *

| ALFAXALONE (5α-PREGNAN-3α-OL-11,20-DIONE) | 03-25-13 | 02-27-14 | 79 FR 10985 | 3/31/2014 | IV |
|---|---|---|---|---|---|
| 3-FLUORO-N-METHYLCATHINONE (3-FMC) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
| 4-FLUORO-N-METHYLCATHINONE (4-FMC) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |
| 4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |  |

MePPP) *

| 4-METHYL-N-ETHYLCATHINONE (4-MEC) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |
|---|---|---|---|---|
| ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |
| ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |
| BUTYLONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |
| NAPHYRONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |
| PENTEDRONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |
| PENTYLONE * | 03-07-14 | 79 FR 12938 | 3/7/2014 | I |

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3- 11-04-13 07-02-14 79 FR 37623 8/18/2014 IV METHOXYPHENYL)CYCLOHEXANOL)

| SUVOREXANT | 02-13-14 | 08-28-14 | 79 FR 52143 | 9/29/2014 | IV |
|---|---|---|---|---|---|
| HYDROCODONE COMBINATION PRODUCTS | 02-27-14 | 08-22-14 | 79 FR 49661 | 10/6/2014 | III → II |
| NALOXEGEL | 10-29-14 | 01-23-15 | 80 FR 3468 | 1/23/2015 | II → NC |
| [1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1- | 01-30-15 | 80 FR 5042 | 1/30/2015 | I |  |

YL)METHANONE (THJ-2201) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 01-30-15 80 FR 5042 1/30/2015 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 01-30-15 80 FR 5042 1/30/2015 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA) *

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-15-15 80 FR 27854 5/15/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) **

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-15-15 80 FR 27854 5/5/2015 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO- UR-144; XLR11) **

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-15-15 80 FR 27854 5/15/2015 I CARBOXAMIDE (APINACA; AKB48) **

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-17-15 80 FR 42381 7/17/2015 I PHENYLACETAMIDE) *

| [123I]IOFLUPANE | 06-03-15 | 09-11-15 | 80 FR 54715 | 9/11/2015 | II → NC |
|---|---|---|---|---|---|
| ELUXADOLINE | 08-11-15 | 11-12-15 | 80 FR 69861 | 12/17/2015 | IV |
| N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- | 02-05-16 | 81 FR 6171 | 2/5/2016 | I |  |

(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- 02-05-16 81 FR 6175 2/5/2016 I 1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 02-05-16 81 FR 6175 2/5/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA) **

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 02-05-16 81 FR 6175 2/5/2016 I CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) **

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE 02-05-16 81 FR 6175 2/5/2016 I (PB–22; QUPIC) **

| 3-FLUORO-N-METHYLCATHINONE (3-FMC) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
|---|---|---|---|---|
| 4-FLUORO-N-METHYLCATHINONE (4-FMC) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
| 4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |

MePPP) **

| 4-METHYL-N-ETHYLCATHINONE (4-MEC) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
|---|---|---|---|---|
| ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
| ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
| BUTYLONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
| NAPHYRONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
| PENTEDRONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |
| PENTYLONE ** | 03-04-16 | 81 FR 11429 | 3/4/2016 | I |

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)

[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3- 05-11-16 81 FR 29142 5/11/2016 I TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUORO- UR-144; XLR11)

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3- 05-11-16 81 FR 29142 5/11/2016 I CARBOXAMIDE (APINACA; AKB48)

| BETA-HYDROXYTHIOFENTANYL * | 05-12-16 | 81 FR 29492 | 5/12/2016 | I |
|---|---|---|---|---|
| BRIVARACETAM (BRV; UCB-34714; BRIVIACT) | 05-12-16 | 81 FR 29487 | 5/12/2016 | V |
| BUTYRYL FENTANYL* | 05-12-16 | 81 FR 29492 | 5/12/2016 | I |
| 3,4-DICHLORO-N-[(1- | 04-14-16 | 81 FR 22023 | 5/15/2016 | I |

DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE (AH- 7921)

| THIAFENTANIL | 08-26-16 | 81 FR 58834 | 8/26/2016 | II |
|---|---|---|---|---|
| N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL- | 09-06-16 | 81 FR 61130 | 9/6/2016 | I |

1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4- 09-06-16 81 FR 61130 9/6/2016 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (AB- FUBINACA)

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 09-06-16 81 FR 61130 9/6/2016 I CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22)

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB- 09-06-16 81 FR 61130 9/6/2016 I 22; QUPIC)

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 11-14-16 81 FR 79389 11/14/2016 I METHYLBENZAMIDE (U-47700) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-16 81 FR 85873 11/29/2016 I CARBOXAMIDE (FURANYL FENTANYL) *

| 3-FLUORO-N-METHYLCATHINONE (3-FMC) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
|---|---|---|---|---|---|
| 4-FLUORO-N-METHYLCATHINONE (4-FMC) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| 4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4- | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |

MePPP)

| 4-METHYL-N-ETHYLCATHINONE (4-MEC) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
|---|---|---|---|---|---|
| ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| BUTYLONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| NAPHYRONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| PENTEDRONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| PENTYLONE | 03-04-16 | 03-01-17 | 82 FR 12171 | 3/1/2017 | I |
| DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCT | 03-23-17 | 82 FR 14815 | 3/23/2017 | II |  |

APPROVED FOR MARKETING BY U.S. FOOD AND DRUG ADMINISTRATION

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB–FUBINACA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) *

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-10-17 82 FR 17119 4/10/2017 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) *

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-10-17 82 FR 17119 4/10/2017 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) *

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-10-17 82 FR 17119 4/10/2017 I 3-CARBOXAMIDE (5F–APINACA; 5F–AKB48) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 05-03-17 82 FR 20544 5/3/2017 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL) *

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 06-07-17 82 FR 26349 6/7/2017 I PHENYLACETAMIDE)

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 07-14-17 82 FR 32453 7/14/2017 I PHENYLACRYLAMIDE) *

[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1- 10-16-17 82 FR 47971 10/16/2017 I YL)METHANONE (THJ-2201)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1- 10-16-17 82 FR 47971 10/16/2017 I (CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (AB- CHMINACA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H- 10-16-17 82 FR 47971 10/16/2017 I INDAZOLE-3-CARBOXAMIDE (AB-PINACA)

METHOXYACETYL FENTANYL (2-METHOXY-N-(1- 10-26-17 82 FR 49504 10/26/2017 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE) *

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-26-17 82 FR 49504 10/26/2017 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)) *

TETRAHYDROFURANYL FENTANYL (N-(1- 10-26-17 82 FR 49504 10/26/2017 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE) *

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 11-03-17 82 FR 51154 11/3/2017 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) *

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- 01-04-18 83 FR 469 1/4/2018 I YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE) *

MT-45 (1-CYCLOHEXYL-4-(1,2- 12-13-17 82 FR 58557 1/12/2018 I DIPHENYLETHYL)PIPERAZINE))

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-30-18 83 FR 4411 1/30/2018 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 02-01-18 83 FR 4580 2/1/2018 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) *

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 02-01-18 83 FR 4580 2/1/2018 I (VALERYL FENTANYL) *

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 02-01-18 83 FR 4580 2/1/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL) *

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) *

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL) *

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 02-01-18 83 FR 4580 2/1/2018 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) *

FENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21 02-06-18 83 FR 5188 2/6/2018 I CFR 1308.11(h)*

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-N- 04-20-18 83 FR 17486 4/20/2018 I METHYLBENZAMIDE (U-47700)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE 04-20-18 83 FR 17486 4/20/2018 I (BUTYRYL FENTANYL)

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-10-18 83 FR 31877 7/10/2018 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-10-18 83 FR 31877 7/10/2018 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) *

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-10-18 83 FR 31877 7/10/2018 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) *

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-10-18 83 FR 31877 7/10/2018 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) *

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 07-10-18 83 FR 31877 7/10/2018 I CARBOXYLATE (NM2201; CBL2201) *

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-31-18 83 FR 44474 8/31/2018 I ONE (N-ETHYLPENTYLONE; EPHYLONE) *

APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD 09-28-18 83 FR 48953 9/28/2018 V AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-29-18 83 FR 61320 11/29/2018 I PHENYLACRYLAMIDE)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2- 11-29-18 83 FR 61320 11/29/2018 I CARBOXAMIDE (FURANYL FENTANYL)

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-29-18 83 FR 61320 11/29/2018 I YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)

TETRAHYDROFURANYL FENTANYL (N-(1- 11-29-18 83 FR 61320 11/29/2018 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1- 01-29-19 84 FR 444 1/29/2019 I (CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE (MAB-CHMINACA)

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA) **

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 04-08-19 84 FR 13796 4/8/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA) **

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 04-08-19 84 FR 13796 4/8/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB–FUBINACA) **

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 04-08-19 84 FR 13796 4/8/2019 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48) **

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 04-16-19 84 FR 15505 4/16/2019 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) *

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-16-19 84 FR 15505 4/16/2019 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) *

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 04-16-19 84 FR 15505 4/16/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) *

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-16-19 84 FR 15505 4/16/2019 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) *

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-16-19 84 FR 15505 4/16/2019 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) *

| BETA-HYDROXYTHIOFENTANYL | 05-08-19 | 84 FR 20023 | 5/8/2019 | I |
|---|---|---|---|---|
| BREXANOLONE (3α-HYDROXY-5α-PREGNAN-20-ONE), | 06-17-19 | 84 FR 27938 | 6/17/2019 | IV |

ALLOPREGNANOLONE

SOLRIAMFETOL (2-AMINO-3-PHENYLPROPYL CAR- 06-17-19 84 FR 27943 6/17/2019 IV BAMATE; BENZENEPROPANOL,BETA-AMINO-, CARBAMATE (ESTER))

| 4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |
|---|---|---|---|---|
| 4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |

CHLORO-α-PVP) *

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-19 84 FR 34291 7/18/2019 I *

| ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |
|---|---|---|---|---|
| ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |
| N-ETHYLHEXEDRONE * | 07-18-19 | 84 FR 34291 | 7/18/2019 | I |
| CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4- | 10-25-19 | 84 FR 57323 | 10/25/2019 | I |

YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)

METHOXYACETYL FENTANYL (2-METHOXY-N-(1- 10-25-19 84 FR 57323 10/25/2019 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 10-25-19 84 FR 57323 10/25/2019 I YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2- 10-25-19 84 FR 57323 10/25/2019 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 10-30-19 84 FR 58045 11/3/2019 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE) **

6β-NALTREXOL ((5a,6β)-17-(CYCLOPROPYLMETHYL)-4,5- 01-24-20 85 FR 4215 1/24/2020 II → NC EPOXYMORPHINAN-3,6,14-TRIOL)

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- FUBINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB; 5F- MDMB-PINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 01-24-20 85 FR 4211 1/24/2020 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMB- CHMICA)

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4- 01-24-20 85 FR 4211 1/24/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADB- FUBINACA)

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE- 01-24-20 85 FR 4211 1/24/2020 I 3-CARBOXAMIDE (5F-APINACA; 5F-AKB48)

LASMIDITAN [2,4,6-TRIFLUORO-N-(6-(1-METHYLPIPERIDINE- 01-31-20 85 FR 5557 1/31/2020 V 4-CARBONYL)PYRIDINE-2-YL-BENZAMIDE]

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 01-30-20 85 FR 5321 2/1/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) **

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 01-30-20 85 FR 5321 2/1/2020 I (VALERYL FENTANYL) **

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL) **

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 01-30-20 85 FR 5321 2/1/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) **

CENOBAMATE [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2- 03-10-20 85 FR 13741 3/10/2020 V YL)ETHYL]CARBAMATE

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4- 03-30-20 85 FR 17494 3/30/2020 I FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3- METHYLBUTANOATE)

| LEMBOREXANT | 04-07-20 | 85 FR 19387 | 4/7/2020 | IV |  |
|---|---|---|---|---|---|
| NORFENTANYL (N-PHENYL-N-(PIPERIDIN-4- | 09-17-19 | 04-17-20 | 85 FR 21320 | 5/18/2020 | II |

YL)PROPIONAMIDE)

ETHYLONE (Prior control as a positional isomer of BUTYLONE: 06-08-20 85 FR 34607 6/8/2020 I See 85 FR 34967 03/07/2014)

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 07-13-20 85 FR 42296 7/10/2020 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA) **

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA) **

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 07-13-20 85 FR 42296 7/10/2020 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA) **

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 07-13-20 85 FR 42296 7/10/2020 I CARBOXYLATE (NM2201; CBL2201) **

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 08-20-20 85 FR 51342 8/20/2020 I ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE) *

APPROVED CANNABIDIOL DRUG PRODUCTS BY U.S. FOOD 08-21-20 85 FR 51639 8/21/2020 V → NC AND DRUG ADMINISTRATION DERIVED FROM CANNABIS AND NO MORE THAN 0.1 % (W/W) RESIDUAL

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 08-27-20 85 FR 52915 8/31/2020 I ONE (N-ETHYLPENTYLONE; EPHYLONE) **

CROTONYL FENTANYL ((E)-N-(1-PHENETHYLPIPERIDIN-4- 10-02-20 85 FR 62215 10/2/2020 I YL)-N-PHENYLBUT-2-ENAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

REMIMAZOLAM (4H-IMIDAZOL[1,2-A][1,4]BENZODIAZEPINE- 10-06-20 85 FR 63014 10/6/2020 IV 4-PROPIONIC ACID)

| OLICERIDINE | 10-30-20 | 85 FR 68749 | 10/30/2020 | II |
|---|---|---|---|---|
| N-(1-PHENETHYLPIPERIDIN-4-YL)-N- | 11-25-20 | 85 FR 75231 | 11/25/2020 | I |

PHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N- 11-25-20 85 FR 75231 11/25/2020 I PHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE 11-25-20 85 FR 75231 11/25/2020 I (VALERYL FENTANYL)

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYL FENTANYL)

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- 11-25-20 85 FR 75231 11/25/2020 I YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3- 03-01-21 86 FR 11862 3/1/2021 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE) *

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- 03-31-21 86 FR 16669 4/16/2021 I TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) **

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 03-31-21 86 FR 16669 4/16/2021 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) **

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA) **

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 03-31-21 86 FR 16669 4/16/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA) **

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 03-31-21 86 FR 16669 4/16/2021 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) **

| SAMIDORPHAN | 04-19-21 | 86 FR 20284 | 4/19/2021 | II → NC |
|---|---|---|---|---|
| 2'-FLUORO ORTHO-FLUOROFENTANYL (Prior control under | 04-27-21 | 86 FR 22113 | 4/27/2021 | I |

Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4'-METHYL ACETYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

BETA-METHYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

BETA'-PHENYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROBUTYRYL FENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL ACETYLFENTANYL (Prior control under 04-27-21 86 FR 22113 4/27/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYL METHOXYACETYL FENTANYL (Prior control 04-27-21 86 FR 22113 4/27/2021 I under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHYLFENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PHENYL FENTANYL (Prior control under Temporary Order for 04-27-21 86 FR 22113 4/27/2021 I Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

THIOFURANYL FENTANYL (Prior control under Temporary 04-27-21 86 FR 22113 4/27/2021 I Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

FENTANYL CARBAMATE (Prior control under Temporary Order 05-04-21 86 FR 23602 5/4/2021 I for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROACRYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROISOBUTYRYL FENTANYL (Prior control 05-04-21 86 FR 23602 5/4/2021 I under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO FURANYL FENTANYL (Prior control under 05-04-21 86 FR 23602 5/4/2021 I Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

| SERDEXMETHYLPHENIDATE | 05-07-21 | 86 FR 24487 | 5/7/2021 | IV |
|---|---|---|---|---|
| 1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- | 06-10-21 | 86 FR 30775 | 6/10/2021 | I |

INDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 06-10-21 86 FR 30775 6/10/2021 I PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYL- P7AICA)

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA; AMB-CHMICA)

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5- 06-10-21 86 FR 30775 6/10/2021 I FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-AB- PINACA)

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3- 06-10-21 86 FR 30775 6/10/2021 I CARBOXYLATE (NM2201; CBL2201)

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1- 06-14-21 86 FR 31427 6/14/2021 I ONE (N-ETHYLPENTYLONE; EPHYLONE)

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL 2-(1-(4-FLUOROBUTYL)-1H-INDAZOLE-3- 06-22-21 86 FR 32633 6/22/2021 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (4F-MDMB- BINACA) (Prior control as a positional isomer of 5F-AMB: See 86 FR 32633 04/10/2017)

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) 07-18-21 86 FR 37672 7/18/2021 I **

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- 07-18-21 86 FR 37672 7/18/2021 I CHLORO-α-PVP) **

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) 07-18-21 86 FR 37672 7/18/2021 I **

| ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) ** | 07-18-21 | 86 FR 37672 | 7/18/2021 | I |  |
|---|---|---|---|---|---|
| ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) ** | 07-18-21 | 86 FR 37672 | 7/18/2021 | I |  |
| N-ETHYLHEXEDRONE ** | 07-18-21 | 86 FR 37672 | 7/18/2021 | I |  |
| PARA-METHOXYMETHAMPHETAMINE (PMMA), 1-(4- | 05-15-20 | 06-25-21 | 86 FR 33508 | 7/26/2021 | I |

METHOXYPHENYL)-N-METHYLPROPAN-2-AMINE

4,4′-DIMETHYLAMINOREX (4,4′-DMAR; 4,5-DIHYDRO-4- 04-07-20 08-12-21 86 FR 44270 9/13/2021 I METHYL-5-(4-METHYLPHENYL)-2-OXAZOLAMINE)

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4 11-04-21 86 FR 60761 12/6/2021 I ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1- YL)ETHAN-1-AMINE)

| 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
|---|---|---|---|---|
| 5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
| 5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
| 5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO-01-14-22 | 01-14-22 | 87 FR 2376 | I |  |

MiPT)

| N,N-DIISOPROPYLTRYPTAMINE (DiPT) | 01-14-22 | 01-14-22 | 87 FR 2376 | I |
|---|---|---|---|---|
| (1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3- | 04-07-22 | 87 FR 20318 | 4/7/2022 | I |

TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144)

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1H- 04-07-22 87 FR 20318 4/7/2022 I INDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25)

| DARIDOREXANT (QUVIVIQ) | 04-07-22 | 87 FR 20313 | 4/7/2022 | IV |
|---|---|---|---|---|
| ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3- | 04-07-22 | 87 FR 20318 | 4/7/2022 | I |

CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMB- PINACA)

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3- 04-07-22 87 FR 20318 4/7/2022 I CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMB- PICA)

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE- 04-07-22 87 FR 20318 4/7/2022 I 3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA)

| 2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC) | 04-11-22 | 04-11-22 | 87 FR 21069 | I |
|---|---|---|---|---|
| 2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI) | 04-11-22 | 04-11-22 | 87 FR 21069 | I |
| 2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- | 04-12-22 | 87 FR 21556 | 4/12/2022 | I |

N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) *

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-12-22 87 FR 21556 4/12/2022 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE) *

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-12-22 87 FR 21556 4/12/2022 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE) *

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-12-22 87 FR 21556 4/12/2022 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) *

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE) *

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-12-22 87 FR 21556 4/12/2022 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE) *

| 4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |
|---|---|---|---|---|
| 4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4- | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |

CHLORO-α-PVP)

| 4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4-MEAP) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |
|---|---|---|---|---|
| ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |
| ALPHA-PYRROLIDINOHEXANOPHENONE (α-PHP) | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |
| GANAXOLONE (3α-HYDROXY-3β-METHYL-5α-PREGNAN-20- | 06-01-22 | 87 FR 32991 | 6/1/2022 | V |

ONE)

| N-ETHYLHEXEDRONE | 06-01-22 | 87 FR 32996 | 6/1/2022 | I |  |
|---|---|---|---|---|---|
| METHOXETAMINE | 12-07-21 | 06-07-22 | 87 FR 34166 | 7/6/2022 | I |
| 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT) | 01-14-22 | 07-27-22 | 87 FR 45076 | I Withdrew |  |

2022 proposed rule

5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT) 01-14-22 07-27-22 87 FR 45076 I Withdrew 2022 proposed rule

5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET) 01-14-22 07-27-22 87 FR 45076 I Withdrew 2022 proposed rule

| 5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO-01-14-22 | 07-27-22 | 87 FR 45076 | I Withdrew |
|---|---|---|---|
| MiPT) | 2022 |  |  |

proposed rule

N,N-DIISOPROPYLTRYPTAMINE (DiPT) 01-14-22 07-27-22 87 FR 45076 I Withdrew 2022 proposed rule

2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC) 04-11-22 08-29-22 87 FR 52712 I Withdrew 2022 proposed rule

2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI) 04-11-22 08-29-22 87 FR 52712 I Withdrew 2022 proposed rule

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

AMINEPTINE (7-[(10,11-DIHYDRO-5H- 07-22-22 11-17-22 87 FR 68895 12/19/2022 I DIBENZO[A,D]CYCLOHEPTEN-5-YL)AMINO]HEPTANOIC ACID)

| [18F]FP-CIT | 11-04-21 | 11-21-22 | 87 FR 70715 | 12/21/2022 II → NC |  |
|---|---|---|---|---|---|
| ZIPEPROL (1-METHOXY-3-[4-(2-METHOXY-2- | 05-14-20 | 11-21-22 | 87 FR 70717 | 12/21/2022 | I |

PHENYLETHYL)PIPERAZIN-1-YL]-1-PHENYLPROPAN-2-OL)

MESOCARB (N-PHENYL-N'-(3-(1-PHENYLPROPAN-2-YL)- 08-11-21 11-22-22 87 FR 71247 12/22/2022 I 1,2,3-OXADIAZOL-3-IUM-5-YL)CARBAMIMIDATE)

| FENFLURAMINE | 07-19-22 | 12-23-22 | 87 FR 78857 | 12/23/2022 IV → NC |  |
|---|---|---|---|---|---|
| METHIOPROPAMINE (N-METHYL-1-(THIOPHEN-2- | 09-02-21 | 12-09-22 | 87 FR 75470 | 1/9/2023 | I |

YL)PROPANE-2-AMINE)

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3- 03-06-23 88 FR 13692 4/5/2023 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE)

EUTYLONE (1-(1,3-BENZODIOXOL-5-YL)-2- 04-10-23 88 FR 21101 4/10/2023 I (ETHYLAMINO)BUTAN-1-ONE) (Prior control as a positional isomer of PENTYLONE: See 88 FR 21101 03/07/2014)

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-26-23 88 FR 48112 7/26/2023 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) *

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) *

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-26-23 88 FR 48112 7/26/2023 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) *

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) *

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-26-23 88 FR 48112 7/26/2023 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) *

ANABOLIC STEROIDS (amended regulations consistent with 08-01-23 88 FR 50036 8/1/2023 III DASCA; updated and moved specific listing to 21 CFR 1308.13(f))

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1H- 08-18-23 88 FR 56466 9/18/2023 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE)

| ZURANOLONE | 10-31-23 | 88 FR 74347 | 10/31/2023 | IV |
|---|---|---|---|---|
| 2',5'-DIMETHOXYFENTANYL (N-(1-(2,5- | 12-07-23 | 88 FR 85104 | 12/7/2023 | I |

DIMETHOXYPHENETHYL)PIPERIDINE-4-YL)-N- PHENYLPROPIONAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

3-FURANYL FENTANYL (N-(1-PHENTHYLPIPERIDIN-4-YL)-N- 12-07-23 88 FR 85104 12/7/2023 I PHENYLFURAN-3-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ALPHA'-METHYL BUTYRYL FENTANYL (2-METHYL-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ISOVALERY FENTANYL (3-METHYL-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

META-FLUOROFENTANYL (N-(3-FLUORPHENYL)-N-(1- 12-07-23 88 FR 85104 12/7/2023 I PHENETHYLPIPERIDIN-4-YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROISOBUTYRYL FENTANYL (N-(3- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)ISOBUTYRAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-FLUOROFURANYL FENTANYL (N-(2- 12-07-23 88 FR 85104 12/7/2023 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)FURAN- 2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHOXYFURANYL FENTANYL (N-(4- 12-07-23 88 FR 85104 12/7/2023 I METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)FURAN-2-CARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-METHYLCYCLOPROPYL FENTANYL (N-(4- 12-07-23 88 FR 85104 12/7/2023 I METHYLPHENYL)-N-(1-PHENYLPIPERIDIN-4- YL)CYCLOPROPANECARBOXAMIDE) (Prior control under Temporary Order for Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-12-23 88 FR 86040 12/12/2023 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-12-23 88 FR 86040 12/12/2023 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-12-23 88 FR 86040 12/12/2023 I 1-ONE (CUMYL-PEGACLONE, SGT-151) *

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-12-23 88 FR 86040 12/12/2023 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) *

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 12-12-23 88 FR 86040 12/12/2023 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) *

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-12-23 88 FR 86040 12/12/2023 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) *

3-MMC (2-(METHYLAMINO)-1-(3-METHYLPHENYL)PROPAN-1- 12-13-23 88 FR 86266 12/13/2023 I ONE) (Prior control as a positional isomer of MEPHEDRONE: See 88 FR 86266 07/09/2012)

ADB-BUTINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2- 12-13-23 88 FR 86266 12/13/2023 I YL)-1-BUTYL-1H-INDAZOLE-3-CARBOXAMIDE) (Prior control as a positional isomer of AB-PINACA: See 88 FR 86266 01/30/2015)

ALPHA-PIHP (4-METHYL-1-PHENYL-2-(PYRROLIDIN-1- 12-13-23 88 FR 86266 12/13/2023 I YL)PENTAN-1-ONE) (Prior control as a positional isomer of A- PHP: See 88 FR 86266 07/18/2019)

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,N- 04-11-24 89 FR 25514 4/11/2024 I DIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 04-11-24 89 FR 25514 4/11/2024 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ETONITAZENE)

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 04-11-24 89 FR 25514 4/11/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE)

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 04-11-24 89 FR 25517 4/12/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) **

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 04-11-24 89 FR 25517 4/12/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) **

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 04-11-24 89 FR 25517 4/12/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE) **

2-METHYL AP-237 (1-(2-METHYL-4-(3-PHENYLPROP-2-EN-1- 03-15-24 89 FR 18793 4/15/2024 I YL)PIPERAZIN-1-YL)BUTAN-1-ONE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1- 07-29-24 89 FR 60817 7/29/2024 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE) *

N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- 07-29-24 89 FR 60817 7/29/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE) *

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-25-24 89 FR 85047 10/25/2024 I N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE)

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1H- 10-25-24 89 FR 85047 10/25/2024 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE)

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL- 10-25-24 89 FR 85047 10/25/2024 I 1-YL)ETHAN-1-AMINE (METODESNITAZENE)

ETHYLPHENIDATE (ETHYL 2-PHENYL-2-(PIPERIDIN-2- 09-22-23 10-22-24 89 FR 84281 11/21/2024 I YL)ACETATE)

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 12-30-24 89 FR 106311 12/31/2024 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 12-30-24 89 FR 106311 12/31/2024 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2-CARBOXAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 12-30-24 89 FR 106311 12/31/2024 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 12-30-24 89 FR 106311 12/31/2024 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 12-30-24 89 FR 106311 12/31/2024 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) ** (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2- 07-25-25 90 FR 35236 7/26/2025 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) **

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM) **

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO- 07-25-25 90 FR 35236 7/26/2025 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) **

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM) **

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 90 FR 35236 7/26/2025 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM) **

1-(1,3-BENZODIOXOL-5-YL)-2-(DIMETHYLAMINO)PENTAN-1- 08-08-25 90 FR 38396 8/8/2025 I ONE (N,N-DIMETHYLPENTYLONE; DIPENTYLONE) (Prior control as a positional isomer of N-ETHYLPENTYLONE: See 90 FR 38396 08/31/2018)

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE) *

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 08-15-25 90 FR 39314 8/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE) *

BETA-METHYLACETYL FENTANYL (N-PHENYL-N-(1-(2- 09-18-25 90 FR 44979 9/18/2025 I PHENYLPROPYL)PIPERIDIN-4-YL)ACETAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

META-FLUOROFURANYL FENTANYL (N-3-FLUOROPHENYL)- 09-18-25 90 FR 44979 9/18/2025 I N-(1-PHENETHYLPIPIERIDIN-4-YL)FURAN-2- CARBOXAMIDE (Prior control under Temporary Order Fentanyl- Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-CHLOROFENTANYL (N-(2-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

ORTHO-METHYLCYCLOPROPYLFENTANYL (N-2- 09-18-25 90 FR 44979 9/18/2025 I METHYLPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)CYLCOPROPANECARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-CHLOROFENTANYL (N-4-CHLOROPHENYL)-N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)PROPIONAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

PARA-FLUORO VALERYL FENTANYL (N-(4- 09-18-25 90 FR 44979 9/18/2025 I FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4- YL)PENTANAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

TETRAHYDROTHIOFURANYL FENTANYL (N-(1- 09-18-25 90 FR 44979 9/18/2025 I PHENETHYLPIPERIDIN-4-YL)-N- PHENYLTETRAHYDROTHIOPHENE-2-CARBOXAMIDE) (Prior control under Temporary Order Fentanyl-Related Substances: See 83 FR 5188 02/06/2018)

2-(2-((2,3-DIHYDROBENZOFURAN-5-YL)METHYL)-5-NITRO- 10-15-25 90 FR 48259 10/15/2025 I 1H-BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (ETHYLENEOXYNITAZENE) *

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

2-(2-(4-ETHOXYBENZYL)-5-METHYL-1H-BENZIMIDAZOL-1- 10-15-25 90 FR 48259 10/15/2025 I YL)-N,N-DIETHYLETHAN-1-AMINE (5-METHYL ETODESNITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N,N-DIMETHYLETHAN-1-AMINE (N,N-DIMETHYLAMINO ETONITAZENE) *

2-(2-(4-ETHOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)- 10-15-25 90 FR 48259 10/15/2025 I N-ETHYLETHAN-1-AMINE (N-DESETHYL ETONITAZENE) *

2-(2-(BENZODIOXOL-5-YLMETHYL)-5-NITRO-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)-N,N-DIETHYLETHAN-1-AMINE (METHYLENEDIOXYNITAZENE; 3′,4′- METHYLENEDIOXYNITAZENE) *

2-(4-ISOPROPOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 10-15-25 90 FR 48259 10/15/2025 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO ISOTONITAZENE) *

N-ETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1H- 10-15-25 90 FR 48259 10/15/2025 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL PROTONITAZENE) *

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL- 12-11-25 90 FR 57542 12/12/2025 I 1-ONE (CUMYL-PEGACLONE, SGT-151) **

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 12-11-25 90 FR 57356 12/12/2025 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) **

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-16-25 90 FR 58149 12/12/2025 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) **

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN- 12-16-25 90 FR 58149 12/12/2025 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE) **

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE- 12-16-25 90 FR 58149 12/12/2025 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE) **

4-CHLOROMETHCATHINONE (4-CMC, 1-(4- 11-17-25 90 FR 51102 12/17/2025 I CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1- 12-23-25 90 FR 59969 1/22/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PIPERIDINYL ETONITAZENE; ETONITAZEPIPNE)

N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1H- 12-23-25 90 FR 59969 1/22/2026 I BENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL ISOTONITAZENE)

2-(4-METHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO METONITAZENE; METONITAZEPYNE)

5-NITRO-2-(4-PROPOXYBENZYL)-1-(2-(PYRROLIDIN-1- 01-12-26 91 FR 1089 2/11/2026 I YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINO PROTONITAZENE; PROTONITAZEPYNE)

4-FLUOROAMPHETAMINE (4–FA, 1-(4- 06-03-25 01-15-26 91 FR 1692 2/17/2026 I FLUOROPHENYL)PROPAN-2-AMINE, PARA- FLUOROAMPHETAMINE)

(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (AM–1220)

(1-(5-FLUOROPENTYL)-1H-INDOL-3-YL)(4- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLNAPHTHALEN-1-YL)METHANONE (MAM–2201)

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

(1-HEXYL-5-PHENYL-1H-PYRROL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–147)

(2-IODOPHENYL)(1-((1-METHYLPIPERIDIN-2-YL)METHYL)-1H-04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (AM–2233)

(2-METHYL-1-PENTYL-1H-INDOL-3-YL)(NAPHTHALEN-1- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–007)

(4-ETHYLNAPHTHALEN-1-YL)(1-(5-FLUOROPENTYL)-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (EAM–2201)

(4-ETHYLNAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–210)

(4-FLUORONAPHTHALEN-1-YL)(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–412)

(4-METHOXYNAPHTHALEN-1-YL)(2-METHYL-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOL-3-YL)METHANONE (JWH–098)

(4-METHYLNAPHTHALEN-1-YL)(1-(2-MORPHOLINOETHYL)- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1H-INDOL-3-YL)METHANONE (JWH–193)

(5-(2-FLUOROPHENYL)-1-PENTYL-1H-PYRROL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)(NAPHTHALEN-1-YL)METHANONE (JWH–307)

(5-METHYL-3-(MORPHOLINOMETHYL)-2,3-DIHYDRO- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I [1,4]OXAZINO[2,3,4-HI]INDOL-6-YL)(NAPHTHALEN-1- YL)METHANONE (WIN 55,212– 2)

1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE (AM2201) 04-13-23 01-20-26 91 FR 2297 2/19/2026 I (Prior control under SDAPA: See 78 FR 664 01/04/2013)

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLDECAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C9 HOMOLOG)

2-(3-HYDROXYCYCLOHEXYL)-5-(2-METHYLHEPTAN-2- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)PHENOL (CP–47,497 C6 HOMOLOG)

2-(3-METHOXYPHENYL)-1-(1-PENTYL-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)ETHAN-1-ONE (JWH–302)

2-(5-HYDROXY-2-(3-HYDROXYPROPYL)CYCLOHEXYL)-5-(2-04-13-23 01-20-26 91 FR 2297 2/19/2026 I METHYLOCTAN-2-YL)PHENOL (CP–55,940)

3-((4-METHYLNAPHTHALEN-1-YL)METHYL)-1-PENTYL-1H- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I INDOLE (JWH–184)

CANNABIMIMETIC AGENTS (as defined in 21 CFR § 04-13-23 01-20-26 91 FR 2297 2/19/2026 I 1308.11(g))

CP-47,497 C8 HOMOLOGUE (Consolidated under 04-13-23 01-20-26 91 FR 2297 2/19/2026 I "CANNABIMIMETIC AGENTS" as defined in 21 CFR § 1308.11(g))

CP-47,497 (Consolidated under "CANNABIMIMETIC AGENTS" 04-13-23 01-20-26 91 FR 2297 2/19/2026 I as defined in 21 CFR § 1308.11(g))

| JWH–018 (Reclassified under 21 CFR § 1308.11(d)) | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |
|---|---|---|---|---|---|
| JWH–073 (Consolidated under "CANNABIMIMETIC AGENTS" | 04-13-23 | 01-20-26 | 91 FR 2297 | 2/19/2026 | I |

as defined in 21 CFR § 1308.11(g))

JWH–200 (Consolidated under "CANNABIMIMETIC AGENTS" 04-13-23 01-20-26 91 FR 2297 2/19/2026 I as defined in 21 CFR § 1308.11(g))

NAPHTHALEN-1-YL(1-(PENT-4-EN-1-YL)-1H-INDOL-3- 04-13-23 01-20-26 91 FR 2297 2/19/2026 I YL)METHANONE (JWH–022)

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

8-BROMO-1-METHYL-6-PHENYL-4H- 03-16-26 91 FR 12504 3/16/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (BROMAZOLAM) *

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2-07-25-25 03-02-26 91 FR 9985 4/1/2026 I F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM)

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (CLONAZOLAM)

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO-07-25-25 03-02-26 91 FR 9985 4/1/2026 I 2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM)

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE (FLUBROMAZOLAM)

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H- 07-25-25 03-02-26 91 FR 9985 4/1/2026 I BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (FLUALPRAZOLAM)

3-METHOXYPHENCYCLIDINE (1-(1-(3- 03-23-26 91 FR 13733 4/22/2026 I METHOXYPHENYL)CYCLOHEXYL)PIPERIDINE; 3-MEO–PCP)

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4- 10-02-25 04-24-26 91 FR 21958 4/27/2026 I EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE)

MARIJUANA EXTRACT, AS DEFINED IN 21 CFR 04-28-26 91 FR 22714 4/28/2026 III 1308.11(D)(58), IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

MARIJUANA, AS DEFINED IN 21 U.S.C. 802(16), IN A U.S. 04-28-26 91 FR 22714 4/28/2026 III FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

NATURALLY DERIVED DELTA-9- 04-28-26 91 FR 22714 4/28/2026 III TETRAHYDROCANNABINOLS IN A U.S. FOOD AND DRUG ADMINISTRATION APPROVED PRODUCT OR IN MARIJUANA SUBJECT TO A STATE MEDICAL MARIJUANA LICENSE

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE-12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3- 12-10-25 05-01-26 91 FR 23359 5/1/2026 I CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE)

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-12-10-25 05-01-26 91 FR 23359 5/1/2026 I 2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE)

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE-12-10-25 05-01-26 91 FR 23359 5/1/2026 I 3-CARBOXAMIDO)-3-METHYL BUTANOATE)

6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,9,10,10A-HEXAHYDRO- 05-04-26 91 FR 23913 5/4/2026 I 6H-BENZO[C]CHROMEN-1-OL (HEXAHYDROCANNABINOL, HHC)

5-PENTYL-2-(2-PHENYLPROPAN-2-YL)PYRIDO[4,3-B]INDOL-12-11-25 05-13-26 91 FR 26913 5/13/2026 I 1-ONE (CUMYL-PEGACLONE, SGT-151)

2-FLUORODESCHLOROKETAMINE (2-(2-FLUOROPHENYL)-2- 05-22-26 91 FR 30204 5/22/2026 I (METHYLAMINO)CYCLOHEXAN-1-ONE; 2-FDCK) *

O-DESMETHYLTRAMADOL (O-DSMT; DESMETRAMADOL; 3- 08-12-26 91 FR 52013 8/12/2026 I [(1R,2R)-2-[(DIMETHYLAMINO)METHYL]-1- HYDROXYCYCLOHEXYL]PHENOL) *

Scheduling Actions - Chronological Order

*Scheduled under 21 USC 811(h) FINAL ORDER **Extension of temporary control NC = Not Controlled PROPOSAL FEDERAL PUBLICATION PUBLICATION REGISTER EFFECTIVE CSA SUBSTANCE DATE DATE CITATION DATE SCHEDULE

METHYL (E)-2-((1′S,6′S,7′S)-6′-ETHYL-4-METHOXY-3-OXO- 08-26-26 91 FR 54948 8/26/2026 I 3′,5′,6′,7′,8′,8A′-HEXAHYDRO-2′H-SPIRO[INDOLINE-2,1′- INDOLIZINE]-7′-YL)-3-METHOXYACRYLATE (MITRAGYNINE PSEUDOINDOXYL) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-7A- 08-26-26 91 FR 54948 8/26/2026 I HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–15, DIHYDRO-7- HYDROXYMITRAGYNINE) *

METHYL (E)-2-((2S,3S,7AS,12AR,12BS)-3-ETHYL-9-FLUORO- 08-26-26 91 FR 54948 8/26/2026 I 7A-HYDROXY-8-METHOXY-1,2,3,4,6,7,7A,12,12A,12B- DECAHYDROINDOLO[2,3-A]QUINOLIZIN-2-YL)-3- METHOXYACRYLATE (MGM–16) *

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-5,6- 08-27-26 91 FR 55252 8/27/2026 I DICHLORO-1,3-DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6- DICHLORO BRORPHINE, SR–14968) *

3-(3-(1-(1-(4-CHLOROPHENYL)ETHYL)PIPERIDIN-4-YL)-2- 08-27-26 91 FR 55252 8/27/2026 I OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-1- YL)PROPANENITRILE (N-PROPIONITRILE CHLORPHINE, CYCHLORPHINE) *

5,6-DICHLORO-1-(1-(4-CHLOROBENZYL)PIPERIDIN-4-YL)-1,3- 08-27-26 91 FR 55252 8/27/2026 I DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (5,6-DICHLORO DESMETHYLCHLORPHINE,SR–17018) *

8-(1-(4-CHLOROPHENYL)ETHYL)-1-PHENYL-1,3,8- 08-27-26 91 FR 55252 8/27/2026 I TRIAZASPIRO[4.5]DECAN-4-ONE (SPIROCHLORPHINE, R–6890) *

| CIPEPOFOL | 08-27-26 | 91 FR 55259 | 8/27/2026 | IV |  |
|---|---|---|---|---|---|
| DIPHENIDINE (1-(1,2-DIPHENYLETHYL)PIPERIDINE) | 05-26-26 | 09-21-26 | 91 FR 59695 | 10/21/2026 | I |
| CENTANAFADINE | 10-30-26 | 91 FR 68470 | 10/30/2026 | III |  |
| 3-CHLOROMETHCATHINONE (3-CMC; 1-(3- | 11-06-26 | 91 FR 70009 | 11/6/2026 | I |  |

CHLOROPHENYL)-2-(METHYLAMINO)PROPAN-1-ONE)

OVEPOREXTON 11-12-26 91 FR 72775 11/12/2026 IV

Scheduling Actions - Chronological Order

## Alphabetical OrderControlled Substances

## Controlled Substances

### CSA

SUBSTANCE CSCN SCH NARC OTHER NAMES

(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3- 7000 I N yl)(naphthalen-1-yl)methanone (AM–1220)

(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB-144 tetramethylcyclopropyl)methanone

(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen- 7000 I N 1-yl)methanone (MAM–2201)

(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–147)

(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H- 7000 I N indol-3-yl)methanone (AM–2233)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–007)

(4-Ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H-indol-3- 7000 I N yl)methanone (EAM–2201)

(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–210)

(4-Fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–412)

(4-Methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol- 7000 I N 3-yl)methanone (JWH–098)

(4-Methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H- 7000 I N indol-3-yl)methanone (JWH–193)

(5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen- 7000 I N 1-yl)methanone (JWH–307)

(5-Methyl-3-(morpholinomethyl)-2,3-dihydro- 7000 I N [1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1- yl)methanone (WIN 55,212–2)

| [3,2-c]-Furazan-5α-androstan-17β-ol | 4000 | III | N |  |
|---|---|---|---|---|
| [3,2-c]Pyrazole-androst-4-en-17β-ol | 4000 | III | N |  |
| 1-(1-(1-(4-Bromophenyl)ethyl)piperidin-4-yl)-5,6- | 9097 | I | Y | 5,6-Dichloro brorphine; SR–14968 |

dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one

| 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one 7552 | I | N | Dipentylone; N,N-dimethylpentylone |  |
|---|---|---|---|---|
| 1-(1-Phenylcyclohexyl)pyrrolidine | 7458 | I | N | PCPy; PHP; rolicyclidine |
| 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine | 9663 | I | Y | PEPAP; synthetic heroin |
| 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole- | 7083 | I | N | 5F-CUMYL-PINACA; SGT-25 |

3-carboxamide

| 1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I | N | TCP; tenocyclidine |
|---|---|---|---|---|
| 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine | 7473 | I | N | TCPy |
| 13β-Ethyl-17β-hydroxygon-4-en-3-one | 4000 | III | N |  |
| 17α-Methyl-3α,17β-dihydroxy-5α-androstane | 4000 | III | N |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| 17α-Methyl-3β,17β-dihydroxy-5α-androstane | 4000 | III | N |
|---|---|---|---|
| 17α-Methyl-3β,17β-dihydroxyandrost-4-ene | 4000 | III | N |
| 17α-Methyl-4-hydroxynandrolone (17α-methyl-4- | 4000 | III | N |

hydroxy-17β-hydroxyestr-4-en-3-one)

| 17α-Methyl-5α-androstan-17β-ol | 4000 | III | N |  |
|---|---|---|---|---|
| 17α-Methyl-androst-2-ene-3,17β-diol | 4000 | III | N |  |
| 17α-Methyl-androsta-1,4-diene-3,17β-diol | 4000 | III | N |  |
| 17α-Methyl-androstan-3-hydroxyimine-17β-ol | 4000 | III | N |  |
| 17α-Methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α- | 4000 | III | N | 17α-Methyl-1-testosterone |

methyl-5α-androst-1-en-3-one)

| 17β-Hydroxy-androstano[2,3-d]isoxazole | 4000 | III | N |
|---|---|---|---|
| 17β-Hydroxy-androstano[3,2-c]isoxazole | 4000 | III | N |
| 18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one | 4000 | III | N |
| 19-Nor-4,9(10)-androstadienedione (estra-4,9(10)- | 4000 | III | N |

diene-3,17-dione)

| 19-Nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene) | 4000 | III | N |  |
|---|---|---|---|---|
| 19-Nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene) | 4000 | III | N |  |
| 19-Nor-4-androstenedione (estr-4-en-3,17-dione) | 4000 | III | N |  |
| 19-Nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) | 4000 | III | N |  |
| 19-Nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene) | 4000 | III | N |  |
| 19-Nor-5-androstenedione (estr-5-en-3,17-dione) | 4000 | III | N |  |
| 1-Androstenediol (3α,17β-dihydroxy-5α-androst-1-ene) | 4000 | III | N |  |
| 1-Androstenediol (3β,17β-dihydroxy-5α-androst-1-ene) | 4000 | III | N |  |
| 1-Androstenedione (5α-androst-1-en-3,17-dione) | 4000 | III | N |  |
| 1-Methyl-4-phenyl-4-propionoxypiperidine | 9661 | I | Y | MPPP; synthetic heroin |
| 1-Phenylcyclohexylamine | 7460 | II | N | PCP precursor |
| 1-Piperidinocyclohexanecarbonitrile | 8603 | II | N | PCC; PCP precursor |
| 2-(2-((2,3-Dihydrobenzofuran-5-yl)methyl)-5-nitro-1H- | 9770 | I | Y | Ethyleneoxynitazene |

benzimidazol-1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)- 9767 I Y 5-Methyl etodesnitazene N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)- 9771 I Y N,N-Dimethylamino etonitazene N,N-dimethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N- 9768 I Y N-Desethyl etonitazene ethylethan-1-amine

| 2-(2-(Benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol- | 9766 | I | Y | Methylenedioxynitazene; 3′,4′- |
|---|---|---|---|---|
| 1-yl)-N,N-diethylethan-1-amine | Methylenedioxynitazene |  |  |  |
| 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C- | 7524 | I | N | 2C-P |

P)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) 7509 I N 2C-E

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

| 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) | 7508 | I | N | 2C-D |
|---|---|---|---|---|
| 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) | 7521 | I | N | 2C-N |
| 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) | 7517 | I | N | 2C-H |
| 2-(3-Hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol | 7000 | I | N |  |

(CP–47,497 C9 homolog)

2-(3-Hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol 7000 I N (CP–47,497 C6 homolog)

2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1- 7000 I N one (JWH–302)

2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I N 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 ethanamine (25B-NBOMe)

| 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) | 7519 | I | N | 2C-C |
|---|---|---|---|---|
| 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) | 7537 | I | N | 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82 |

ethanamine (25C-NBOMe)

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T- 7385 I N 2C-T-2 2)

| 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) | 7518 | I | N | 2C-I |
|---|---|---|---|---|
| 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) | 7538 | I | N | 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5 |

ethanamine (25I-NBOMe)

2-(4-Isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1- 9772 I Y N-Pyrrolidino isotonitazene yl)ethyl)-1H-benzimidazole

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine 7532 I N 2C-T-4 (2C-T-4) (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2-(4-Methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)- 9762 I Y Metonitazepyne 1H-benzimidazole (N-pyrrolidino metonitazene)

2-(5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2- 7000 I N methyloctan-2-yl)phenol (CP–55,940)

2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 7286 I N MXE; methoxetamine (methoxetamine)

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) 7348 I N 2C-T-7

(Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET

(Positional Isomer: 1-(2,5-dimethoxy-4- methylphenyl)butan-2-amine)

| 2,5-Dimethoxyamphetamine | 7396 | I | N | DMA; 2,5-DMA |
|---|---|---|---|---|
| 2',5'-Dimethoxyfentanyl (N-(1-(2,5- | 9861 | I | Y |  |

dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

2'-Fluoro ortho-fluorofentanyl (N-(1-(2- 9855 I Y fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl)

2-Fluorodeschloroketamine 7284 I N 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1- one; 2-FDCK

2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I Y Methoxyacetyl fentanyl phenylacetamide

2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1- 9664 I Y yl)piperazin-1-yl)butan-1-one)

| 2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one | 4000 | III | N |
|---|---|---|---|
| 2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol | 4000 | III | N |
| 3-((4-Methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole | 7000 | I | N |

(JWH–184)

3-(3-(1-(1-(4-Chlorophenyl)ethyl)piperidin-4-yl)-2-oxo- 9094 I Y N-Propionitrile chlorphine; cychlorphine 2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile

3,4,5-Trimethoxyamphetamine 7390 I N TMA

(Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA-5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline)

3,4-Methylenedioxyamphetamine 7400 I N MDA; Love Drug

(Positional Isomer: 2,3-methylenedioxyamphetamine (2,3-MDA))

3,4-Methylenedioxymethamphetamine 7405 I N MDMA; Ecstasy; XTC

(Positional Isomer: 3,4-methylenedioxyphenyl-2- butanamine (BDB))

3,4-Methylenedioxy-N-ethylamphetamine 7404 I N N-Ethyl MDA; MDE; MDEA

(Positional Isomer: MBDB)

3-Chloromethcathinone 1241 I N 3-CMC; 1-(3-chlorophenyl)-2-(methylamino)propan-1- one

3-Fluoro-N-methylcathinone (3-FMC) 1233 I N 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one

(Positional Isomer: 2-FMC)

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9860 I Y phenylfuran-3-carboxamide)

3-Methoxyphencyclidine 7457 I N 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine; 3- MeO–PCP

| 3-Methylfentanyl | 9813 | I | Y | China White; fentanyl |
|---|---|---|---|---|
| 3-Methylmethcathinone (2-(methylamino)-1-(3- | 1259 | I | N | 3-MMC; 3-methylmethcathinone |

methylphenyl)propan-1-one)

| 3-Methylthiofentanyl | 9833 | I | Y | China White; fentanyl |
|---|---|---|---|---|
| 3α,17β-Dihydroxy-5α-androstane | 4000 | III | N |  |
| 3β,17β-Dihydroxy-5α-androstane | 4000 | III | N |  |
| 3β-Hydroxy-estra-4,9,11-trien-17-one | 4000 | III | N |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- 1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

4´-Methyl-alpha-pyrrolidinohexiophenone (MPHP) 7446 I N MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1- (4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one

(Positional Isomer: 2-methyl-α-pyrrolidinoisohexanophenone (2-Me-α-PiHP))

| 4-Androstenediol (3β,17β-dihydroxy-androst-4-ene) | 4000 | III | N | 4-AD |
|---|---|---|---|---|
| 4-Androstenedione (androst-4-en-3,17-dione) | 4000 | III | N |  |
| 4-Anilino-N-phenethyl-4-piperidine (ANPP) | 8333 | II | N | ANPP; despropionyl fentanyl |
| 4-Bromo-2,5-dimethoxyamphetamine | 7391 | I | N | DOB; 4-bromo-DMA |
| 4-Bromo-2,5-dimethoxyphenethylamine | 7392 | I | N | 2C-B; Nexus; has been sold as Ecstasy, i.e. MDMA |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one | 4000 | III | N |  |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11- | 4000 | III | N |  |

dione

| 4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol | 4000 | III | N |  |
|---|---|---|---|---|
| 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol | 4000 | III | N |  |
| 4'-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α- | 7443 | I | N | 4-Chloro-α-PVP; 4'-chloro-α- |
| PVP) | pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2- |  |  |  |

(pyrrolidin-1-yl)pentan-1-one

4-Chloromethcathinone 1239 I N 4-CMC; 1-(4-chlorophenyl)-2-(methylamino)propan-1- one

| 4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2- | 7089 | I | N | 4-Cyano-CUMYL-BUTINACA; 4-CN-CUMYL |
|---|---|---|---|---|
| phenylpropan-2-yl)-1 H-indazole-3-carboxamide) | BINACA; CUMYL-4CN-BINACA; SGT-78 |  |  |  |
| 4-Dihydrotestosterone (17β-hydroxy-androstan-3-one) | 4000 | III | N | Anabolex; Andractim; Pesomax; Stanolone |
| 4-Fluoroamphetamine (4–FA, 1-(4-fluorophenyl)propan- | 1476 | I | N | 4–FA; 1-(4-fluorophenyl)propan-2-amine; para- |
| 2-amine, para-fluoroamphetamine) | fluoroamphetamine |  |  |  |
| 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- | 9824 | I | Y | para-Fluoroisobutyryl fentanyl |

phenethylpiperidin-4-yl)isobutyramide)

4-Fluoro-N-methylcathinone (4-FMC) 1238 I N Flephedrone; 1-(4-fluorophenyl)-2- (methylamino)propan-1-one

(Positional Isomer: 2-FMC)

4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- 7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate)

4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- 7091 I N 4F-MDMB-BUTICA; 4F-MDMB-BICA carbonyl]amino]-3,3-dimethyl-butanoate)

4-Hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4- 4000 III N en-3-one)

4-Hydroxy-androst-4-ene-3,17-dione 4000 III N Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- c]pyrazole-5α-androstan-17β-ol

4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- 4000 III N one)

4-Methoxyamphetamine 7411 I N PMA

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

4'-Methyl acetyl fentanyl (N-(1-(4- 9819 I Y methylphenethyl)piperidin-4-yl)-N-phenylacetamide)

4-Methyl-2,5-dimethoxyamphetamine 7395 I N DOM; STP

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

4-Methyl-alpha-ethylaminopentiophenone (4-MEAP) 7245 I N 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1- one

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) 7498 I N MePPP; 4-methyl-α-pyrrolidinopropiophenone; 1-(4- methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one

| 4-Methylaminorex (cis isomer) | 1590 | I | N | U4Euh; McN-422 |
|---|---|---|---|---|
| 4-Methyl-N-ethylcathinone (4-MEC) | 1249 | I | N | 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one |

(Positional Isomers: 3-methylethcathinone (3-MEC), 4-ethylmethcathinone (4-EMC), 4-methylbuphedrone (4-MeMABP;4-MeBP), 3,4- dimethylmethcathinone(3,4-DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

5,6-Dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3- 9096 I Y 5,6-Dichloro desmethylchlorphine; SR–17018 dihydro-2H-benzo[d]imidazol-2-one

| 5-Androstenediol (3β,17β-dihydroxy-androst-5-ene) | 4000 | III | N |
|---|---|---|---|
| 5-Androstenedione (androst-5-en-3,17-dione) | 4000 | III | N |
| 5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- | 7025 | I | N |

1-(5-fluoropentyl)-1 H-indazole-3-carboxamide)

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5- 7034 I N 5F-ADB; 5F-MDMB-PINACA fluoropentyl)-1H-indazole-3-carboxamido)-3,3-

| dimethylbutanoate) | (Positional isomers: 5F-AEB; 5F-EMB-PINACA) |  |  |  |
|---|---|---|---|---|
| 5F–AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- | 7033 | I | N | 5F-AMB |

carboxamido)-3-methylbutanoate)

5F–APINACA; 5F–AKB48 (N-(adamantan-1-yl)-1-(5- 7049 I N 5F-APINACA; 5F-AKB48 fluoropentyl)-1H-indazole-3-carboxamide)

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I N phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3- carboxamide)

5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- 7094 I N 5F-EDMB-PICA; 5F-EDMB-2201 carbonyl]amino]-3,3-dimethyl-butanoate)

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I N 5-Fluoro-UR-144; XLR-11; XLR11 indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- 7225 I N 5-Fluoro-PB-22; 5F-PB-22 carboxylate)

| 5-Methoxy-3,4-methylenedioxyamphetamine | 7401 | I | N | MMDA |
|---|---|---|---|---|
| 5-Methoxy-N,N-diisopropyltryptamine | 7439 | I | N | 5-MeO-DIPT |

(Positional Isomer: 5-Methoxy-N,N-dipropyltryptamine (5-MeO-DPT))

5-Methoxy-N,N-dimethyltryptamine 7431 I N 5-MeO-DMT

(Positional Isomer: 4-Methoxy-N,N-dimethyltryptamine (4-MeO-DMT, 4-methoxy-DMT))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)- 9763 I Y Protonitazepyne 1H-benzimidazole (N-pyrrolidino protonitazene)

| 5α-Androstan-3,17-dione | 4000 | III | N | Androstanedione |
|---|---|---|---|---|
| 5α-Androstan-3,6,17-trione | 4000 | III | N |  |
| 6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H- | 7220 | I | N | Hexahydrocannabinol; HHC |

benzo[c]chromen-1-ol

| 6-Bromo-androsta-1,4-diene-3,17-dione | 4000 | III | N |  |
|---|---|---|---|---|
| 6-Bromo-androstan-3,17-dione | 4000 | III | N |  |
| 6α-Methyl-androst-4-ene-3,17-dione | 4000 | III | N |  |
| 8-(1-(4-Chlorophenyl)ethyl)-1-phenyl-1,3,8- | 9093 | I | Y | Spirochlorphine; R–6890 |

triazaspiro[4.5]decan-4-one

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I N AB-CHMINACA yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7012 I N AB-FUBINACA 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7023 I N AB-PINACA pentyl-1H-indazole-3-carboxamide)

| Acetorphine | 9319 | I | Y |
|---|---|---|---|
| Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9821 | I | Y |

phenylacetamide)

| Acetyl-alpha-methylfentanyl | 9815 | I | Y |  |
|---|---|---|---|---|
| Acetyldihydrocodeine | 9051 | I | Y | Acetylcodone |
| Acetylmethadol | 9601 | I | Y | Methadyl acetate |
| Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9811 | I | Y | Acryloylfentanyl |

phenylacrylamide)

ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- 7092 I N ADB-4en-PINACA oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide)

ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7027 I N ADB-BUTINACA 2-yl)-1-butyl-1H-indazole-3-carboxamide)

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7010 I N ADB-FUBINACA 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2- 7035 I N ADB-PINACA yl)-1-pentyl-1H-indazole-3-carboxamide)

AH-7921 (3,4-dichloro-N-[(1- 9551 I Y dimethylamino)cyclohexylmethyl]benzamide))

| Alfaxalone | 2731 | IV | N | Alfaxan; 5α-pregnan-3α-ol-11,20-dione |
|---|---|---|---|---|
| Alfentanil | 9737 | II | Y | Alfenta |
| Allylprodine | 9602 | I | Y |  |
| Alphacetylmethadol except levo-alphacetylmethadol | 9603 | I | Y |  |
| Alpha-ethyltryptamine | 7249 | I | N | ET; Trip |
| Alphameprodine | 9604 | I | Y |  |
| Alphamethadol | 9605 | I | Y |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

alpha'-Methyl butyryl fentanyl (2-methyl-N-(1- 9864 I Y phenethylpiperidin-4-yl)-N-phenylbutanamide)

| alpha-Methylfentanyl | 9814 | I | Y | China White; fentanyl |
|---|---|---|---|---|
| alpha-Methylthiofentanyl | 9832 | I | Y | China White; fentanyl |
| alpha-Methyltryptamine | 7432 | I | N | AMT |

(Positional Isomer: N-Methyltryptamine)

| Alphaprodine | 9010 | II | Y | Nisentil |
|---|---|---|---|---|
| alpha-pyrrolidinobutiophenone (α-PBP) | 7546 | I | N | 1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one |
| alpha-Pyrrolidinoheptaphenone (PV8) | 7548 | I | N | PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one |

(Positional Isomer: α-pyrrolidinoisoheptanophenone (α-PiHPP; iso-PV8))

alpha-Pyrrolidinohexanophenone (α-PHP) 7544 I N α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2- (pyrrolidin-1-yl)hexan-1-one

alpha-Pyrrolidinopentiophenone (α-PVP) 7545 I N α-Pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomers: 4-methyl-α-pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2- (piperidin-1-yl)butan-1-one)

| Alprazolam | 2882 | IV | N | Xanax |
|---|---|---|---|---|
| AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) | 7201 | I | N |  |
| AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) | 7000 | I | N | Prior drug code 7694 under Synthetic Drug Abuse |

Prevention Act; consolidated to 7000 under 91 FR 2297

Amineptine (7-[(10,11-dihydro-5H- 1219 I N dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)

| Aminorex | 1585 | I | N | Has been sold as methamphetamine |
|---|---|---|---|---|
| Amobarbital | 2125 | II | N | Amytal; Tuinal |
| Amobarbital & noncontrolled active ingred. | 2126 | III | N |  |
| Amobarbital suppository dosage form | 2126 | III | N |  |
| Amphetamine | 1100 | II | N | Dexedrine; Adderall; Obetrol |
| Anabolic steroids | 4000 | III | N | Any substance meeting the definition of anabolic |

steroid as set forth in 21 CFR 1300.01

| Anileridine | 9020 | II | Y | Leritine |
|---|---|---|---|---|
| APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H- | 7048 | I | N | APINACA; AKB48 |

indazole-3-carboxamide

| Aprobarbital | 2100 | III | N | Alurate |
|---|---|---|---|---|
| Barbital | 2145 | IV | N | Veronal; Plexonal; barbitone |
| Barbituric acid derivative | 2100 | III | N | Barbiturates not specifically listed |
| Benzethidine | 9606 | I | Y |  |
| Benzphetamine | 1228 | III | N | Didrex; Inapetyl |
| Benzylmorphine | 9052 | I | Y |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Betacetylmethadol | 9607 | I | Y |  |
|---|---|---|---|---|
| beta-Hydroxy-3-methylfentanyl | 9831 | I | Y | China White; fentanyl |
| beta-Hydroxyfentanyl | 9830 | I | Y | China White; fentanyl |
| beta-Hydroxythiofentanyl | 9836 | I | Y | N-[1-[2-Hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]- |

N-phenylpropionamide; N-[1-[2-hydroxy-2-(2- thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide

| Betameprodine | 9608 | I | Y |
|---|---|---|---|
| Betamethadol | 9609 | I | Y |
| beta-Methyl fentanyl (N-phenyl-N-(1-(2- | 9856 | I | Y |

phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl)

beta-Methylacetyl fentanyl (N-phenyl-N-(1-(2- 9868 I Y phenylpropyl)piperidin-4-yl)acetamide)

beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- 9842 I Y diphenylpropanamide; also known as β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)

| Betaprodine | 9611 | I | Y |  |
|---|---|---|---|---|
| Bezitramide | 9800 | II | Y | Burgodin |
| Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4- | 4000 | III | N |  |

en-3-one)

| Boldenone (17β-hydroxyandrost-1,4-diene-3-one) | 4000 | III | N | Equipoise; Parenabol; Vebonol; dehydrotestosterone |
|---|---|---|---|---|
| Boldione (androsta-1,4-diene-3,17-dione) | 4000 | III | N |  |
| Brexanolone (3α-hydroxy-5α-pregnan-20-one) | 2400 | IV | N | Allopregnanolone |
| Brivaracetam | 2710 | V | N | BRV; UCB-34714; Briviact; ((2S)-2-[(4R)-2-oxo-4- |

propylpyrrolidin-1-yl] butanamide)

| Bromazepam | 2748 | IV | N | Lexotan; Lexatin; Lexotanil |
|---|---|---|---|---|
| Bromazolam (8-bromo-1-methyl-6-phenyl-4H- | 2778 | I | N |  |

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)- | 9098 | I | Y | 1-[1-[1-(4-Bromophenyl)ethyl]-4-piperidinyl]-1,3- |
|---|---|---|---|---|
| 1,3-dihydro-2H-benzo[d]imidazol-2-one) | dihydro-2H-benzimidazol-2-one |  |  |  |
| Bufotenine | 7433 | I | N | Mappine; N,N-dimethylserotonin |
| Buprenorphine | 9064 | III | Y | Buprenex; Temgesic; Subutex; Suboxone |
| Butabarbital (secbutabarbital) | 2100 | III | N | Butisol; Butibel |
| Butalbital | 2100 | III | N | Fiorinal; Butalbital with aspirin |
| Butobarbital (butethal) | 2100 | III | N | Soneryl (UK) |
| Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H- | 9751 | I | Y |  |

benzimidazol-1-yl)-N,N-diethylethan-1-amine)

| Butorphanol | 9720 | IV | N | Stadol; Stadol NS; Torbugesic; Torbutrol |
|---|---|---|---|---|
| Butylone | 7541 | I | N | bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2- |

(methylamino)butan-1-one

(Positional Isomers: ￿dimethylone (bk-MDDMA; MDDMC), N,N-dimethyl-3,4- methylenedioxycathinone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Butyryl Fentanyl 9822 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide; N- (1-phenethylpiperidin-4-yl)-N-phenylbutanamide

Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4- 4000 III N Methosarb en-3-one)

| Camazepam | 2749 | IV | N | Albego; Limpidon; Paxor |
|---|---|---|---|---|
| Cannabimimetic agents | 7000 | I | N | Any substance meeting the definition of |

cannabimimetic agent as set forth in 21 CFR § 1308.11(g)

| Carfentanil | 9743 | II | Y | Wildnil |
|---|---|---|---|---|
| Carisoprodol | 8192 | IV | N | Soma |
| Cathine | 1230 | IV | N | Constituent of "Khat" plant; (+)-norpseudoephedrine |
| Cathinone | 1235 | I | N | Constituent of "Khat" plant |
| Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2- | 2720 | V | N | 2H-Tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, |
| yl)ethyl]carbamate) | carbamate (ester), (alphaR)-; carbamic acid ®-(+)-1- |  |  |  |

(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)

| Centanafadine | 1641 | III | N |  |
|---|---|---|---|---|
| Chloral betaine | 2460 | IV | N | Beta Chlor |
| Chloral hydrate | 2465 | IV | N | Noctec |
| Chlordiazepoxide | 2744 | IV | N | Librium; Libritabs; Limbitrol; SK-Lygen |
| Chlorhexadol | 2510 | III | N | Mechloral; Mecoral; Medodorm; Chloralodol |
| Chlorphentermine | 1645 | III | N | Pre-Sate; Lucofen; Apsedon; Desopimon |
| Cipepofol | 2139 | IV | N |  |
| Clobazam | 2751 | IV | N | Urbadan; Urbanyl |
| Clonazepam | 2737 | IV | N | Klonopin; Clonopin |
| Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H- | 2786 | I | N |  |

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Clonitazene | 9612 | I | Y |  |
|---|---|---|---|---|
| Clorazepate | 2768 | IV | N | Tranxene |
| Clortermine | 1647 | III | N | Voranil |
| Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one) | 4000 | III | N | Alfa-Trofodermin; Clostene; 4-chlorotestosterone |
| Clotiazepam | 2752 | IV | N | Trecalmo; Rize; Clozan; Veratran |
| Cloxazolam | 2753 | IV | N | Akton; Lubalix; Olcadil; Sepazon |
| Coca Leaves | 9040 | II | Y |  |
| Cocaine | 9041 | II | Y | Methyl benzoylecgonine; Crack |
| Codeine | 9050 | II | Y | Morphine methyl ester; methyl morphine |
| Codeine & isoquinoline alkaloid 90 mg/du | 9803 | III | Y | Codeine with papaverine or noscapine |
| Codeine combination product 90 mg/du | 9804 | III | Y | Empirin; Fiorinal; Tylenol; ASA or APAP w/codeine |
| Codeine methylbromide | 9070 | I | Y |  |
| Codeine preparations - 200 mg/(100 ml or 100 gm) | V | Y | Cosanyl; Robitussin A-C; Cheracol; Cerose; Pediacof |  |
| Codeine-N-oxide | 9053 | I | Y |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- | 7000 | I | N | Prior drug code 7297 under Synthetic Drug Abuse |
|---|---|---|---|---|
| hydroxycyclohexy]-phenol) | Prevention Act; consolidated to 7000 under 91 FR |  |  |  |

2297

| CP-47,497 C8 Homologue (5-(1,1-dimethyloctyl)-2- | 7000 | I | N | Prior drug code 7298 under Synthetic Drug Abuse |
|---|---|---|---|---|
| [(1R,3S)3-hydroxycyclohexyl]-phenol) | Prevention Act; consolidated to 7000 under 91 FR |  |  |  |

2297

Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N- 9844 I Y phenylbut-2-enamide)

CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- 7093 I N CUMYL-PEGACLONE; SGT-151 yl)pyrido[4,3-b]indol-1-one)

Cyclopentyl fentanyl 9847 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide

Cyclopropyl Fentanyl 9845 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide

| Cyprenorphine | 9054 | I | Y |  |
|---|---|---|---|---|
| Daridorexant ([(S)-2-(5-chloro-4-methyl- | 2410 | IV | N | QUVIVIQ |

1H benzo[d]imidazol-2-yl)-2methylpyrrolidin-1-yl](5- methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone)

Dehydrochloromethyltestosterone (4-chloro-17β- 4000 III N Oral-Turinabol hydroxy-17α-methyl-androst-1,4-dien-3-one)

| Delorazepam | 2754 | IV | N |  |
|---|---|---|---|---|
| Desomorphine | 9055 | I | Y |  |
| Desoxymethyltestosterone (17α-methyl-5α-androst-2- | 4000 | III | N | Madol |

en-17β-ol)

| Dextromoramide | 9613 | I | Y | Palfium; Jetrium; Narcolo |
|---|---|---|---|---|
| Dextropropoxyphene dosage forms | 9278 | IV | Y | Darvon; propoxyphene; Darvocet; Propacet |
| Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II | Y | Propoxyphene |
| Diampromide | 9615 | I | Y |  |
| Diazepam | 2765 | IV | N | Valium; Diastat |
| Dichloralphenazone | 2467 | IV | N | Midrin; dichloralantipyrine |
| Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- | 2789 | I | N |  |

methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)

| Diethylpropion | 1610 | IV | N | Tenuate; Tepanil |
|---|---|---|---|---|
| Diethylthiambutene | 9616 | I | Y |  |
| Diethyltryptamine | 7434 | I | N | DET, N,N-diethyltryptamine |

(Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))

| Difenoxin | 9168 | I | Y | Lyspafen |
|---|---|---|---|---|
| Difenoxin 1 mg/25 ug AtSO4/du | 9167 | IV | Y | Motofen |
| Difenoxin preparations - 0.5 mg/25 ug AtSO4/du | V | Y | Motofen |  |
| Dihydrocodeine | 9120 | II | Y | Didrate; Parzone |
| Dihydrocodeine combination product 90 mg/du | 9807 | III | Y | Synalgos-DC; Compal |
| Dihydrocodeine preparations 100mg/(100 ml or 100 gm) | V | Y | Cophene-S, various others |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Dihydroetorphine | 9334 | II | Y | DHE |
|---|---|---|---|---|
| Dihydromorphine | 9145 | I | Y |  |
| Dimenoxadol | 9617 | I | Y |  |
| Dimepheptanol | 9618 | I | Y |  |
| Dimethylthiambutene | 9619 | I | Y |  |
| Dimethyltryptamine | 7435 | I | N | DMT |
| Dioxaphetyl butyrate | 9621 | I | Y |  |
| Diphenidine | 7292 | I | Y | 1-(1,2-Diphenylethyl)piperidine |
| Diphenoxylate | 9170 | II | Y |  |
| Diphenoxylate preparations 2.5 mg/25 ug AtSO4 | V | Y | Lomotil; Logen |  |
| Dipipanone | 9622 | I | Y | Dipipan; phenylpiperone HCl; Diconal; Wellconal |
| Dronabinol (synthetic) in sesame oil in soft gelatin | 7369 | III | N | Marinol; synthetic THC in sesame oil/soft gelatin as |
| capsule as approved by FDA | approved by FDA |  |  |  |
| Dronabinol in an oral solution in a drug product | 7365 | II | N | Syndros |

approved for marketing by the U.S. Food and Drug Administration

Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3- 4000 III N Drolban; Masterid; Permastril one)

| Drotebanol | 9335 | I | Y | Metebanyl; oxymethebanol |
|---|---|---|---|---|
| Ecgonine | 9180 | II | Y | Cocaine precursor, in Coca leaves |
| Eluxadoline | 9725 | IV | N | VIBERZI |
| Embutramide | 2020 | III | N | Tributane |
| Estazolam | 2756 | IV | N | ProSom; Domnamid; Eurodin; Nuctalon |
| Estra-4,9,11-triene-3,17-dione | 4000 | III | N |  |
| Ethchlorvynol | 2540 | IV | N | Placidyl |
| Ethinamate | 2545 | IV | N | Valmid; Valamin |
| Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)- | 7036 | I | N | 5F-EDMB-PINACA |

3,3-dimethylbutanoate

| Ethyl loflazepate | 2758 | IV | N |  |
|---|---|---|---|---|
| Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene) | 4000 | III | N | Maxibolin; Orabolin; Durabolin-O; Duraboral |
| Ethylmethylthiambutene | 9623 | I | Y |  |
| Ethylmorphine | 9190 | II | Y | Dionin |
| Ethylmorphine combination product 15 mg/du | 9808 | III | Y |  |
| Ethylmorphine preparations 100 mg/(100 ml or 100 gm) | V | Y |  |  |
| Ethylone | 7547 | I | N | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one; |

3,4-methylenedioxy-N-ethylcathinone; bk-MDEA; MDEC

| Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) | 1727 | I | N |
|---|---|---|---|
| Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H- | 2780 | I | N |

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1H- 9765 I Y benzimidazol-1-yl)-N,N-diethylethan-1-amine)

| Etonitazene | 9624 | I | Y |  |
|---|---|---|---|---|
| Etorphine (except HCl) | 9056 | I | Y |  |
| Etorphine HCl | 9059 | II | Y | M 99 |
| Etoxeridine | 9625 | I | Y |  |
| Eutylone | 7549 | I | N | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one; |

bk-EBDB

| Ezogabine | 2779 | V | N | Potiga |
|---|---|---|---|---|
| Fencamfamin | 1760 | IV | N | Reactivan |
| Fenethylline | 1503 | I | N | Captagon; amfetyline; ethyltheophylline amphetamine |
| Fenproporex | 1575 | IV | N | Gacilin; Solvolip |
| Fentanyl | 9801 | II | Y | Duragesic; Oralet; Actiq; Sublimaze; Innovar |
| Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- | 9851 | I | Y |  |

yl)(phenyl)carbamate)

Fentanyl-related substances as defined in 21 CFR 9850 I Y 1308.11(h)

Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H- 2785 I N benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl- | 2788 | I | N | 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H- |
|---|---|---|---|---|
| 4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | [1,2,4]triazolo[4,3-a][1,4]benzodiazepine |  |  |  |
| Fludiazepam | 2759 | IV | N |  |
| Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- | 9756 | I | Y |  |

1H-benzimidazol-1-yl)ethan-1-amine)

| Flunitrazepam | 2763 | IV | N | Rohypnol; Narcozep; Darkene; Roipnol |
|---|---|---|---|---|
| Fluoxymesterone (9-fluoro-17α-methyl-11β,17β- | 4000 | III | N | Anadroid-F; Halotestin; Ora-Testryl |

dihydroxyandrost-4-en-3-one)

| Flurazepam | 2767 | IV | N | Dalmane |
|---|---|---|---|---|
| Formebolone (2-formyl-17α-methyl-11α,17β- | 4000 | III | N | Esiclene; Hubernol |

dihydroxyandrost-1,4-dien-3-one)

| Fospropofol | 2138 | IV | N | Lusedra |
|---|---|---|---|---|
| Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9834 | I | Y |  |

phenylfuran-2-carboxamide)

Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]- 4000 III N Frazalon; Miotolon; Qu Zhi Shu furazan)

| Furethidine | 9626 | I | Y |  |
|---|---|---|---|---|
| Gamma Hydroxybutyric Acid | 2010 | I | N | GHB; gamma hydroxybutyrate; sodium oxybate |
| Gamma Hydroxybutyric Acid preparations | 2012 | III | N | Xyrem |
| Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one) 2401 | V | N |  |  |
| Glutethimide | 2550 | II | N | Doriden; Dorimide |
| Halazepam | 2762 | IV | N | Paxipam |
| Haloxazolam | 2771 | IV | N |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Heroin | 9200 | I | Y | Diacetylmorphine; diamorphine |
|---|---|---|---|---|
| Hydrocodone | 9193 | II | Y | Dihydrocodeinone |
| Hydromorphinol | 9301 | I | Y |  |
| Hydromorphone | 9150 | II | Y | Dilaudid; dihydromorphinone |
| Hydroxypethidine | 9627 | I | Y |  |
| Ibogaine | 7260 | I | N | Constituent of "Tabernanthe iboga" plant |
| Isobutyryl fentanyl | 9827 | I | Y | N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide |
| Isomethadone | 9226 | II | Y | Isoamidone |
| Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5- | 9614 | I | Y | N,N-Diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5- |
| nitro-1H-benzimidazol-1-yl)ethan-1-amine) | nitro-1H-benzimidazole-1-ethanamine |  |  |  |
| Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4- | 9862 | I | Y |  |

yl)-N-phenylbutanamide)

JWH-018 (also known as AM678) (1-pentyl-3-(1- 7118 I N naphthoyl)indole)

JWH-019 (1-hexyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7019 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-073 (1-butyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7173 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-081 (1-pentyl-3-(1-(4-methoxynaphthoyl)indole)) 7000 I N Prior drug code 7081 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) 7000 I N Prior drug code 7122 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

| JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- | 7000 | I | N | Prior drug code 7200 under Synthetic Drug Abuse |
|---|---|---|---|---|
| naphthoyl)indole) | Prevention Act; consolidated to 7000 under 91 FR |  |  |  |

2297

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) 7000 I N Prior drug code 7203 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) 7000 I N Prior drug code 6250 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) 7000 I N Prior drug code 7398 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

| Ketamine | 7285 | III | N | Ketaset; Ketalar; Special K; K |
|---|---|---|---|---|
| Ketazolam | 2772 | IV | N | Anxon; Loftran; Solatran; Contamex |
| Ketobemidone | 9628 | I | Y | Cliradon |
| Lacosamide | 2746 | V | N | Vimpat |
| Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4- | 2790 | V | N | Reyvow |

carbonyl)pyridine-2-yl-benzamide]

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Lemborexant 2245 IV N (1R,2S)-2-[(2,4-Dimethylpyrimidin-5-yl)oxymethyl]-2- (3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane- 1-carboxamide

| Levo-alphacetylmethadol | 9648 | II | Y | LAAM; long acting methadone; levomethadyl acetate |
|---|---|---|---|---|
| Levomethorphan | 9210 | II | Y |  |
| Levomoramide | 9629 | I | Y |  |
| Levophenacylmorphan | 9631 | I | Y |  |
| Levorphanol | 9220 | II | Y | Levo-Dromoran |
| Lisdexamfetamine | 1205 | II | N | Vyvanse |
| Loprazolam | 2773 | IV | N |  |
| Lorazepam | 2885 | IV | N | Ativan |
| Lorcaserin | 1625 | IV | N | Belviq |
| Lormetazepam | 2774 | IV | N | Noctamid |
| Lysergic acid | 7300 | III | N | LSD precursor |
| Lysergic acid amide | 7310 | III | N | LSD precursor |
| Lysergic acid diethylamide | 7315 | I | N | LSD; lysergide |
| MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan- | 7032 | I | N | MAB-CHMINACA; ADB-CHMINACA |

2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

| Marihuana | 7360 | I | N | Cannabis; marijuana |
|---|---|---|---|---|
| Marihuana Extract | 7350 | I | N |  |
| Marijuana extract, as defined in 21 CFR | 7353 | III | N |  |

1308.11(d)(58), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license

Marijuana, as defined in 21 U.S.C. 802(16), in a U.S. 7362 III N Food and Drug Administration approved product or subject to a state medical marijuana license

| Mazindol | 1605 | IV | N | Sanorex; Mazanor |
|---|---|---|---|---|
| MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- | 7090 | I | N | MDMB-4en-PINACA |

en-1-yl)-1H-indazole-3-carboxamido)butanoate)

MDMB–CHMICA; MMB–CHMINACA (methyl 2-(1- 7042 I N MDMB-CHMICA; MMB-CHMINACA (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate)

MDMB–FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H- 7020 I N MDMB-FUBINACA indazole-3-carboxamido)-3,3-dimethylbutanoate) (Positional Isomer: EMB-FUBINACA)

MDPV (3,4-Methylenedioxypyrovalerone) 7535 I N

(Positional Isomers: 1-(1,3-benzodioxol-5-yl)-2- (cyclohexylamino)propan-1-one(n-cyclohexyl methylone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone) ; 1-(1,3-benzodioxol- 4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3- methylenedioxy pyrovalerone)

Mebutamate 2800 IV N Capla

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Mecloqualone | 2572 | I | N | Nubarene |
|---|---|---|---|---|
| Medazepam | 2836 | IV | N | Nobrium |
| Mefenorex | 1580 | IV | N | Anorexic; Amexate; Doracil; Pondinil |
| Meperidine | 9230 | II | Y | Demerol; Mepergan; pethidine |
| Meperidine intermediate-A | 9232 | II | Y | Meperidine precursor |
| Meperidine intermediate-B | 9233 | II | Y | Meperidine precursor; normeperidine |
| Meperidine intermediate-C | 9234 | II | Y | Meperidine precursor |
| Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I | N | 4-MMC |

(Positional Isomers: Buphedrone, Ethcathinone, N,N- Dimethyl-cathinone)

| Meprobamate | 2820 | IV | N | Miltown; Equanil; Micrainin; Equagesic; Meprospan |
|---|---|---|---|---|
| Mescaline | 7381 | I | N | Constituent of "Peyote" cacti |
| Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3- | 1227 | I | N |  |

oxadiazol-3-ium-5-yl)carbamimidate)

Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Assimil; Ermalone; Methybol; Tantarone one)

Mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Androviron; Proviron; Testiwop one)

meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- 9857 I Y phenethylpiperidin-4-yl)propionamide)

meta-Fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1- 9871 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1- 9858 I Y phenethylpiperidin-4-yl)isobutyramide)

| Metazocine | 9240 | II | Y |  |
|---|---|---|---|---|
| Methadone | 9250 | II | Y | Dolophine; Methadose; Amidone |
| Methadone intermediate (4-cyano-2-dimethylamino-4,4- | 9254 | II | Y | Methadone precursor |

diphenylbutane)

| Methamphetamine | 1105 | II | N | Desoxyn; D-desoxyephedrine; ICE; Crank; Speed |
|---|---|---|---|---|
| Methandienone (17α-methyl-17β-hydroxyandrost-1,4- | 4000 | III | N | Dianabol; Metabolina; Nerobol; Perbolin |

dien-3-one)

Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- 4000 III N Sinesex; Stenediol; Troformone ene)

| Methaqualone | 2565 | I | N | Quaalude; Parest; Somnafac; Opitimil; Mandrax |
|---|---|---|---|---|
| Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3- | 4000 | III | N | Methasterone; 2α,17α-dimethyl-17β-hydroxy-5α- |
| one) | androstan-3-one |  |  |  |
| Methcathinone | 1237 | I | N | N-Methylcathinone, "cat" |
| Methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3- | 4000 | III | N | Primobolan; Primobolan Depot; Primobolan S |

one)

Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- 1478 I N amine)

Methohexital 2264 IV N Brevital

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

Methyl (E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-oxo- 9672 I Y Mitragynine pseudoindoxyl 3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′- indolizine]-7′-yl)-3-methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a- 9673 I Y MGM–15; dihydro-7-hydroxymitragynine hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

| Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro- | 9674 | I | Y | MGM–16; 9-fluoro-dihydro-7-hydroxymitragynine; 10- |
|---|---|---|---|---|
| 7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b- | fluoro-dihydro-7-hydroxymitragynine |  |  |  |

decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3- 7021 I N FUB–AMB; MMB– FUBINACA; AMB–FUBINACA carboxamido)-3-methylbutanoate

Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 7041 I N 5F-MDMB-PICA 3,3-dimethylbutanoate (Positional Isomer: 5F-EMB-PICA or 5-fluoro-EMB- PICA)

| Methyldesorphine | 9302 | I | Y |
|---|---|---|---|
| Methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)- | 4000 | III | N |

dien-3-one)

| Methyldihydromorphine | 9304 | I | Y |
|---|---|---|---|
| Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I | N |

(Positional Isomer: ￿2,3- methylenedioxymethcathinone (2,3-MDMC, 1- (benzo[d][1,3]dioxol-4-yl)-2-(methylamino)propan-1- one))

| Methylphenidate | 1724 | II | N | Concerta; Ritalin; Methylin |
|---|---|---|---|---|
| Methylphenobarbital (mephobarbital) | 2250 | IV | N | Mebaral; mephobarbital |
| Methyltestosterone (17α-methyl-17β-hydroxyandrost-4- | 4000 | III | N | Android; Oreton; Testred; Virilon |

en-3-one)

Methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11- 4000 III N Metribolone trien-3-one)

| Methyprylon | 2575 | III | N | Noludar |
|---|---|---|---|---|
| Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- | 9764 | I | Y |  |

1H-benzimidazol-1-yl)ethan-1-amine)

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- 9757 I Y nitro-1H-benzimidazol-1-yl)ethan-1-amine)

| Metopon | 9260 | II | Y |  |
|---|---|---|---|---|
| Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3- | 4000 | III | N | Cheque; Matenon |

one)

| Midazolam | 2884 | IV | N | Versed |
|---|---|---|---|---|
| MMB-CHMICA; AMB-CHMICA (methyl 2-(1- | 7044 | I | N |  |

(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3- methylbutanoate)

MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole- 7095 I N MMB-FUBICA 3-carboxamido)-3-methyl butanoate)

| Modafinil | 1680 | IV | N | Provigil |
|---|---|---|---|---|
| Moramide-intermediate | 9802 | II | Y |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Morpheridine | 9632 | I | Y |  |
|---|---|---|---|---|
| Morphine | 9300 | II | Y | MS Contin; Roxanol; Oramorph; RMS; MSIR |
| Morphine combination product/50 mg/(100 ml or 100 | 9810 | III | Y |  |

gm)

| Morphine methylbromide | 9305 | I | Y |  |
|---|---|---|---|---|
| Morphine methylsulfonate | 9306 | I | Y |  |
| Morphine-N-oxide | 9307 | I | Y |  |
| MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) | 9560 | I | Y |  |
| Myrophine | 9308 | I | Y |  |
| N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran- | 9843 | I | Y | Tetrahydrofuranyl fentanyl |

2-carboxamide

N-(2-Fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I Y ortho-Fluorofentanyl or 2-fluorofentanyl yl)propionamide

| N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3- | 7047 | I | N | FUB-AKB48; FUB-APINACA; AKB48 N-(4- |
|---|---|---|---|---|
| carboxamide | FLUOROBENZYL) |  |  |  |
| N,N-Dimethylamphetamine | 1480 | I | N |  |
| Nabilone | 7379 | II | N | Cesamet |
| Nalorphine | 9400 | III | Y | Nalline |
| Nandrolone (17β-hydroxyestr-4-en-3-one) | 4000 | III | N | Deca-Durabolin; Durabolin; Durabolin-50 |
| Naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3- | 7000 | I | N |  |

yl)methanone (JWH–022)

Naphyrone 1258 I N Naphthylpyrovalerone; 1-(naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1-one

(Positional Isomer: α-naphyrone)

| Naturally derived delta-9-tetrahydrocannabinols in a | 7386 | III | N | (i) Naturally derived delta-9-tetrahydrocannabinols |
|---|---|---|---|---|
| U.S. Food and Drug Administration approved product | means those delta-9-tetrahydrocannabinols, except |  |  |  |
| or in marijuana subject to a state medical marijuana | as in paragraphs 21 CFR 1308.13(g)(2) and (3), that |  |  |  |
| license | are naturally contained in a plant of the genus |  |  |  |

Cannabis (cannabis plant) (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C 802(16)(B)(ii)

| N-Benzylpiperazine | 7493 | I | N | BZP; 1-benzylpiperazine |
|---|---|---|---|---|
| N-Desethyl isotonitazene (N-ethyl-2-(2-(4- | 9760 | I | Y |  |

isopropoxylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan- 1-amin)

| N-Ethyl-1-phenylcyclohexylamine | 7455 | I | N | PCE |
|---|---|---|---|---|
| N-Ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H- | 9769 | I | Y | N-Desethyl protonitazene |

benzimidazol-1-yl)ethan-1-amine

| N-Ethyl-3-piperidyl benzilate | 7482 | I | N | JB 323 |
|---|---|---|---|---|
| N-Ethylamphetamine | 1475 | I | N | NEA |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

N-Ethylhexedrone 7246 I N α-Ethylaminohexanophenone; 2-(ethylamino)-1- phenylhexan-1-one

N-Ethylpentylone (1-(1,3-benzodioxol-5-yl)-2- 7543 I N Ephylone (ethylamino)-pentan-1-one) (Positional Isomers: 3,4-methylenedioxy-α-propylaminobutiophenone; isopropyl butylone (MDIPBP))

| N-Hydroxy-3,4-methylenedioxyamphetamine | 7402 | I | N | N-Hydroxy MDA |
|---|---|---|---|---|
| Nicocodeine | 9309 | I | Y |  |
| Nicomorphine | 9312 | I | Y | Vilan |
| Nimetazepam | 2837 | IV | N | Erimin |
| Nitrazepam | 2834 | IV | N | Mogadon |
| NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)- | 7221 | I | N |  |

1H-indole-3-carboxylate)

| N-Methyl-3-piperidyl benzilate | 7484 | I | N | JB 336 |
|---|---|---|---|---|
| Noracymethadol | 9633 | I | Y |  |
| Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3- | 4000 | III | N | Genabol |

one)

| Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) | 4000 | III | N | Anabol-4-19; Lentabol |
|---|---|---|---|---|
| Nordiazepam | 2838 | IV | N | Nordazepam; Demadar; Madar |
| Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3- | 4000 | III | N | Nilevar; Pronabol; Solevar |

one)

| Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) | 8366 | II | Y |  |
|---|---|---|---|---|
| Norlevorphanol | 9634 | I | Y |  |
| Normethadone | 9635 | I | Y | Phenyldimazone |
| Normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3- | 4000 | III | N | Lutenin; Matronal; Orgasteron |

one)

| Normorphine | 9313 | I | Y |  |
|---|---|---|---|---|
| Noroxymorphone | 9668 | II | Y |  |
| Norpipanone | 9636 | I | Y |  |
| N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- | 9761 | I | Y | Etonitazepipne |

(2-(piperidin-1-yl)ethyl-1H-benzimidazole)

N-Pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9758 I Y Etonitazepyne (2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)

Ocfentanil 9838 I Y N-(2-Fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4-yl)acetamide

O-Desmethyltramadol 9667 I Y O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol

Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2- 9245 II Y [(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl{time} )amine fumarate)

| Opium combination product 25 mg/du | 9809 | III | Y | Paregoric, other combination products |
|---|---|---|---|---|
| Opium extracts | 9610 | II | Y |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Opium fluid extract | 9620 | II | Y |  |
|---|---|---|---|---|
| Opium poppy | 9650 | II | Y | Papaver somniferum |
| Opium preparations - 100 mg/(100 ml or 100 gm) | V | Y | Parepectolin; Kapectolin PG; Kaolin Pectin P.G. |  |
| Opium tincture | 9630 | II | Y | Laudanum |
| Opium, granulated | 9640 | II | Y | Granulated opium |
| Opium, powdered | 9639 | II | Y | Powdered opium |
| Opium, raw | 9600 | II | Y | Raw opium; gum opium |
| Oripavine | 9330 | II | Y |  |
| ortho-Chlorofentanyl (N-(2-chlorophenyl)-N-(1- | 9828 | I | Y |  |

phenethylpiperidin-4-yl)propionamide)

ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- 9852 I Y phenethylpiperidin-4-yl)acrylamide)

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9846 I Y phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl fentanyl)

ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- 9863 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9853 I Y phenethylpiperidin-4-yl)isobutyramide)

ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- 9848 I Y phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl)

ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- 9820 I Y 2-Methyl methoxyacetyl fentanyl methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide)

ortho-Methylcyclopropylfentanyl (N-(2-methylphenyl)-N- 9849 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

Oveporexton 1775 IV N N-[(2S,3R)-2-[[3-(3,5-Difluorophenyl)-2- fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2- methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide; Orzeyful

Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α- 4000 III N Anavar; Lonavar; Oxandrin; Provitar; Vasorome androstan-3-one)

| Oxazepam | 2835 | IV | N | Serax; Serenid-D |
|---|---|---|---|---|
| Oxazolam | 2839 | IV | N | Serenal; Convertal |
| Oxycodone | 9143 | II | Y | OxyContin; Percocet; Endocet; Roxicodone; Roxicet |
| Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4- | 4000 | III | N | Anamidol; Balnimax; Oranabol; Oranabol 10 |

en-3-one)

Oxymetholone (17α-methyl-2-hydroxymethylene-17β- 4000 III N Anadrol-50; Adroyd; Anapolon; Anasteron; Pardroyd hydroxy-5α-androstan-3-one)

| Oxymorphone | 9652 | II | Y | Numorphan |
|---|---|---|---|---|
| para-Chlorofentanyl (N-(4-chlorophenyl)-N-(1- | 9818 | I | Y |  |

phenethylpiperidin-4-yl)propionamide)

para-Chloroisobutyryl fentanyl 9826 I Y N-(4-Chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- 9854 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1- 9870 I Y phenethylpiperidin-4-yl)pentanamide)

para-Fluorobutyryl fentanyl 9823 I Y N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

| para-Fluorofentanyl | 9812 | I | Y | China White; fentanyl |
|---|---|---|---|---|
| Parahexyl | 7374 | I | N | Synhexyl |
| Paraldehyde | 2585 | IV | N | Paral |
| para-Methoxybutyryl fentanyl | 9837 | I | Y | N-(4-Methoxyphenyl)-N-(1-phenethylpiperidin-4- |

yl)butyramide

para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- 9859 I Y (1-phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Methoxymethamphetamine (PMMA); 1-(4- 1245 I N (Positional isomer: methoxyphenamine (OMMA)) methoxyphenyl)-N-methylpropan-2-amine

para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- 9865 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

para-Methylfentanyl (N-(4-methylphenyl)-N-(1- 9817 I Y phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl)

| PB-22 (quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) | 7222 | I | N | QUPIC; PB-22 |
|---|---|---|---|---|
| Pemoline | 1530 | IV | N | Cylert |
| Pentazocine | 9709 | IV | N | Talwin; Talwin NX; Talacen; Talwin Compound |
| Pentedrone (α-methylaminovalerophenone) | 1246 | I | N | 2-(Methylamino)-1-phenylpentan-1-one |

(Positional Isomers: 3-methylethcathinone (3-MEC), 4-ethylmethcathinone (4-EMC), 4-methylbuphedrone (4-MeMABP;4-MeBP), 3,4-dimethylmethcathinone (3,4-DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

| Pentobarbital | 2270 | II | N | Nembutal |
|---|---|---|---|---|
| Pentobarbital & noncontrolled active ingred. | 2271 | III | N | FP-3 |
| Pentobarbital suppository dosage form | 2271 | III | N | WANS |
| Pentylone | 7542 | I | N | bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2- |

(methylamino)pentan-1-one

(Positional Isomers: dibutylone (bk-DMBDB) and propylone (3',4'-methylenedioxy-N-propylaminocathinone; 1-(benzo[d][1,3]dioxol-5-yl)-2- (propylamino)propan-1-one); 2,3-methylenedioxy-α-ethylaminobutiophenone)

Perampanel 2261 III N Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2- dihydropyridin-3-yl) benzonitrile]

| Petrichloral | 2591 | IV | N | Pentaerythritol chloral; Periclor |
|---|---|---|---|---|
| Peyote | 7415 | I | N | Cactus which contains mescaline |
| Phenadoxone | 9637 | I | Y |  |
| Phenampromide | 9638 | I | Y |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Phenazocine | 9715 | II | Y | Narphen; Prinadol |
|---|---|---|---|---|
| Phencyclidine | 7471 | II | N | PCP; Sernylan |
| Phendimetrazine | 1615 | III | N | Plegine; Prelu-2; Bontril; Melfiat; Statobex |
| Phenmetrazine | 1631 | II | N | Preludin |
| Phenobarbital | 2285 | IV | N | Luminal; Bellergal-S |
| Phenomorphan | 9647 | I | Y |  |
| Phenoperidine | 9641 | I | Y | Operidine; Lealgin |
| Phentermine | 1640 | IV | N | Ionamin; Fastin; Adipex-P; Obe-Nix; Zantryl |
| Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9841 | I | Y |  |

phenylbenzamide; also known as benzoyl fentanyl)

| Phenylacetone | 8501 | II | N | P2P; phenyl-2-propanone; benzyl methyl ketone |
|---|---|---|---|---|
| Pholcodine | 9314 | I | Y | Copholco; Adaphol; Codisol; Lantuss; Pholcolin |
| Piminodine | 9730 | II | Y |  |
| Pinazepam | 2883 | IV | N | Domar |
| Pipradrol | 1750 | IV | N | Detari; Stimolag Fortis |
| Piritramide | 9642 | I | Y | Piridolan |
| Poppy Straw | 9650 | II | Y | Opium poppy capsules; poppy heads |
| Poppy Straw Concentrate | 9670 | II | Y | Concentrate of Poppy Straw, CPS |
| Prazepam | 2764 | IV | N | Centrax |
| Pregabalin | 2782 | V | N | Lyrica |
| Proheptazine | 9643 | I | Y |  |
| Properidine | 9644 | I | Y |  |
| Propiram | 9649 | I | Y | Algeril |
| Prostanozol (17β-hydroxy-5α-androstano[3,2- | 4000 | III | N | Prostanozol; [3,2-c]pyrazole-5α-androstan-17β-ol |

c]pyrazole)

Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- 9759 I Y propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)

| Psilocybin | 7437 | I | N | Constituent of "Magic mushrooms" |
|---|---|---|---|---|
| Psilocyn | 7438 | I | N | Psilocin, constituent of "Magic mushrooms" |

(Positional Isomers: 6-hydroxy DMT; 7-hydroxy DMT)

| Pyrovalerone | 1485 | V | N | Centroton; Thymergix |
|---|---|---|---|---|
| Quazepam | 2881 | IV | N | Doral |
| Racemethorphan | 9732 | II | Y |  |
| Racemoramide | 9645 | I | Y |  |
| Racemorphan | 9733 | II | Y | Dromoran |
| Remifentanil | 9739 | II | Y | Ultiva |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine- | 2846 | IV | N | 8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester, |
|---|---|---|---|---|
| 4-propionic acid) | benzenesulfonate (1:1); methyl 3-[(4S)-8-bromo-1- |  |  |  |

methyl-6-pyridin-2-yl-4H-imidazo[1,2- a][1,4]benzodiazepin- 4yl]propanoate benzenesulfonic acid

| Secobarbital | 2315 | II | N | Seconal; Tuinal |
|---|---|---|---|---|
| Secobarbital & noncontrolled active ingred | 2316 | III | N |  |
| Secobarbital suppository dosage form | 2316 | III | N |  |
| Serdexmethylphenidate | 1729 | IV | N |  |
| Sibutramine | 1675 | IV | N | Meridia |
| Solriamfetol (2-amino-3-phenylpropyl car-bamate; | 1650 | IV | N |  |

benzenepropanol, beta-amino-, carbamate (ester))

| SPA | 1635 | IV | N | 1-Dimethylamino-1,2-diphenylethane; Lefetamine |
|---|---|---|---|---|
| SR-18 (1-cyclohexylethyl-3-(2-methoxyphenylacetyl) | 7000 | I | N | RCS-8 |
| indole) | Prior drug code 7008 under Synthetic Drug Abuse |  |  |  |

Prevention Act; consolidated to 7000 under 91 FR 2297

SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) 7000 I N RCS-4 Prior drug code 7104 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Stanozolol (17α-methyl-17β-hydroxy-5α-androst-2- 4000 III N Winstrol; Winstrol-V eno[3,2-c]-pyrazole)

Stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3- 4000 III N one)

| Stimulant compounds previously excepted | 1405 | III | N | Mediatric |
|---|---|---|---|---|
| Sufentanil | 9740 | II | Y | Sufenta |
| Sulfondiethylmethane | 2600 | III | N |  |
| Sulfonethylmethane | 2605 | III | N |  |
| Sulfonmethane | 2610 | III | N |  |
| Suvorexant | 2223 | IV | N | MK-4305; [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7- |

methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3- triazol-2-yl)phenyl]methanone

| Talbutal | 2100 | III | N | Lotusate |
|---|---|---|---|---|
| Tapentadol | 9780 | II | Y |  |
| Temazepam | 2925 | IV | N | Restoril |
| Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta- | 4000 | III | N | Teolit; Teslac |

1,4-dien-17-oic acid lactone)

| Testosterone (17β-hydroxyandrost-4-en-3-one) | 4000 | III | N | Android-T; Androlan; Depotest; Delatestryl |
|---|---|---|---|---|
| Tetrahydrocannabinols | 7370 | I | N | THC; Delta-8 THC; Delta-9 THC; dronabinol and |

others

Tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon- 4000 III N THG 4,9,11-trien-3-one)

Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin- 9869 I Y Tetrahydrothiophene fentanyl 4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Tetrazepam | 2886 | IV | N | Myolastan; Musaril |
|---|---|---|---|---|
| Thebacon | 9315 | I | Y | Acetylhydrocodone; Acedicon; Thebacetyl |
| Thebaine | 9333 | II | Y | Precursor of many narcotics |
| Thiafentanil | 9729 | II | Y | Thianil |
| Thiamylal | 2100 | III | N | Surital |
| Thiofentanyl | 9835 | I | Y | Chine white; fentanyl |
| Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9839 | I | Y |  |

phenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl; thiophene fentanyl)

| Thiopental | 2100 | III | N | Pentothal |
|---|---|---|---|---|
| THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- | 7024 | I | N |  |

yl](naphthalen-1-yl)methanone)

| Tiletamine & Zolazepam Combination Product | 7295 | III | N | Telazol |
|---|---|---|---|---|
| Tilidine | 9750 | I | Y | Tilidate; Valoron; Kitadol; Lak; Tilsa |
| Tramadol (2-[(dimethylamino)methyl]-1-(3- | 9752 | IV | Y | Tramadol |

methoxyphenyl)cyclohexanol)

| Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) | 4000 | III | N | Finaplix-S; Finajet; Parabolan |
|---|---|---|---|---|
| Triazolam | 2887 | IV | N | Halcion |
| Trimeperidine | 9646 | I | Y | Promedolum |
| U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]- | 9547 | I | Y |  |

N-methylbenzamide)

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I N tetramethylcyclopropyl)metanone

| Valeryl fentanyl | 9840 | I | Y | N-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide |
|---|---|---|---|---|
| Vinbarbital | 2100 | III | N | Delvinal; vinbarbitone |
| Zaleplon | 2781 | IV | N | Sonata |
| Zipeprol (1-methoxy-3[-4-(2-methoxy-2- | 9873 | I | Y |  |

phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)

| Zolpidem | 2783 | IV | N | Ambien; Ivadal; Stilnoct; Stilnox |
|---|---|---|---|---|
| Zopiclone | 2784 | IV | N | Lunesta |
| Zuranolone | 2420 | IV | N | ZURZUVAE |
| α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- | 7551 | I | N | α-PiHP; alpha-PiHP |

one)

Δ1-Dihydrotestosterone (17β-hydroxy-5α-androst-1-en- 4000 III N 1-Testosterone 3-one)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - Alphabetical Order

## DEA Drug Code NumberControlled Substances

## - by Controlled Substance Code Number -

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Codeine preparations - 200 mg/(100 ml or 100 gm) | V | Y Cosanyl; Robitussin A-C; Cheracol; Cerose; Pediacof |  |
|---|---|---|---|
| Difenoxin preparations - 0.5 mg/25 ug AtSO4/du | V | Y Motofen |  |
| Dihydrocodeine preparations 100mg/(100 ml or 100 gm) | V | Y Cophene-S, various others |  |
| Diphenoxylate preparations 2.5 mg/25 ug AtSO4 | V | Y Lomotil; Logen |  |
| Ethylmorphine preparations 100 mg/(100 ml or 100 gm) | V | Y |  |
| Opium preparations - 100 mg/(100 ml or 100 gm) | V | Y Parepectolin; Kapectolin PG; Kaolin Pectin P.G. |  |
| Amphetamine | 1100 | II | N Dexedrine; Adderall; Obetrol |
| Methamphetamine | 1105 | II | N Desoxyn; D-desoxyephedrine; ICE; Crank; Speed |
| Lisdexamfetamine | 1205 | II | N Vyvanse |
| Amineptine (7-[(10,11-dihydro-5H- | 1219 | I | N |

dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)

Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3- 1227 I N oxadiazol-3-ium-5-yl)carbamimidate)

| Benzphetamine | 1228 | III | N Didrex; Inapetyl |
|---|---|---|---|
| Cathine | 1230 | IV | N Constituent of "Khat" plant; (+)-norpseudoephedrine |
| 3-Fluoro-N-methylcathinone (3-FMC) | 1233 | I | N 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one |

(Positional Isomer: 2-FMC)

| Cathinone | 1235 | I | N Constituent of "Khat" plant |
|---|---|---|---|
| Methcathinone | 1237 | I | N N-Methylcathinone, "cat" |
| 4-Fluoro-N-methylcathinone (4-FMC) | 1238 | I | N Flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1- |

one

(Positional Isomer: 2-FMC)

| 4-Chloromethcathinone | 1239 | I | N 4-CMC; 1-(4-chlorophenyl)-2-(methylamino)propan-1-one |
|---|---|---|---|
| 3-Chloromethcathinone | 1241 | I | N 3-CMC; 1-(3-chlorophenyl)-2-(methylamino)propan-1-one |
| para-Methoxymethamphetamine (PMMA); 1-(4- | 1245 | I | N (Positional isomer: methoxyphenamine (OMMA)) |

methoxyphenyl)-N-methylpropan-2-amine

Pentedrone (α-methylaminovalerophenone) 1246 I N 2-(Methylamino)-1-phenylpentan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone (3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

Mephedrone (4-Methyl-N-methylcathinone) 1248 I N 4-MMC

(Positional Isomers: Buphedrone, Ethcathinone, N,N- Dimethyl-cathinone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

4-Methyl-N-ethylcathinone (4-MEC) 1249 I N 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone(3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

Naphyrone 1258 I N Naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomer: α-naphyrone)

3-Methylmethcathinone (2-(methylamino)-1-(3- 1259 I N 3-MMC; 3-methylmethcathinone methylphenyl)propan-1-one)

| Stimulant compounds previously excepted | 1405 | III | N Mediatric |
|---|---|---|---|
| N-Ethylamphetamine | 1475 | I | N NEA |
| 4-Fluoroamphetamine (4–FA, 1-(4-fluorophenyl)propan- | 1476 | I | N 4–FA; 1-(4-fluorophenyl)propan-2-amine; para- |
| 2-amine, para-fluoroamphetamine) | fluoroamphetamine |  |  |
| Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- | 1478 | I | N |

amine)

| N,N-Dimethylamphetamine | 1480 | I | N |
|---|---|---|---|
| Pyrovalerone | 1485 | V | N Centroton; Thymergix |
| Fenethylline | 1503 | I | N Captagon; amfetyline; ethyltheophylline amphetamine |
| Pemoline | 1530 | IV | N Cylert |
| Fenproporex | 1575 | IV | N Gacilin; Solvolip |
| Mefenorex | 1580 | IV | N Anorexic; Amexate; Doracil; Pondinil |
| Aminorex | 1585 | I | N Has been sold as methamphetamine |
| 4-Methylaminorex (cis isomer) | 1590 | I | N U4Euh; McN-422 |
| 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- | 1595 | I | N |

methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

| Mazindol | 1605 | IV | N Sanorex; Mazanor |
|---|---|---|---|
| Diethylpropion | 1610 | IV | N Tenuate; Tepanil |
| Phendimetrazine | 1615 | III | N Plegine; Prelu-2; Bontril; Melfiat; Statobex |
| Lorcaserin | 1625 | IV | N Belviq |
| Phenmetrazine | 1631 | II | N Preludin |
| SPA | 1635 | IV | N 1-Dimethylamino-1,2-diphenylethane; Lefetamine |
| Phentermine | 1640 | IV | N Ionamin; Fastin; Adipex-P; Obe-Nix; Zantryl |
| Centanafadine | 1641 | III | N |
| Chlorphentermine | 1645 | III | N Pre-Sate; Lucofen; Apsedon; Desopimon |
| Clortermine | 1647 | III | N Voranil |
| Solriamfetol (2-amino-3-phenylpropyl car-bamate; | 1650 | IV | N |

benzenepropanol, beta-amino-, carbamate (ester))

| Sibutramine | 1675 | IV | N Meridia |
|---|---|---|---|
| Modafinil | 1680 | IV | N Provigil |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Methylphenidate | 1724 | II | N Concerta; Ritalin; Methylin |
|---|---|---|---|
| Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) | 1727 | I | N |
| Serdexmethylphenidate | 1729 | IV | N |
| Pipradrol | 1750 | IV | N Detari; Stimolag Fortis |
| Fencamfamin | 1760 | IV | N Reactivan |
| Oveporexton | 1775 | IV | N N-[(2S,3R)-2-[[3-(3,5-Difluorophenyl)-2- |

fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2- methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide; Orzeyful

| Gamma Hydroxybutyric Acid | 2010 | I | N GHB; gamma hydroxybutyrate; sodium oxybate |
|---|---|---|---|
| Gamma Hydroxybutyric Acid preparations | 2012 | III | N Xyrem |
| Embutramide | 2020 | III | N Tributane |
| Aprobarbital | 2100 | III | N Alurate |
| Barbituric acid derivative | 2100 | III | N Barbiturates not specifically listed |
| Butabarbital (secbutabarbital) | 2100 | III | N Butisol; Butibel |
| Butalbital | 2100 | III | N Fiorinal; Butalbital with aspirin |
| Butobarbital (butethal) | 2100 | III | N Soneryl (UK) |
| Talbutal | 2100 | III | N Lotusate |
| Thiamylal | 2100 | III | N Surital |
| Thiopental | 2100 | III | N Pentothal |
| Vinbarbital | 2100 | III | N Delvinal; vinbarbitone |
| Amobarbital | 2125 | II | N Amytal; Tuinal |
| Amobarbital & noncontrolled active ingred. | 2126 | III | N |
| Amobarbital suppository dosage form | 2126 | III | N |
| Fospropofol | 2138 | IV | N Lusedra |
| Cipepofol | 2139 | IV | N |
| Barbital | 2145 | IV | N Veronal; Plexonal; barbitone |
| Suvorexant | 2223 | IV | N MK-4305; [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl- |

1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2- yl)phenyl]methanone

Lemborexant 2245 IV N (1R,2S)-2-[(2,4-Dimethylpyrimidin-5-yl)oxymethyl]-2-(3- fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1- carboxamide

| Methylphenobarbital (mephobarbital) | 2250 | IV | N Mebaral; mephobarbital |
|---|---|---|---|
| Perampanel | 2261 | III | N Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2- |

dihydropyridin-3-yl) benzonitrile]

| Methohexital | 2264 | IV | N Brevital |
|---|---|---|---|
| Pentobarbital | 2270 | II | N Nembutal |
| Pentobarbital & noncontrolled active ingred. | 2271 | III | N FP-3 |
| Pentobarbital suppository dosage form | 2271 | III | N WANS |
| Phenobarbital | 2285 | IV | N Luminal; Bellergal-S |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Secobarbital | 2315 | II | N Seconal; Tuinal |
|---|---|---|---|
| Secobarbital & noncontrolled active ingred | 2316 | III | N |
| Secobarbital suppository dosage form | 2316 | III | N |
| Brexanolone (3α-hydroxy-5α-pregnan-20-one) | 2400 | IV | N Allopregnanolone |
| Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one) | 2401 | V | N |
| Daridorexant ([(S)-2-(5-chloro-4-methyl- | 2410 | IV | N QUVIVIQ |

1H benzo[d]imidazol-2-yl)-2methylpyrrolidin-1-yl](5- methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone)

| Zuranolone | 2420 | IV | N ZURZUVAE |
|---|---|---|---|
| Chloral betaine | 2460 | IV | N Beta Chlor |
| Chloral hydrate | 2465 | IV | N Noctec |
| Dichloralphenazone | 2467 | IV | N Midrin; dichloralantipyrine |
| Chlorhexadol | 2510 | III | N Mechloral; Mecoral; Medodorm; Chloralodol |
| Ethchlorvynol | 2540 | IV | N Placidyl |
| Ethinamate | 2545 | IV | N Valmid; Valamin |
| Glutethimide | 2550 | II | N Doriden; Dorimide |
| Methaqualone | 2565 | I | N Quaalude; Parest; Somnafac; Opitimil; Mandrax |
| Mecloqualone | 2572 | I | N Nubarene |
| Methyprylon | 2575 | III | N Noludar |
| Paraldehyde | 2585 | IV | N Paral |
| Petrichloral | 2591 | IV | N Pentaerythritol chloral; Periclor |
| Sulfondiethylmethane | 2600 | III | N |
| Sulfonethylmethane | 2605 | III | N |
| Sulfonmethane | 2610 | III | N |
| Brivaracetam | 2710 | V | N BRV; UCB-34714; Briviact; ((2S)-2-[(4R)-2-oxo-4- |

propylpyrrolidin-1-yl] butanamide)

| Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2- | 2720 | V | N 2H-Tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, |
|---|---|---|---|
| yl)ethyl]carbamate) | carbamate (ester), (alphaR)-; carbamic acid ®-(+)-1-(2- |  |  |

chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)

| Alfaxalone | 2731 | IV | N Alfaxan; 5α-pregnan-3α-ol-11,20-dione |
|---|---|---|---|
| Clonazepam | 2737 | IV | N Klonopin; Clonopin |
| Chlordiazepoxide | 2744 | IV | N Librium; Libritabs; Limbitrol; SK-Lygen |
| Lacosamide | 2746 | V | N Vimpat |
| Bromazepam | 2748 | IV | N Lexotan; Lexatin; Lexotanil |
| Camazepam | 2749 | IV | N Albego; Limpidon; Paxor |
| Clobazam | 2751 | IV | N Urbadan; Urbanyl |
| Clotiazepam | 2752 | IV | N Trecalmo; Rize; Clozan; Veratran |
| Cloxazolam | 2753 | IV | N Akton; Lubalix; Olcadil; Sepazon |
| Delorazepam | 2754 | IV | N |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Estazolam | 2756 | IV | N ProSom; Domnamid; Eurodin; Nuctalon |
|---|---|---|---|
| Ethyl loflazepate | 2758 | IV | N |
| Fludiazepam | 2759 | IV | N |
| Halazepam | 2762 | IV | N Paxipam |
| Flunitrazepam | 2763 | IV | N Rohypnol; Narcozep; Darkene; Roipnol |
| Prazepam | 2764 | IV | N Centrax |
| Diazepam | 2765 | IV | N Valium; Diastat |
| Flurazepam | 2767 | IV | N Dalmane |
| Clorazepate | 2768 | IV | N Tranxene |
| Haloxazolam | 2771 | IV | N |
| Ketazolam | 2772 | IV | N Anxon; Loftran; Solatran; Contamex |
| Loprazolam | 2773 | IV | N |
| Lormetazepam | 2774 | IV | N Noctamid |
| Bromazolam (8-bromo-1-methyl-6-phenyl-4H- | 2778 | I | N |

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Ezogabine | 2779 | V | N Potiga |
|---|---|---|---|
| Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H- | 2780 | I | N |

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Zaleplon | 2781 | IV | N Sonata |
|---|---|---|---|
| Pregabalin | 2782 | V | N Lyrica |
| Zolpidem | 2783 | IV | N Ambien; Ivadal; Stilnoct; Stilnox |
| Zopiclone | 2784 | IV | N Lunesta |
| Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H- | 2785 | I | N |

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H- 2786 I N benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl- | 2788 | I | N 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3- |
|---|---|---|---|
| 4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | a][1,4]benzodiazepine |  |  |
| Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- | 2789 | I | N |

methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)

Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4- 2790 V N Reyvow carbonyl)pyridine-2-yl-benzamide]

| Mebutamate | 2800 | IV | N Capla |
|---|---|---|---|
| Meprobamate | 2820 | IV | N Miltown; Equanil; Micrainin; Equagesic; Meprospan |
| Nitrazepam | 2834 | IV | N Mogadon |
| Oxazepam | 2835 | IV | N Serax; Serenid-D |
| Medazepam | 2836 | IV | N Nobrium |
| Nimetazepam | 2837 | IV | N Erimin |
| Nordiazepam | 2838 | IV | N Nordazepam; Demadar; Madar |
| Oxazolam | 2839 | IV | N Serenal; Convertal |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine- | 2846 | IV | N 8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester, |
|---|---|---|---|
| 4-propionic acid) | benzenesulfonate (1:1); methyl 3-[(4S)-8-bromo-1-methyl- |  |  |

6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin- 4yl]propanoate benzenesulfonic acid

| Quazepam | 2881 | IV | N Doral |
|---|---|---|---|
| Alprazolam | 2882 | IV | N Xanax |
| Pinazepam | 2883 | IV | N Domar |
| Midazolam | 2884 | IV | N Versed |
| Lorazepam | 2885 | IV | N Ativan |
| Tetrazepam | 2886 | IV | N Myolastan; Musaril |
| Triazolam | 2887 | IV | N Halcion |
| Temazepam | 2925 | IV | N Restoril |
| [3,2-c]-Furazan-5α-androstan-17β-ol | 4000 | III | N |
| [3,2-c]Pyrazole-androst-4-en-17β-ol | 4000 | III | N |
| 13β-Ethyl-17β-hydroxygon-4-en-3-one | 4000 | III | N |
| 17α-Methyl-3α,17β-dihydroxy-5α-androstane | 4000 | III | N |
| 17α-Methyl-3β,17β-dihydroxy-5α-androstane | 4000 | III | N |
| 17α-Methyl-3β,17β-dihydroxyandrost-4-ene | 4000 | III | N |
| 17α-Methyl-4-hydroxynandrolone (17α-methyl-4- | 4000 | III | N |

hydroxy-17β-hydroxyestr-4-en-3-one)

| 17α-Methyl-5α-androstan-17β-ol | 4000 | III | N |
|---|---|---|---|
| 17α-Methyl-androst-2-ene-3,17β-diol | 4000 | III | N |
| 17α-Methyl-androsta-1,4-diene-3,17β-diol | 4000 | III | N |
| 17α-Methyl-androstan-3-hydroxyimine-17β-ol | 4000 | III | N |
| 17α-Methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α- | 4000 | III | N 17α-Methyl-1-testosterone |

methyl-5α-androst-1-en-3-one)

| 17β-Hydroxy-androstano[2,3-d]isoxazole | 4000 | III | N |
|---|---|---|---|
| 17β-Hydroxy-androstano[3,2-c]isoxazole | 4000 | III | N |
| 18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one | 4000 | III | N |
| 19-Nor-4,9(10)-androstadienedione (estra-4,9(10)- | 4000 | III | N |

diene-3,17-dione)

| 19-Nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene) | 4000 | III | N |
|---|---|---|---|
| 19-Nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene) | 4000 | III | N |
| 19-Nor-4-androstenedione (estr-4-en-3,17-dione) | 4000 | III | N |
| 19-Nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) | 4000 | III | N |
| 19-Nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene) | 4000 | III | N |
| 19-Nor-5-androstenedione (estr-5-en-3,17-dione) | 4000 | III | N |
| 1-Androstenediol (3α,17β-dihydroxy-5α-androst-1-ene) | 4000 | III | N |
| 1-Androstenediol (3β,17β-dihydroxy-5α-androst-1-ene) | 4000 | III | N |
| 1-Androstenedione (5α-androst-1-en-3,17-dione) | 4000 | III | N |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| 2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one | 4000 | III | N |
|---|---|---|---|
| 2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol | 4000 | III | N |
| 3α,17β-Dihydroxy-5α-androstane | 4000 | III | N |
| 3β,17β-Dihydroxy-5α-androstane | 4000 | III | N |
| 3β-Hydroxy-estra-4,9,11-trien-17-one | 4000 | III | N |
| 4-Androstenediol (3β,17β-dihydroxy-androst-4-ene) | 4000 | III | N 4-AD |
| 4-Androstenedione (androst-4-en-3,17-dione) | 4000 | III | N |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one | 4000 | III | N |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11- | 4000 | III | N |

dione

| 4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol | 4000 | III | N |
|---|---|---|---|
| 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol | 4000 | III | N |
| 4-Dihydrotestosterone (17β-hydroxy-androstan-3-one) | 4000 | III | N Anabolex; Andractim; Pesomax; Stanolone |
| 4-Hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4- | 4000 | III | N |

en-3-one)

4-Hydroxy-androst-4-ene-3,17-dione 4000 III N Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- c]pyrazole-5α-androstan-17β-ol

4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- 4000 III N one)

| 5-Androstenediol (3β,17β-dihydroxy-androst-5-ene) | 4000 | III | N |
|---|---|---|---|
| 5-Androstenedione (androst-5-en-3,17-dione) | 4000 | III | N |
| 5α-Androstan-3,17-dione | 4000 | III | N Androstanedione |
| 5α-Androstan-3,6,17-trione | 4000 | III | N |
| 6-Bromo-androsta-1,4-diene-3,17-dione | 4000 | III | N |
| 6-Bromo-androstan-3,17-dione | 4000 | III | N |
| 6α-Methyl-androst-4-ene-3,17-dione | 4000 | III | N |
| Anabolic steroids | 4000 | III | N Any substance meeting the definition of anabolic steroid |

as set forth in 21 CFR 1300.01

Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4- 4000 III N en-3-one)

| Boldenone (17β-hydroxyandrost-1,4-diene-3-one) | 4000 | III | N Equipoise; Parenabol; Vebonol; dehydrotestosterone |
|---|---|---|---|
| Boldione (androsta-1,4-diene-3,17-dione) | 4000 | III | N |
| Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4- | 4000 | III | N Methosarb |

en-3-one)

| Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one) | 4000 | III | N Alfa-Trofodermin; Clostene; 4-chlorotestosterone |
|---|---|---|---|
| Dehydrochloromethyltestosterone (4-chloro-17β- | 4000 | III | N Oral-Turinabol |

hydroxy-17α-methyl-androst-1,4-dien-3-one)

Desoxymethyltestosterone (17α-methyl-5α-androst-2- 4000 III N Madol en-17β-ol)

Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3- 4000 III N Drolban; Masterid; Permastril one)

Estra-4,9,11-triene-3,17-dione 4000 III N

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene) | 4000 | III | N Maxibolin; Orabolin; Durabolin-O; Duraboral |
|---|---|---|---|
| Fluoxymesterone (9-fluoro-17α-methyl-11β,17β- | 4000 | III | N Anadroid-F; Halotestin; Ora-Testryl |

dihydroxyandrost-4-en-3-one)

Formebolone (2-formyl-17α-methyl-11α,17β- 4000 III N Esiclene; Hubernol dihydroxyandrost-1,4-dien-3-one)

Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]- 4000 III N Frazalon; Miotolon; Qu Zhi Shu furazan)

Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Assimil; Ermalone; Methybol; Tantarone one)

Mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Androviron; Proviron; Testiwop one)

Methandienone (17α-methyl-17β-hydroxyandrost-1,4- 4000 III N Dianabol; Metabolina; Nerobol; Perbolin dien-3-one)

Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- 4000 III N Sinesex; Stenediol; Troformone ene)

| Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3- | 4000 | III | N Methasterone; 2α,17α-dimethyl-17β-hydroxy-5α-androstan- |
|---|---|---|---|
| one) | 3-one |  |  |
| Methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3- | 4000 | III | N Primobolan; Primobolan Depot; Primobolan S |

one)

Methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)- 4000 III N dien-3-one)

Methyltestosterone (17α-methyl-17β-hydroxyandrost-4- 4000 III N Android; Oreton; Testred; Virilon en-3-one)

Methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11- 4000 III N Metribolone trien-3-one)

Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3- 4000 III N Cheque; Matenon one)

| Nandrolone (17β-hydroxyestr-4-en-3-one) | 4000 | III | N Deca-Durabolin; Durabolin; Durabolin-50 |
|---|---|---|---|
| Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3- | 4000 | III | N Genabol |

one)

| Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) | 4000 | III | N Anabol-4-19; Lentabol |
|---|---|---|---|
| Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3- | 4000 | III | N Nilevar; Pronabol; Solevar |

one)

Normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3- 4000 III N Lutenin; Matronal; Orgasteron one)

Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α- 4000 III N Anavar; Lonavar; Oxandrin; Provitar; Vasorome androstan-3-one)

Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4- 4000 III N Anamidol; Balnimax; Oranabol; Oranabol 10 en-3-one)

Oxymetholone (17α-methyl-2-hydroxymethylene-17β- 4000 III N Anadrol-50; Adroyd; Anapolon; Anasteron; Pardroyd hydroxy-5α-androstan-3-one)

Prostanozol (17β-hydroxy-5α-androstano[3,2- 4000 III N Prostanozol; [3,2-c]pyrazole-5α-androstan-17β-ol c]pyrazole)

Stanozolol (17α-methyl-17β-hydroxy-5α-androst-2- 4000 III N Winstrol; Winstrol-V eno[3,2-c]-pyrazole)

Stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3- 4000 III N one)

Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta- 4000 III N Teolit; Teslac 1,4-dien-17-oic acid lactone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Testosterone (17β-hydroxyandrost-4-en-3-one) | 4000 | III | N Android-T; Androlan; Depotest; Delatestryl |
|---|---|---|---|
| Tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon- | 4000 | III | N THG |

4,9,11-trien-3-one)

| Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) | 4000 | III | N Finaplix-S; Finajet; Parabolan |
|---|---|---|---|
| Δ1-Dihydrotestosterone (17β-hydroxy-5α-androst-1-en- | 4000 | III | N 1-Testosterone |

3-one)

(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3- 7000 I N yl)(naphthalen-1-yl)methanone (AM–1220)

(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen- 7000 I N 1-yl)methanone (MAM–2201)

(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–147)

(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H- 7000 I N indol-3-yl)methanone (AM–2233)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–007)

(4-Ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H-indol-3- 7000 I N yl)methanone (EAM–2201)

(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–210)

(4-Fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–412)

(4-Methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol- 7000 I N 3-yl)methanone (JWH–098)

(4-Methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H- 7000 I N indol-3-yl)methanone (JWH–193)

(5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen- 7000 I N 1-yl)methanone (JWH–307)

(5-Methyl-3-(morpholinomethyl)-2,3-dihydro- 7000 I N [1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1- yl)methanone (WIN 55,212–2)

2-(3-Hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol 7000 I N (CP–47,497 C9 homolog)

2-(3-Hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol 7000 I N (CP–47,497 C6 homolog)

2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1- 7000 I N one (JWH–302)

2-(5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2- 7000 I N methyloctan-2-yl)phenol (CP–55,940)

3-((4-Methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole 7000 I N (JWH–184)

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) 7000 I N Prior drug code 7694 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Cannabimimetic agents 7000 I N Any substance meeting the definition of cannabimimetic agent as set forth in 21 CFR § 1308.11(g)

| CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- | 7000 | I | N Prior drug code 7297 under Synthetic Drug Abuse |
|---|---|---|---|
| hydroxycyclohexy]-phenol) | Prevention Act; consolidated to 7000 under 91 FR 2297 |  |  |
| CP-47,497 C8 Homologue (5-(1,1-dimethyloctyl)-2- | 7000 | I | N Prior drug code 7298 under Synthetic Drug Abuse |
| [(1R,3S)3-hydroxycyclohexyl]-phenol) | Prevention Act; consolidated to 7000 under 91 FR 2297 |  |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

JWH-019 (1-hexyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7019 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-073 (1-butyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7173 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-081 (1-pentyl-3-(1-(4-methoxynaphthoyl)indole)) 7000 I N Prior drug code 7081 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) 7000 I N Prior drug code 7122 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

| JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- | 7000 | I | N Prior drug code 7200 under Synthetic Drug Abuse |
|---|---|---|---|
| naphthoyl)indole) | Prevention Act; consolidated to 7000 under 91 FR 2297 |  |  |
| JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) | 7000 | I | N Prior drug code 7203 under Synthetic Drug Abuse |

Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) 7000 I N Prior drug code 6250 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) 7000 I N Prior drug code 7398 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

Naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3- 7000 I N yl)methanone (JWH–022)

| SR-18 (1-cyclohexylethyl-3-(2-methoxyphenylacetyl) | 7000 | I | N RCS-8 |
|---|---|---|---|
| indole) | Prior drug code 7008 under Synthetic Drug Abuse |  |  |

Prevention Act; consolidated to 7000 under 91 FR 2297

SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) 7000 I N RCS-4 Prior drug code 7104 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7010 I N ADB-FUBINACA 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I N 5-Fluoro-UR-144; XLR-11; XLR11 indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7012 I N AB-FUBINACA 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB-144 tetramethylcyclopropyl)methanone

MDMB–FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H- 7020 I N MDMB-FUBINACA indazole-3-carboxamido)-3,3-dimethylbutanoate) (Positional Isomer: EMB-FUBINACA)

Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3- 7021 I N FUB–AMB; MMB– FUBINACA; AMB–FUBINACA carboxamido)-3-methylbutanoate

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7023 I N AB-PINACA pentyl-1H-indazole-3-carboxamide)

THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I N yl](naphthalen-1-yl)methanone)

5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7025 I N 1-(5-fluoropentyl)-1 H-indazole-3-carboxamide)

ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7027 I N ADB-BUTINACA 2-yl)-1-butyl-1H-indazole-3-carboxamide)

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I N AB-CHMINACA yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan- 7032 I N MAB-CHMINACA; ADB-CHMINACA 2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

5F–AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- 7033 I N 5F-AMB carboxamido)-3-methylbutanoate)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5- 7034 I N 5F-ADB; 5F-MDMB-PINACA fluoropentyl)-1H-indazole-3-carboxamido)-3,3-

| dimethylbutanoate) | (Positional isomers: 5F-AEB; 5F-EMB-PINACA) |  |  |
|---|---|---|---|
| ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2- | 7035 | I | N ADB-PINACA |

yl)-1-pentyl-1H-indazole-3-carboxamide)

Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)- 7036 I N 5F-EDMB-PINACA 3,3-dimethylbutanoate

Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 7041 I N 5F-MDMB-PICA 3,3-dimethylbutanoate (Positional Isomer: 5F-EMB-PICA or 5-fluoro-EMB-PICA)

MDMB–CHMICA; MMB–CHMINACA (methyl 2-(1- 7042 I N MDMB-CHMICA; MMB-CHMINACA (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate)

4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- 7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate)

MMB-CHMICA; AMB-CHMICA (methyl 2-(1- 7044 I N (cyclohexylmethyl)-1 H-indole-3-carboxamido)-3- methylbutanoate)

| N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3- | 7047 | I | N FUB-AKB48; FUB-APINACA; AKB48 N-(4- |
|---|---|---|---|
| carboxamide | FLUOROBENZYL) |  |  |
| APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H- | 7048 | I | N APINACA; AKB48 |

indazole-3-carboxamide

5F–APINACA; 5F–AKB48 (N-(adamantan-1-yl)-1-(5- 7049 I N 5F-APINACA; 5F-AKB48 fluoropentyl)-1H-indazole-3-carboxamide)

1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole- 7083 I N 5F-CUMYL-PINACA; SGT-25 3-carboxamide

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I N phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3- carboxamide)

| 4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2- | 7089 | I | N 4-Cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; |
|---|---|---|---|
| phenylpropan-2-yl)-1 H-indazole-3-carboxamide) | CUMYL-4CN-BINACA; SGT-78 |  |  |
| MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- | 7090 | I | N MDMB-4en-PINACA |

en-1-yl)-1H-indazole-3-carboxamido)butanoate)

4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- 7091 I N 4F-MDMB-BUTICA; 4F-MDMB-BICA carbonyl]amino]-3,3-dimethyl-butanoate)

ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- 7092 I N ADB-4en-PINACA oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide)

CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- 7093 I N CUMYL-PEGACLONE; SGT-151 yl)pyrido[4,3-b]indol-1-one)

5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- 7094 I N 5F-EDMB-PICA; 5F-EDMB-2201 carbonyl]amino]-3,3-dimethyl-butanoate)

MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole- 7095 I N MMB-FUBICA 3-carboxamido)-3-methyl butanoate)

JWH-018 (also known as AM678) (1-pentyl-3-(1- 7118 I N naphthoyl)indole)

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I N tetramethylcyclopropyl)metanone

| AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) | 7201 | I | N |
|---|---|---|---|
| 6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H- | 7220 | I | N Hexahydrocannabinol; HHC |

benzo[c]chromen-1-ol

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)- 7221 I N 1H-indole-3-carboxylate)

| PB-22 (quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) | 7222 | I | N QUPIC; PB-22 |
|---|---|---|---|
| 5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- | 7225 | I | N 5-Fluoro-PB-22; 5F-PB-22 |

carboxylate)

| 4-Methyl-alpha-ethylaminopentiophenone (4-MEAP) | 7245 | I | N 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one |
|---|---|---|---|
| N-Ethylhexedrone | 7246 | I | N α-Ethylaminohexanophenone; 2-(ethylamino)-1- |

phenylhexan-1-one

| Alpha-ethyltryptamine | 7249 | I | N ET; Trip |
|---|---|---|---|
| Ibogaine | 7260 | I | N Constituent of "Tabernanthe iboga" plant |
| 2-Fluorodeschloroketamine | 7284 | I | N 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1-one; 2- |

FDCK

| Ketamine | 7285 | III | N Ketaset; Ketalar; Special K; K |
|---|---|---|---|
| 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one | 7286 | I | N MXE; methoxetamine |

(methoxetamine)

| Diphenidine | 7292 | I | Y 1-(1,2-Diphenylethyl)piperidine |
|---|---|---|---|
| Tiletamine & Zolazepam Combination Product | 7295 | III | N Telazol |
| Lysergic acid | 7300 | III | N LSD precursor |
| Lysergic acid amide | 7310 | III | N LSD precursor |
| Lysergic acid diethylamide | 7315 | I | N LSD; lysergide |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) | 7348 | I | N 2C-T-7 |

(Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

| Marihuana Extract | 7350 | I | N |
|---|---|---|---|
| Marijuana extract, as defined in 21 CFR | 7353 | III | N |

1308.11(d)(58), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license

| Marihuana | 7360 | I | N Cannabis; marijuana |
|---|---|---|---|
| Marijuana, as defined in 21 U.S.C. 802(16), in a U.S. | 7362 | III | N |

Food and Drug Administration approved product or subject to a state medical marijuana license

Dronabinol in an oral solution in a drug product 7365 II N Syndros approved for marketing by the U.S. Food and Drug Administration

| Dronabinol (synthetic) in sesame oil in soft gelatin | 7369 | III | N Marinol; synthetic THC in sesame oil/soft gelatin as |
|---|---|---|---|
| capsule as approved by FDA | approved by FDA |  |  |
| Tetrahydrocannabinols | 7370 | I | N THC; Delta-8 THC; Delta-9 THC; dronabinol and others |
| Parahexyl | 7374 | I | N Synhexyl |
| Nabilone | 7379 | II | N Cesamet |
| Mescaline | 7381 | I | N Constituent of "Peyote" cacti |
| 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T- | 7385 | I | N 2C-T-2 |

2)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Naturally derived delta-9-tetrahydrocannabinols in a | 7386 | III | N (i) Naturally derived delta-9-tetrahydrocannabinols means |
|---|---|---|---|
| U.S. Food and Drug Administration approved product | those delta-9-tetrahydrocannabinols, except as in |  |  |
| or in marijuana subject to a state medical marijuana | paragraphs 21 CFR 1308.13(g)(2) and (3), that are |  |  |
| license | naturally contained in a plant of the genus Cannabis |  |  |

(cannabis plant) (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C 802(16)(B)(ii)

3,4,5-Trimethoxyamphetamine 7390 I N TMA

(Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA- 5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline)

| 4-Bromo-2,5-dimethoxyamphetamine | 7391 | I | N DOB; 4-bromo-DMA |
|---|---|---|---|
| 4-Bromo-2,5-dimethoxyphenethylamine | 7392 | I | N 2C-B; Nexus; has been sold as Ecstasy, i.e. MDMA |
| 4-Methyl-2,5-dimethoxyamphetamine | 7395 | I | N DOM; STP |

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

| 2,5-Dimethoxyamphetamine | 7396 | I | N DMA; 2,5-DMA |
|---|---|---|---|
| 2,5-Dimethoxy-4-ethylamphetamine | 7399 | I | N DOET |

(Positional Isomer: 1-(2,5-dimethoxy-4- methylphenyl)butan-2-amine)

3,4-Methylenedioxyamphetamine 7400 I N MDA; Love Drug

(Positional Isomer: 2,3-methylenedioxyamphetamine (2,3- MDA))

| 5-Methoxy-3,4-methylenedioxyamphetamine | 7401 | I | N MMDA |
|---|---|---|---|
| N-Hydroxy-3,4-methylenedioxyamphetamine | 7402 | I | N N-Hydroxy MDA |
| 3,4-Methylenedioxy-N-ethylamphetamine | 7404 | I | N N-Ethyl MDA; MDE; MDEA |

(Positional Isomer: MBDB)

3,4-Methylenedioxymethamphetamine 7405 I N MDMA; Ecstasy; XTC

(Positional Isomer: 3,4-methylenedioxyphenyl-2- butanamine (BDB))

| 4-Methoxyamphetamine | 7411 | I | N PMA |
|---|---|---|---|
| Peyote | 7415 | I | N Cactus which contains mescaline |
| 5-Methoxy-N,N-dimethyltryptamine | 7431 | I | N 5-MeO-DMT |

(Positional Isomer: 4-Methoxy-N,N-dimethyltryptamine (4- MeO-DMT, 4-methoxy-DMT))

alpha-Methyltryptamine 7432 I N AMT

(Positional Isomer: N-Methyltryptamine)

Bufotenine 7433 I N Mappine; N,N-dimethylserotonin

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

Diethyltryptamine 7434 I N DET, N,N-diethyltryptamine

(Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))

| Dimethyltryptamine | 7435 | I | N DMT |
|---|---|---|---|
| Psilocybin | 7437 | I | N Constituent of "Magic mushrooms" |
| Psilocyn | 7438 | I | N Psilocin, constituent of "Magic mushrooms" |

(Positional Isomers: 6-hydroxy DMT; 7-hydroxy DMT)

5-Methoxy-N,N-diisopropyltryptamine 7439 I N 5-MeO-DIPT

(Positional Isomer: 5-Methoxy-N,N-dipropyltryptamine (5- MeO-DPT))

| 4'-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α- | 7443 | I | N 4-Chloro-α-PVP; 4'-chloro-α-pyrrolidinopentiophenone; 1- |
|---|---|---|---|
| PVP) | (4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one |  |  |
| 4´-Methyl-alpha-pyrrolidinohexiophenone (MPHP) | 7446 | I | N MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1-(4- |

methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one

(Positional Isomer: 2-methyl-α-pyrrolidinoisohexanophenone (2-Me-α-PiHP))

| N-Ethyl-1-phenylcyclohexylamine | 7455 | I | N PCE |
|---|---|---|---|
| 3-Methoxyphencyclidine | 7457 | I | N 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine; 3-MeO–PCP |
| 1-(1-Phenylcyclohexyl)pyrrolidine | 7458 | I | N PCPy; PHP; rolicyclidine |
| 1-Phenylcyclohexylamine | 7460 | II | N PCP precursor |
| 1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I | N TCP; tenocyclidine |
| Phencyclidine | 7471 | II | N PCP; Sernylan |
| 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine | 7473 | I | N TCPy |
| N-Ethyl-3-piperidyl benzilate | 7482 | I | N JB 323 |
| N-Methyl-3-piperidyl benzilate | 7484 | I | N JB 336 |
| N-Benzylpiperazine | 7493 | I | N BZP; 1-benzylpiperazine |
| 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) | 7498 | I | N MePPP; 4-methyl-α-pyrrolidinopropiophenone; 1-(4- |

methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one

| 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) | 7508 | I | N 2C-D |
|---|---|---|---|
| 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) | 7509 | I | N 2C-E |

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

| 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) | 7517 | I | N 2C-H |
|---|---|---|---|
| 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) | 7518 | I | N 2C-I |
| 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) | 7519 | I | N 2C-C |
| 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) | 7521 | I | N 2C-N |
| 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C- | 7524 | I | N 2C-P |

P)

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine 7532 I N 2C-T-4 (2C-T-4) (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

MDPV (3,4-Methylenedioxypyrovalerone) 7535 I N

(Positional Isomers: 1-(1,3-benzodioxol-5-yl)-2- (cyclohexylamino)propan-1-one(n-cyclohexyl methylone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone) ;1- (1,3-benzodioxol-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3- methylenedioxy pyrovalerone)

2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I N 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 ethanamine (25B-NBOMe)

2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7537 I N 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82 ethanamine (25C-NBOMe)

2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7538 I N 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5 ethanamine (25I-NBOMe)

Methylone (3,4-Methylenedioxy-N-methylcathinone) 7540 I N (Positional Isomer: ￿2,3-methylenedioxymethcathinone (2,3-MDMC, 1-(benzo[d][1,3]dioxol-4-yl)-2- (methylamino)propan-1-one))

Butylone 7541 I N bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan- 1-one

(Positional Isomers: ￿dimethylone (bk-MDDMA; MDDMC), N,N-dimethyl-3,4-methylenedioxycathinone)

Pentylone 7542 I N bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2- (methylamino)pentan-1-one

(Positional Isomers: dibutylone (bk-DMBDB) and propylone (3',4'-methylenedioxy-N-propylaminocathinone; 1-(benzo[d][1,3]dioxol-5-yl)-2-(propylamino)propan-1-one); 2,3-methylenedioxy-α-ethylaminobutiophenone)

N-Ethylpentylone (1-(1,3-benzodioxol-5-yl)-2- 7543 I N Ephylone (ethylamino)-pentan-1-one) (Positional Isomers: 3,4-methylenedioxy-α-propylaminobutiophenone; isopropyl butylone (MDIPBP))

alpha-Pyrrolidinohexanophenone (α-PHP) 7544 I N α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2- (pyrrolidin-1-yl)hexan-1-one

alpha-Pyrrolidinopentiophenone (α-PVP) 7545 I N α-Pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomers: 4-methyl-α-pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2-(piperidin-1-yl)butan-1-one)

| alpha-pyrrolidinobutiophenone (α-PBP) | 7546 | I | N 1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one |
|---|---|---|---|
| Ethylone | 7547 | I | N 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one; 3,4- |

methylenedioxy-N-ethylcathinone; bk-MDEA; MDEC

alpha-Pyrrolidinoheptaphenone (PV8) 7548 I N PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one

(Positional Isomer: α-pyrrolidinoisoheptanophenone (α- PiHPP; iso-PV8))

Eutylone 7549 I N 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one; bk- EBDB

α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- 7551 I N α-PiHP; alpha-PiHP one)

| 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | 7552 | I | N Dipentylone; N,N-dimethylpentylone |
|---|---|---|---|
| Carisoprodol | 8192 | IV | N Soma |
| 4-Anilino-N-phenethyl-4-piperidine (ANPP) | 8333 | II | N ANPP; despropionyl fentanyl |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) | 8366 | II | Y |
|---|---|---|---|
| Phenylacetone | 8501 | II | N P2P; phenyl-2-propanone; benzyl methyl ketone |
| 1-Piperidinocyclohexanecarbonitrile | 8603 | II | N PCC; PCP precursor |
| Alphaprodine | 9010 | II | Y Nisentil |
| Anileridine | 9020 | II | Y Leritine |
| Coca Leaves | 9040 | II | Y |
| Cocaine | 9041 | II | Y Methyl benzoylecgonine; Crack |
| Codeine | 9050 | II | Y Morphine methyl ester; methyl morphine |
| Acetyldihydrocodeine | 9051 | I | Y Acetylcodone |
| Benzylmorphine | 9052 | I | Y |
| Codeine-N-oxide | 9053 | I | Y |
| Cyprenorphine | 9054 | I | Y |
| Desomorphine | 9055 | I | Y |
| Etorphine (except HCl) | 9056 | I | Y |
| Etorphine HCl | 9059 | II | Y M 99 |
| Buprenorphine | 9064 | III | Y Buprenex; Temgesic; Subutex; Suboxone |
| Codeine methylbromide | 9070 | I | Y |
| 8-(1-(4-Chlorophenyl)ethyl)-1-phenyl-1,3,8- | 9093 | I | Y Spirochlorphine; R–6890 |

triazaspiro[4.5]decan-4-one

3-(3-(1-(1-(4-Chlorophenyl)ethyl)piperidin-4-yl)-2-oxo- 9094 I Y N-Propionitrile chlorphine; cychlorphine 2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile

5,6-Dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3- 9096 I Y 5,6-Dichloro desmethylchlorphine; SR–17018 dihydro-2H-benzo[d]imidazol-2-one

1-(1-(1-(4-Bromophenyl)ethyl)piperidin-4-yl)-5,6- 9097 I Y 5,6-Dichloro brorphine; SR–14968 dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one

| Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)- | 9098 | I | Y 1-[1-[1-(4-Bromophenyl)ethyl]-4-piperidinyl]-1,3-dihydro- |
|---|---|---|---|
| 1,3-dihydro-2H-benzo[d]imidazol-2-one) | 2H-benzimidazol-2-one |  |  |
| Dihydrocodeine | 9120 | II | Y Didrate; Parzone |
| Oxycodone | 9143 | II | Y OxyContin; Percocet; Endocet; Roxicodone; Roxicet |
| Dihydromorphine | 9145 | I | Y |
| Hydromorphone | 9150 | II | Y Dilaudid; dihydromorphinone |
| Difenoxin 1 mg/25 ug AtSO4/du | 9167 | IV | Y Motofen |
| Difenoxin | 9168 | I | Y Lyspafen |
| Diphenoxylate | 9170 | II | Y |
| Ecgonine | 9180 | II | Y Cocaine precursor, in Coca leaves |
| Ethylmorphine | 9190 | II | Y Dionin |
| Hydrocodone | 9193 | II | Y Dihydrocodeinone |
| Heroin | 9200 | I | Y Diacetylmorphine; diamorphine |
| Levomethorphan | 9210 | II | Y |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Levorphanol | 9220 | II | Y Levo-Dromoran |
|---|---|---|---|
| Isomethadone | 9226 | II | Y Isoamidone |
| Meperidine | 9230 | II | Y Demerol; Mepergan; pethidine |
| Meperidine intermediate-A | 9232 | II | Y Meperidine precursor |
| Meperidine intermediate-B | 9233 | II | Y Meperidine precursor; normeperidine |
| Meperidine intermediate-C | 9234 | II | Y Meperidine precursor |
| Metazocine | 9240 | II | Y |
| Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2- | 9245 | II | Y |

[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl{time} )amine fumarate)

| Methadone | 9250 | II | Y Dolophine; Methadose; Amidone |
|---|---|---|---|
| Methadone intermediate (4-cyano-2-dimethylamino-4,4- | 9254 | II | Y Methadone precursor |

diphenylbutane)

| Metopon | 9260 | II | Y |
|---|---|---|---|
| Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II | Y Propoxyphene |
| Dextropropoxyphene dosage forms | 9278 | IV | Y Darvon; propoxyphene; Darvocet; Propacet |
| Morphine | 9300 | II | Y MS Contin; Roxanol; Oramorph; RMS; MSIR |
| Hydromorphinol | 9301 | I | Y |
| Methyldesorphine | 9302 | I | Y |
| Methyldihydromorphine | 9304 | I | Y |
| Morphine methylbromide | 9305 | I | Y |
| Morphine methylsulfonate | 9306 | I | Y |
| Morphine-N-oxide | 9307 | I | Y |
| Myrophine | 9308 | I | Y |
| Nicocodeine | 9309 | I | Y |
| Nicomorphine | 9312 | I | Y Vilan |
| Normorphine | 9313 | I | Y |
| Pholcodine | 9314 | I | Y Copholco; Adaphol; Codisol; Lantuss; Pholcolin |
| Thebacon | 9315 | I | Y Acetylhydrocodone; Acedicon; Thebacetyl |
| Acetorphine | 9319 | I | Y |
| Oripavine | 9330 | II | Y |
| Thebaine | 9333 | II | Y Precursor of many narcotics |
| Dihydroetorphine | 9334 | II | Y DHE |
| Drotebanol | 9335 | I | Y Metebanyl; oxymethebanol |
| Nalorphine | 9400 | III | Y Nalline |
| U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]- | 9547 | I | Y |

N-methylbenzamide)

AH-7921 (3,4-dichloro-N-[(1- 9551 I Y dimethylamino)cyclohexylmethyl]benzamide))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) | 9560 | I | Y |
|---|---|---|---|
| Opium, raw | 9600 | II | Y Raw opium; gum opium |
| Acetylmethadol | 9601 | I | Y Methadyl acetate |
| Allylprodine | 9602 | I | Y |
| Alphacetylmethadol except levo-alphacetylmethadol | 9603 | I | Y |
| Alphameprodine | 9604 | I | Y |
| Alphamethadol | 9605 | I | Y |
| Benzethidine | 9606 | I | Y |
| Betacetylmethadol | 9607 | I | Y |
| Betameprodine | 9608 | I | Y |
| Betamethadol | 9609 | I | Y |
| Opium extracts | 9610 | II | Y |
| Betaprodine | 9611 | I | Y |
| Clonitazene | 9612 | I | Y |
| Dextromoramide | 9613 | I | Y Palfium; Jetrium; Narcolo |
| Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5- | 9614 | I | Y N,N-Diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro- |
| nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 1H-benzimidazole-1-ethanamine |  |  |
| Diampromide | 9615 | I | Y |
| Diethylthiambutene | 9616 | I | Y |
| Dimenoxadol | 9617 | I | Y |
| Dimepheptanol | 9618 | I | Y |
| Dimethylthiambutene | 9619 | I | Y |
| Opium fluid extract | 9620 | II | Y |
| Dioxaphetyl butyrate | 9621 | I | Y |
| Dipipanone | 9622 | I | Y Dipipan; phenylpiperone HCl; Diconal; Wellconal |
| Ethylmethylthiambutene | 9623 | I | Y |
| Etonitazene | 9624 | I | Y |
| Etoxeridine | 9625 | I | Y |
| Furethidine | 9626 | I | Y |
| Hydroxypethidine | 9627 | I | Y |
| Ketobemidone | 9628 | I | Y Cliradon |
| Levomoramide | 9629 | I | Y |
| Opium tincture | 9630 | II | Y Laudanum |
| Levophenacylmorphan | 9631 | I | Y |
| Morpheridine | 9632 | I | Y |
| Noracymethadol | 9633 | I | Y |
| Norlevorphanol | 9634 | I | Y |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Normethadone | 9635 | I | Y Phenyldimazone |
|---|---|---|---|
| Norpipanone | 9636 | I | Y |
| Phenadoxone | 9637 | I | Y |
| Phenampromide | 9638 | I | Y |
| Opium, powdered | 9639 | II | Y Powdered opium |
| Opium, granulated | 9640 | II | Y Granulated opium |
| Phenoperidine | 9641 | I | Y Operidine; Lealgin |
| Piritramide | 9642 | I | Y Piridolan |
| Proheptazine | 9643 | I | Y |
| Properidine | 9644 | I | Y |
| Racemoramide | 9645 | I | Y |
| Trimeperidine | 9646 | I | Y Promedolum |
| Phenomorphan | 9647 | I | Y |
| Levo-alphacetylmethadol | 9648 | II | Y LAAM; long acting methadone; levomethadyl acetate |
| Propiram | 9649 | I | Y Algeril |
| Opium poppy | 9650 | II | Y Papaver somniferum |
| Poppy Straw | 9650 | II | Y Opium poppy capsules; poppy heads |
| Oxymorphone | 9652 | II | Y Numorphan |
| 1-Methyl-4-phenyl-4-propionoxypiperidine | 9661 | I | Y MPPP; synthetic heroin |
| 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine | 9663 | I | Y PEPAP; synthetic heroin |
| 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1- | 9664 | I | Y |

yl)piperazin-1-yl)butan-1-one)

O-Desmethyltramadol 9667 I Y O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol

| Noroxymorphone | 9668 | II | Y |
|---|---|---|---|
| Poppy Straw Concentrate | 9670 | II | Y Concentrate of Poppy Straw, CPS |
| Methyl (E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-oxo- | 9672 | I | Y Mitragynine pseudoindoxyl |

3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′- indolizine]-7′-yl)-3-methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a- 9673 I Y MGM–15; dihydro-7-hydroxymitragynine hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

| Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro- | 9674 | I | Y MGM–16; 9-fluoro-dihydro-7-hydroxymitragynine; 10- |
|---|---|---|---|
| 7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b- | fluoro-dihydro-7-hydroxymitragynine |  |  |

decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

| Pentazocine | 9709 | IV | N Talwin; Talwin NX; Talacen; Talwin Compound |
|---|---|---|---|
| Phenazocine | 9715 | II | Y Narphen; Prinadol |
| Butorphanol | 9720 | IV | N Stadol; Stadol NS; Torbugesic; Torbutrol |
| Eluxadoline | 9725 | IV | N VIBERZI |
| Thiafentanil | 9729 | II | Y Thianil |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Piminodine | 9730 | II | Y |
|---|---|---|---|
| Racemethorphan | 9732 | II | Y |
| Racemorphan | 9733 | II | Y Dromoran |
| Alfentanil | 9737 | II | Y Alfenta |
| Remifentanil | 9739 | II | Y Ultiva |
| Sufentanil | 9740 | II | Y Sufenta |
| Carfentanil | 9743 | II | Y Wildnil |
| Tilidine | 9750 | I | Y Tilidate; Valoron; Kitadol; Lak; Tilsa |
| Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H- | 9751 | I | Y |

benzimidazol-1-yl)-N,N-diethylethan-1-amine)

Tramadol (2-[(dimethylamino)methyl]-1-(3- 9752 IV Y Tramadol methoxyphenyl)cyclohexanol)

Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- 9756 I Y 1H-benzimidazol-1-yl)ethan-1-amine)

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- 9757 I Y nitro-1H-benzimidazol-1-yl)ethan-1-amine)

N-Pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9758 I Y Etonitazepyne (2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)

Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- 9759 I Y propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)

N-Desethyl isotonitazene (N-ethyl-2-(2-(4- 9760 I Y isopropoxylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan- 1-amin)

N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9761 I Y Etonitazepipne (2-(piperidin-1-yl)ethyl-1H-benzimidazole)

2-(4-Methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)- 9762 I Y Metonitazepyne 1H-benzimidazole (N-pyrrolidino metonitazene)

5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)- 9763 I Y Protonitazepyne 1H-benzimidazole (N-pyrrolidino protonitazene)

Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 9764 I Y 1H-benzimidazol-1-yl)ethan-1-amine)

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1H- 9765 I Y benzimidazol-1-yl)-N,N-diethylethan-1-amine)

2-(2-(Benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol- 9766 I Y Methylenedioxynitazene; 3′,4′-Methylenedioxynitazene 1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)- 9767 I Y 5-Methyl etodesnitazene N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N- 9768 I Y N-Desethyl etonitazene ethylethan-1-amine

N-Ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H- 9769 I Y N-Desethyl protonitazene benzimidazol-1-yl)ethan-1-amine

2-(2-((2,3-Dihydrobenzofuran-5-yl)methyl)-5-nitro-1H- 9770 I Y Ethyleneoxynitazene benzimidazol-1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)- 9771 I Y N,N-Dimethylamino etonitazene N,N-dimethylethan-1-amine

2-(4-Isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1- 9772 I Y N-Pyrrolidino isotonitazene yl)ethyl)-1H-benzimidazole

Tapentadol 9780 II Y

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Bezitramide | 9800 | II | Y Burgodin |
|---|---|---|---|
| Fentanyl | 9801 | II | Y Duragesic; Oralet; Actiq; Sublimaze; Innovar |
| Moramide-intermediate | 9802 | II | Y |
| Codeine & isoquinoline alkaloid 90 mg/du | 9803 | III | Y Codeine with papaverine or noscapine |
| Codeine combination product 90 mg/du | 9804 | III | Y Empirin; Fiorinal; Tylenol; ASA or APAP w/codeine |
| Dihydrocodeine combination product 90 mg/du | 9807 | III | Y Synalgos-DC; Compal |
| Ethylmorphine combination product 15 mg/du | 9808 | III | Y |
| Opium combination product 25 mg/du | 9809 | III | Y Paregoric, other combination products |
| Morphine combination product/50 mg/(100 ml or 100 | 9810 | III | Y |

gm)

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9811 I Y Acryloylfentanyl phenylacrylamide)

| para-Fluorofentanyl | 9812 | I | Y China White; fentanyl |
|---|---|---|---|
| 3-Methylfentanyl | 9813 | I | Y China White; fentanyl |
| alpha-Methylfentanyl | 9814 | I | Y China White; fentanyl |
| Acetyl-alpha-methylfentanyl | 9815 | I | Y |
| N-(2-Fluorophenyl)-N-(1-phenethylpiperidin-4- | 9816 | I | Y ortho-Fluorofentanyl or 2-fluorofentanyl |

yl)propionamide

para-Methylfentanyl (N-(4-methylphenyl)-N-(1- 9817 I Y phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl)

para-Chlorofentanyl (N-(4-chlorophenyl)-N-(1- 9818 I Y phenethylpiperidin-4-yl)propionamide)

4'-Methyl acetyl fentanyl (N-(1-(4- 9819 I Y methylphenethyl)piperidin-4-yl)-N-phenylacetamide)

ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- 9820 I Y 2-Methyl methoxyacetyl fentanyl methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide)

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9821 I Y phenylacetamide)

Butyryl Fentanyl 9822 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide

para-Fluorobutyryl fentanyl 9823 I Y N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- 9824 I Y para-Fluoroisobutyryl fentanyl phenethylpiperidin-4-yl)isobutyramide)

2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I Y Methoxyacetyl fentanyl phenylacetamide

para-Chloroisobutyryl fentanyl 9826 I Y N-(4-Chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide

| Isobutyryl fentanyl | 9827 | I | Y N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide |
|---|---|---|---|
| ortho-Chlorofentanyl (N-(2-chlorophenyl)-N-(1- | 9828 | I | Y |

phenethylpiperidin-4-yl)propionamide)

| beta-Hydroxyfentanyl | 9830 | I | Y China White; fentanyl |
|---|---|---|---|
| beta-Hydroxy-3-methylfentanyl | 9831 | I | Y China White; fentanyl |
| alpha-Methylthiofentanyl | 9832 | I | Y China White; fentanyl |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

| 3-Methylthiofentanyl | 9833 | I | Y China White; fentanyl |
|---|---|---|---|
| Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9834 | I | Y |

phenylfuran-2-carboxamide)

| Thiofentanyl | 9835 | I | Y Chine white; fentanyl |
|---|---|---|---|
| beta-Hydroxythiofentanyl | 9836 | I | Y N-[1-[2-Hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N- |

phenylpropionamide; N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4- piperidinyl]-N-phenylpropanamide

para-Methoxybutyryl fentanyl 9837 I Y N-(4-Methoxyphenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

Ocfentanil 9838 I Y N-(2-Fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4- yl)acetamide

Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9839 I Y phenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl; thiophene fentanyl)

| Valeryl fentanyl | 9840 | I | Y N-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide |
|---|---|---|---|
| Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9841 | I | Y |

phenylbenzamide; also known as benzoyl fentanyl)

beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- 9842 I Y diphenylpropanamide; also known as β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)

N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran- 9843 I Y Tetrahydrofuranyl fentanyl 2-carboxamide

Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N- 9844 I Y phenylbut-2-enamide)

Cyclopropyl Fentanyl 9845 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9846 I Y phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl fentanyl)

Cyclopentyl fentanyl 9847 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide

ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- 9848 I Y phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl)

ortho-Methylcyclopropylfentanyl (N-(2-methylphenyl)-N- 9849 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

Fentanyl-related substances as defined in 21 CFR 9850 I Y 1308.11(h)

Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- 9851 I Y yl)(phenyl)carbamate)

ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- 9852 I Y phenethylpiperidin-4-yl)acrylamide)

ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9853 I Y phenethylpiperidin-4-yl)isobutyramide)

para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- 9854 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

2'-Fluoro ortho-fluorofentanyl (N-(1-(2- 9855 I Y fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

SUBSTANCE CSCN SCH NARC OTHER NAMES

beta-Methyl fentanyl (N-phenyl-N-(1-(2- 9856 I Y phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl)

meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- 9857 I Y phenethylpiperidin-4-yl)propionamide)

meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1- 9858 I Y phenethylpiperidin-4-yl)isobutyramide)

para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- 9859 I Y (1-phenethylpiperidin-4-yl)furan-2-carboxamide)

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9860 I Y phenylfuran-3-carboxamide)

2',5'-Dimethoxyfentanyl (N-(1-(2,5- 9861 I Y dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)

Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4- 9862 I Y yl)-N-phenylbutanamide)

ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- 9863 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

alpha'-Methyl butyryl fentanyl (2-methyl-N-(1- 9864 I Y phenethylpiperidin-4-yl)-N-phenylbutanamide)

para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- 9865 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

beta-Methylacetyl fentanyl (N-phenyl-N-(1-(2- 9868 I Y phenylpropyl)piperidin-4-yl)acetamide)

Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin- 9869 I Y Tetrahydrothiophene fentanyl 4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)

para-Fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1- 9870 I Y phenethylpiperidin-4-yl)pentanamide)

meta-Fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1- 9871 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

Zipeprol (1-methoxy-3[-4-(2-methoxy-2- 9873 I Y phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by Controlled Substance Code Number

## CSA ScheduleControlled Substances

## - by CSA Schedule -

SUBSTANCE CSCN SCH NARC OTHER NAMES

(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3- 7000 I N yl)(naphthalen-1-yl)methanone (AM–1220)

(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB-144 tetramethylcyclopropyl)methanone

(1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen- 7000 I N 1-yl)methanone (MAM–2201)

(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–147)

(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H- 7000 I N indol-3-yl)methanone (AM–2233)

(2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1- 7000 I N yl)methanone (JWH–007)

(4-Ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H-indol-3- 7000 I N yl)methanone (EAM–2201)

(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–210)

(4-Fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3- 7000 I N yl)methanone (JWH–412)

(4-Methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol- 7000 I N 3-yl)methanone (JWH–098)

(4-Methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H- 7000 I N indol-3-yl)methanone (JWH–193)

(5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen- 7000 I N 1-yl)methanone (JWH–307)

(5-Methyl-3-(morpholinomethyl)-2,3-dihydro- 7000 I N [1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1- yl)methanone (WIN 55,212–2)

1-(1-(1-(4-Bromophenyl)ethyl)piperidin-4-yl)-5,6- 9097 I Y 5,6-Dichloro brorphine; SR–14968 dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one

| 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | 7552 | I | N Dipentylone; N,N-dimethylpentylone |
|---|---|---|---|
| 1-(1-Phenylcyclohexyl)pyrrolidine | 7458 | I | N PCPy; PHP; rolicyclidine |
| 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine | 9663 | I | Y PEPAP; synthetic heroin |
| 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole- | 7083 | I | N 5F-CUMYL-PINACA; SGT-25 |

3-carboxamide

| 1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I | N TCP; tenocyclidine |
|---|---|---|---|
| 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine | 7473 | I | N TCPy |
| 1-Methyl-4-phenyl-4-propionoxypiperidine | 9661 | I | Y MPPP; synthetic heroin |
| 2-(2-((2,3-Dihydrobenzofuran-5-yl)methyl)-5-nitro-1H- | 9770 | I | Y Ethyleneoxynitazene |

benzimidazol-1-yl)-N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)- 9767 I Y 5-Methyl etodesnitazene N,N-diethylethan-1-amine

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)- 9771 I Y N,N-Dimethylamino etonitazene N,N-dimethylethan-1-amine

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N- 9768 I Y N-Desethyl etonitazene ethylethan-1-amine

2-(2-(Benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol- 9766 I Y Methylenedioxynitazene; 3′,4′-Methylenedioxynitazene 1-yl)-N,N-diethylethan-1-amine

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C- 7524 I N 2C-P P)

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) 7509 I N 2C-E

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

| 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) | 7508 | I | N 2C-D |
|---|---|---|---|
| 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) | 7521 | I | N 2C-N |
| 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) | 7517 | I | N 2C-H |
| 2-(3-Hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol | 7000 | I | N |

(CP–47,497 C9 homolog)

2-(3-Hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol 7000 I N (CP–47,497 C6 homolog)

2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1- 7000 I N one (JWH–302)

2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) 7536 I N 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 ethanamine (25B-NBOMe)

| 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) | 7519 | I | N 2C-C |
|---|---|---|---|
| 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) | 7537 | I | N 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82 |

ethanamine (25C-NBOMe)

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T- 7385 I N 2C-T-2 2)

| 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) | 7518 | I | N 2C-I |
|---|---|---|---|
| 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) | 7538 | I | N 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5 |

ethanamine (25I-NBOMe)

2-(4-Isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1- 9772 I Y N-Pyrrolidino isotonitazene yl)ethyl)-1H-benzimidazole

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine 7532 I N 2C-T-4 (2C-T-4) (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2-(4-Methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)- 9762 I Y Metonitazepyne 1H-benzimidazole (N-pyrrolidino metonitazene)

2-(5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2- 7000 I N methyloctan-2-yl)phenol (CP–55,940)

2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 7286 I N MXE; methoxetamine (methoxetamine)

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) 7348 I N 2C-T-7

(Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2))

2,5-Dimethoxy-4-ethylamphetamine 7399 I N DOET

(Positional Isomer: 1-(2,5-dimethoxy-4- methylphenyl)butan-2-amine)

2,5-Dimethoxyamphetamine 7396 I N DMA; 2,5-DMA

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

2',5'-Dimethoxyfentanyl (N-(1-(2,5- 9861 I Y dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)

2'-Fluoro ortho-fluorofentanyl (N-(1-(2- 9855 I Y fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl)

2-Fluorodeschloroketamine 7284 I N 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1-one; 2- FDCK

2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I Y Methoxyacetyl fentanyl phenylacetamide

2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1- 9664 I Y yl)piperazin-1-yl)butan-1-one)

3-((4-Methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole 7000 I N (JWH–184)

3-(3-(1-(1-(4-Chlorophenyl)ethyl)piperidin-4-yl)-2-oxo- 9094 I Y N-Propionitrile chlorphine; cychlorphine 2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile

3,4,5-Trimethoxyamphetamine 7390 I N TMA

(Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA- 5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline)

3,4-Methylenedioxyamphetamine 7400 I N MDA; Love Drug

(Positional Isomer: 2,3-methylenedioxyamphetamine (2,3- MDA))

3,4-Methylenedioxymethamphetamine 7405 I N MDMA; Ecstasy; XTC

(Positional Isomer: 3,4-methylenedioxyphenyl-2- butanamine (BDB))

3,4-Methylenedioxy-N-ethylamphetamine 7404 I N N-Ethyl MDA; MDE; MDEA

(Positional Isomer: MBDB)

| 3-Chloromethcathinone | 1241 | I | N 3-CMC; 1-(3-chlorophenyl)-2-(methylamino)propan-1-one |
|---|---|---|---|
| 3-Fluoro-N-methylcathinone (3-FMC) | 1233 | I | N 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one |

(Positional Isomer: 2-FMC)

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9860 I Y phenylfuran-3-carboxamide)

| 3-Methoxyphencyclidine | 7457 | I | N 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine; 3-MeO–PCP |
|---|---|---|---|
| 3-Methylfentanyl | 9813 | I | Y China White; fentanyl |
| 3-Methylmethcathinone (2-(methylamino)-1-(3- | 1259 | I | N 3-MMC; 3-methylmethcathinone |

methylphenyl)propan-1-one)

| 3-Methylthiofentanyl | 9833 | I | Y China White; fentanyl |
|---|---|---|---|
| 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- | 1595 | I | N |

methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

4´-Methyl-alpha-pyrrolidinohexiophenone (MPHP) 7446 I N MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1-(4- methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one

(Positional Isomer: 2-methyl-α-pyrrolidinoisohexanophenone (2-Me-α-PiHP))

4-Bromo-2,5-dimethoxyamphetamine 7391 I N DOB; 4-bromo-DMA

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| 4-Bromo-2,5-dimethoxyphenethylamine | 7392 | I | N 2C-B; Nexus; has been sold as Ecstasy, i.e. MDMA |
|---|---|---|---|
| 4'-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α- | 7443 | I | N 4-Chloro-α-PVP; 4'-chloro-α-pyrrolidinopentiophenone; 1- |
| PVP) | (4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one |  |  |
| 4-Chloromethcathinone | 1239 | I | N 4-CMC; 1-(4-chlorophenyl)-2-(methylamino)propan-1-one |
| 4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2- | 7089 | I | N 4-Cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; |
| phenylpropan-2-yl)-1 H-indazole-3-carboxamide) | CUMYL-4CN-BINACA; SGT-78 |  |  |
| 4-Fluoroamphetamine (4–FA, 1-(4-fluorophenyl)propan- | 1476 | I | N 4–FA; 1-(4-fluorophenyl)propan-2-amine; para- |
| 2-amine, para-fluoroamphetamine) | fluoroamphetamine |  |  |
| 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1- | 9824 | I | Y para-Fluoroisobutyryl fentanyl |

phenethylpiperidin-4-yl)isobutyramide)

4-Fluoro-N-methylcathinone (4-FMC) 1238 I N Flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1- one

(Positional Isomer: 2-FMC)

4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2- 7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate)

4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- 7091 I N 4F-MDMB-BUTICA; 4F-MDMB-BICA carbonyl]amino]-3,3-dimethyl-butanoate)

| 4-Methoxyamphetamine | 7411 | I | N PMA |
|---|---|---|---|
| 4'-Methyl acetyl fentanyl (N-(1-(4- | 9819 | I | Y |

methylphenethyl)piperidin-4-yl)-N-phenylacetamide)

4-Methyl-2,5-dimethoxyamphetamine 7395 I N DOM; STP

(Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G))

| 4-Methyl-alpha-ethylaminopentiophenone (4-MEAP) | 7245 | I | N 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one |
|---|---|---|---|
| 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) | 7498 | I | N MePPP; 4-methyl-α-pyrrolidinopropiophenone; 1-(4- |

methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one

| 4-Methylaminorex (cis isomer) | 1590 | I | N U4Euh; McN-422 |
|---|---|---|---|
| 4-Methyl-N-ethylcathinone (4-MEC) | 1249 | I | N 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one |

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone(3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

5,6-Dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3- 9096 I Y 5,6-Dichloro desmethylchlorphine; SR–17018 dihydro-2H-benzo[d]imidazol-2-one

5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7025 I N 1-(5-fluoropentyl)-1 H-indazole-3-carboxamide)

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5- 7034 I N 5F-ADB; 5F-MDMB-PINACA fluoropentyl)-1H-indazole-3-carboxamido)-3,3-

| dimethylbutanoate) | (Positional isomers: 5F-AEB; 5F-EMB-PINACA) |  |  |
|---|---|---|---|
| 5F–AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- | 7033 | I | N 5F-AMB |

carboxamido)-3-methylbutanoate)

5F–APINACA; 5F–AKB48 (N-(adamantan-1-yl)-1-(5- 7049 I N 5F-APINACA; 5F-AKB48 fluoropentyl)-1H-indazole-3-carboxamide)

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I N phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3- carboxamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- 7094 I N 5F-EDMB-PICA; 5F-EDMB-2201 carbonyl]amino]-3,3-dimethyl-butanoate)

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H- 7011 I N 5-Fluoro-UR-144; XLR-11; XLR11 indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

5F-PB-22 (quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- 7225 I N 5-Fluoro-PB-22; 5F-PB-22 carboxylate)

| 5-Methoxy-3,4-methylenedioxyamphetamine | 7401 | I | N MMDA |
|---|---|---|---|
| 5-Methoxy-N,N-diisopropyltryptamine | 7439 | I | N 5-MeO-DIPT |

(Positional Isomer: 5-Methoxy-N,N-dipropyltryptamine (5- MeO-DPT))

5-Methoxy-N,N-dimethyltryptamine 7431 I N 5-MeO-DMT

(Positional Isomer: 4-Methoxy-N,N-dimethyltryptamine (4- MeO-DMT, 4-methoxy-DMT))

5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)- 9763 I Y Protonitazepyne 1H-benzimidazole (N-pyrrolidino protonitazene)

6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H- 7220 I N Hexahydrocannabinol; HHC benzo[c]chromen-1-ol

8-(1-(4-Chlorophenyl)ethyl)-1-phenyl-1,3,8- 9093 I Y Spirochlorphine; R–6890 triazaspiro[4.5]decan-4-one

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7031 I N AB-CHMINACA yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)- 7012 I N AB-FUBINACA 1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 7023 I N AB-PINACA pentyl-1H-indazole-3-carboxamide)

| Acetorphine | 9319 | I | Y |
|---|---|---|---|
| Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9821 | I | Y |

phenylacetamide)

| Acetyl-alpha-methylfentanyl | 9815 | I | Y |
|---|---|---|---|
| Acetyldihydrocodeine | 9051 | I | Y Acetylcodone |
| Acetylmethadol | 9601 | I | Y Methadyl acetate |
| Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9811 | I | Y Acryloylfentanyl |

phenylacrylamide)

ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1- 7092 I N ADB-4en-PINACA oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide)

ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7027 I N ADB-BUTINACA 2-yl)-1-butyl-1H-indazole-3-carboxamide)

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan- 7010 I N ADB-FUBINACA 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2- 7035 I N ADB-PINACA yl)-1-pentyl-1H-indazole-3-carboxamide)

AH-7921 (3,4-dichloro-N-[(1- 9551 I Y dimethylamino)cyclohexylmethyl]benzamide))

| Allylprodine | 9602 | I | Y |
|---|---|---|---|
| Alphacetylmethadol except levo-alphacetylmethadol | 9603 | I | Y |
| Alpha-ethyltryptamine | 7249 | I | N ET; Trip |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Alphameprodine | 9604 | I | Y |
|---|---|---|---|
| Alphamethadol | 9605 | I | Y |
| alpha'-Methyl butyryl fentanyl (2-methyl-N-(1- | 9864 | I | Y |

phenethylpiperidin-4-yl)-N-phenylbutanamide)

| alpha-Methylfentanyl | 9814 | I | Y China White; fentanyl |
|---|---|---|---|
| alpha-Methylthiofentanyl | 9832 | I | Y China White; fentanyl |
| alpha-Methyltryptamine | 7432 | I | N AMT |

(Positional Isomer: N-Methyltryptamine)

| alpha-pyrrolidinobutiophenone (α-PBP) | 7546 | I | N 1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one |
|---|---|---|---|
| alpha-Pyrrolidinoheptaphenone (PV8) | 7548 | I | N PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one |

(Positional Isomer: α-pyrrolidinoisoheptanophenone (α- PiHPP; iso-PV8))

alpha-Pyrrolidinohexanophenone (α-PHP) 7544 I N α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2- (pyrrolidin-1-yl)hexan-1-one

alpha-Pyrrolidinopentiophenone (α-PVP) 7545 I N α-Pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomers: 4-methyl-α-pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2-(piperidin-1-yl)butan-1-one)

| AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) | 7201 | I | N |
|---|---|---|---|
| AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) | 7000 | I | N Prior drug code 7694 under Synthetic Drug Abuse |

Prevention Act; consolidated to 7000 under 91 FR 2297

Amineptine (7-[(10,11-dihydro-5H- 1219 I N dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)

| Aminorex | 1585 | I | N Has been sold as methamphetamine |
|---|---|---|---|
| APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H- | 7048 | I | N APINACA; AKB48 |

indazole-3-carboxamide

| Benzethidine | 9606 | I | Y |
|---|---|---|---|
| Benzylmorphine | 9052 | I | Y |
| Betacetylmethadol | 9607 | I | Y |
| beta-Hydroxy-3-methylfentanyl | 9831 | I | Y China White; fentanyl |
| beta-Hydroxyfentanyl | 9830 | I | Y China White; fentanyl |
| beta-Hydroxythiofentanyl | 9836 | I | Y N-[1-[2-Hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N- |

phenylpropionamide; N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4- piperidinyl]-N-phenylpropanamide

| Betameprodine | 9608 | I | Y |
|---|---|---|---|
| Betamethadol | 9609 | I | Y |
| beta-Methyl fentanyl (N-phenyl-N-(1-(2- | 9856 | I | Y |

phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl)

beta-Methylacetyl fentanyl (N-phenyl-N-(1-(2- 9868 I Y phenylpropyl)piperidin-4-yl)acetamide)

beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- 9842 I Y diphenylpropanamide; also known as β'-phenyl fentanyl; 3-phenylpropanoyl fentanyl)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Betaprodine | 9611 | I | Y |
|---|---|---|---|
| Bromazolam (8-bromo-1-methyl-6-phenyl-4H- | 2778 | I | N |

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)- | 9098 | I | Y 1-[1-[1-(4-Bromophenyl)ethyl]-4-piperidinyl]-1,3-dihydro- |
|---|---|---|---|
| 1,3-dihydro-2H-benzo[d]imidazol-2-one) | 2H-benzimidazol-2-one |  |  |
| Bufotenine | 7433 | I | N Mappine; N,N-dimethylserotonin |
| Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H- | 9751 | I | Y |

benzimidazol-1-yl)-N,N-diethylethan-1-amine)

Butylone 7541 I N bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan- 1-one

(Positional Isomers: ￿dimethylone (bk-MDDMA; MDDMC), N,N-dimethyl-3,4-methylenedioxycathinone)

Butyryl Fentanyl 9822 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1- phenethylpiperidin-4-yl)-N-phenylbutanamide

Cannabimimetic agents 7000 I N Any substance meeting the definition of cannabimimetic agent as set forth in 21 CFR § 1308.11(g)

| Cathinone | 1235 | I | N Constituent of "Khat" plant |
|---|---|---|---|
| Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H- | 2786 | I | N |

benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Clonitazene | 9612 | I | Y |
|---|---|---|---|
| Codeine methylbromide | 9070 | I | Y |
| Codeine-N-oxide | 9053 | I | Y |
| CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- | 7000 | I | N Prior drug code 7297 under Synthetic Drug Abuse |
| hydroxycyclohexy]-phenol) | Prevention Act; consolidated to 7000 under 91 FR 2297 |  |  |
| CP-47,497 C8 Homologue (5-(1,1-dimethyloctyl)-2- | 7000 | I | N Prior drug code 7298 under Synthetic Drug Abuse |
| [(1R,3S)3-hydroxycyclohexyl]-phenol) | Prevention Act; consolidated to 7000 under 91 FR 2297 |  |  |
| Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N- | 9844 | I | Y |

phenylbut-2-enamide)

CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- 7093 I N CUMYL-PEGACLONE; SGT-151 yl)pyrido[4,3-b]indol-1-one)

Cyclopentyl fentanyl 9847 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide

Cyclopropyl Fentanyl 9845 I Y N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide

| Cyprenorphine | 9054 | I | Y |
|---|---|---|---|
| Desomorphine | 9055 | I | Y |
| Dextromoramide | 9613 | I | Y Palfium; Jetrium; Narcolo |
| Diampromide | 9615 | I | Y |
| Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- | 2789 | I | N |

methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)

| Diethylthiambutene | 9616 | I | Y |
|---|---|---|---|
| Diethyltryptamine | 7434 | I | N DET, N,N-diethyltryptamine |

(Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT))

| Difenoxin | 9168 | I | Y Lyspafen |
|---|---|---|---|
| Dihydromorphine | 9145 | I | Y |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Dimenoxadol | 9617 | I | Y |
|---|---|---|---|
| Dimepheptanol | 9618 | I | Y |
| Dimethylthiambutene | 9619 | I | Y |
| Dimethyltryptamine | 7435 | I | N DMT |
| Dioxaphetyl butyrate | 9621 | I | Y |
| Diphenidine | 7292 | I | Y 1-(1,2-Diphenylethyl)piperidine |
| Dipipanone | 9622 | I | Y Dipipan; phenylpiperone HCl; Diconal; Wellconal |
| Drotebanol | 9335 | I | Y Metebanyl; oxymethebanol |
| Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)- | 7036 | I | N 5F-EDMB-PINACA |

3,3-dimethylbutanoate

| Ethylmethylthiambutene | 9623 | I | Y |
|---|---|---|---|
| Ethylone | 7547 | I | N 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one; 3,4- |

methylenedioxy-N-ethylcathinone; bk-MDEA; MDEC

| Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) | 1727 | I | N |
|---|---|---|---|
| Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H- | 2780 | I | N |

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1H- 9765 I Y benzimidazol-1-yl)-N,N-diethylethan-1-amine)

| Etonitazene | 9624 | I | Y |
|---|---|---|---|
| Etorphine (except HCl) | 9056 | I | Y |
| Etoxeridine | 9625 | I | Y |
| Eutylone | 7549 | I | N 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one; bk- |

EBDB

| Fenethylline | 1503 | I | N Captagon; amfetyline; ethyltheophylline amphetamine |
|---|---|---|---|
| Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- | 9851 | I | Y |

yl)(phenyl)carbamate)

Fentanyl-related substances as defined in 21 CFR 9850 I Y 1308.11(h)

Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H- 2785 I N benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)

| Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl- | 2788 | I | N 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3- |
|---|---|---|---|
| 4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | a][1,4]benzodiazepine |  |  |
| Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro- | 9756 | I | Y |

1H-benzimidazol-1-yl)ethan-1-amine)

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- 9834 I Y phenylfuran-2-carboxamide)

| Furethidine | 9626 | I | Y |
|---|---|---|---|
| Gamma Hydroxybutyric Acid | 2010 | I | N GHB; gamma hydroxybutyrate; sodium oxybate |
| Heroin | 9200 | I | Y Diacetylmorphine; diamorphine |
| Hydromorphinol | 9301 | I | Y |
| Hydroxypethidine | 9627 | I | Y |
| Ibogaine | 7260 | I | N Constituent of "Tabernanthe iboga" plant |
| Isobutyryl fentanyl | 9827 | I | Y N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5- | 9614 | I | Y N,N-Diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro- |
|---|---|---|---|
| nitro-1H-benzimidazol-1-yl)ethan-1-amine) | 1H-benzimidazole-1-ethanamine |  |  |
| Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4- | 9862 | I | Y |

yl)-N-phenylbutanamide)

JWH-018 (also known as AM678) (1-pentyl-3-(1- 7118 I N naphthoyl)indole)

JWH-019 (1-hexyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7019 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-073 (1-butyl-3-(1-naphthoyl)indole) 7000 I N Prior drug code 7173 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-081 (1-pentyl-3-(1-(4-methoxynaphthoyl)indole)) 7000 I N Prior drug code 7081 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) 7000 I N Prior drug code 7122 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

| JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- | 7000 | I | N Prior drug code 7200 under Synthetic Drug Abuse |
|---|---|---|---|
| naphthoyl)indole) | Prevention Act; consolidated to 7000 under 91 FR 2297 |  |  |
| JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) | 7000 | I | N Prior drug code 7203 under Synthetic Drug Abuse |

Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) 7000 I N Prior drug code 6250 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) 7000 I N Prior drug code 7398 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

| Ketobemidone | 9628 | I | Y Cliradon |
|---|---|---|---|
| Levomoramide | 9629 | I | Y |
| Levophenacylmorphan | 9631 | I | Y |
| Lysergic acid diethylamide | 7315 | I | N LSD; lysergide |
| MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan- | 7032 | I | N MAB-CHMINACA; ADB-CHMINACA |

2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)

| Marihuana | 7360 | I | N Cannabis; marijuana |
|---|---|---|---|
| Marihuana Extract | 7350 | I | N |
| MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- | 7090 | I | N MDMB-4en-PINACA |

en-1-yl)-1H-indazole-3-carboxamido)butanoate)

MDMB–CHMICA; MMB–CHMINACA (methyl 2-(1- 7042 I N MDMB-CHMICA; MMB-CHMINACA (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- dimethylbutanoate)

MDMB–FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H- 7020 I N MDMB-FUBINACA indazole-3-carboxamido)-3,3-dimethylbutanoate) (Positional Isomer: EMB-FUBINACA)

MDPV (3,4-Methylenedioxypyrovalerone) 7535 I N

(Positional Isomers: 1-(1,3-benzodioxol-5-yl)-2- (cyclohexylamino)propan-1-one(n-cyclohexyl methylone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone) ;1- (1,3-benzodioxol-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3- methylenedioxy pyrovalerone)

| Mecloqualone | 2572 | I | N Nubarene |
|---|---|---|---|
| Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I | N 4-MMC |

(Positional Isomers: Buphedrone, Ethcathinone, N,N- Dimethyl-cathinone)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Mescaline | 7381 | I | N Constituent of "Peyote" cacti |
|---|---|---|---|
| Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3- | 1227 | I | N |

oxadiazol-3-ium-5-yl)carbamimidate)

meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1- 9857 I Y phenethylpiperidin-4-yl)propionamide)

meta-Fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1- 9871 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1- 9858 I Y phenethylpiperidin-4-yl)isobutyramide)

| Methaqualone | 2565 | I | N Quaalude; Parest; Somnafac; Opitimil; Mandrax |
|---|---|---|---|
| Methcathinone | 1237 | I | N N-Methylcathinone, "cat" |
| Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- | 1478 | I | N |

amine)

Methyl (E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-oxo- 9672 I Y Mitragynine pseudoindoxyl 3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′- indolizine]-7′-yl)-3-methoxyacrylate

Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a- 9673 I Y MGM–15; dihydro-7-hydroxymitragynine hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

| Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro- | 9674 | I | Y MGM–16; 9-fluoro-dihydro-7-hydroxymitragynine; 10- |
|---|---|---|---|
| 7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b- | fluoro-dihydro-7-hydroxymitragynine |  |  |

decahydroindolo[2,3-a]quinolizin-2-yl)-3- methoxyacrylate

Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3- 7021 I N FUB–AMB; MMB– FUBINACA; AMB–FUBINACA carboxamido)-3-methylbutanoate

Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 7041 I N 5F-MDMB-PICA 3,3-dimethylbutanoate (Positional Isomer: 5F-EMB-PICA or 5-fluoro-EMB-PICA)

| Methyldesorphine | 9302 | I | Y |
|---|---|---|---|
| Methyldihydromorphine | 9304 | I | Y |
| Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I | N |

(Positional Isomer: ￿2,3-methylenedioxymethcathinone (2,3-MDMC, 1-(benzo[d][1,3]dioxol-4-yl)-2- (methylamino)propan-1-one))

Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 9764 I Y 1H-benzimidazol-1-yl)ethan-1-amine)

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- 9757 I Y nitro-1H-benzimidazol-1-yl)ethan-1-amine)

MMB-CHMICA; AMB-CHMICA (methyl 2-(1- 7044 I N (cyclohexylmethyl)-1 H-indole-3-carboxamido)-3- methylbutanoate)

MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole- 7095 I N MMB-FUBICA 3-carboxamido)-3-methyl butanoate)

| Morpheridine | 9632 | I | Y |
|---|---|---|---|
| Morphine methylbromide | 9305 | I | Y |
| Morphine methylsulfonate | 9306 | I | Y |
| Morphine-N-oxide | 9307 | I | Y |
| MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) | 9560 | I | Y |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Myrophine | 9308 | I | Y |
|---|---|---|---|
| N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran- | 9843 | I | Y Tetrahydrofuranyl fentanyl |

2-carboxamide

N-(2-Fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I Y ortho-Fluorofentanyl or 2-fluorofentanyl yl)propionamide

| N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3- | 7047 | I | N FUB-AKB48; FUB-APINACA; AKB48 N-(4- |
|---|---|---|---|
| carboxamide | FLUOROBENZYL) |  |  |
| N,N-Dimethylamphetamine | 1480 | I | N |
| Naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3- | 7000 | I | N |

yl)methanone (JWH–022)

Naphyrone 1258 I N Naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1- yl)pentan-1-one

(Positional Isomer: α-naphyrone)

| N-Benzylpiperazine | 7493 | I | N BZP; 1-benzylpiperazine |
|---|---|---|---|
| N-Desethyl isotonitazene (N-ethyl-2-(2-(4- | 9760 | I | Y |

isopropoxylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan- 1-amin)

| N-Ethyl-1-phenylcyclohexylamine | 7455 | I | N PCE |
|---|---|---|---|
| N-Ethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H- | 9769 | I | Y N-Desethyl protonitazene |

benzimidazol-1-yl)ethan-1-amine

| N-Ethyl-3-piperidyl benzilate | 7482 | I | N JB 323 |
|---|---|---|---|
| N-Ethylamphetamine | 1475 | I | N NEA |
| N-Ethylhexedrone | 7246 | I | N α-Ethylaminohexanophenone; 2-(ethylamino)-1- |

phenylhexan-1-one

N-Ethylpentylone (1-(1,3-benzodioxol-5-yl)-2- 7543 I N Ephylone (ethylamino)-pentan-1-one) (Positional Isomers: 3,4-methylenedioxy-α-propylaminobutiophenone; isopropyl butylone (MDIPBP))

| N-Hydroxy-3,4-methylenedioxyamphetamine | 7402 | I | N N-Hydroxy MDA |
|---|---|---|---|
| Nicocodeine | 9309 | I | Y |
| Nicomorphine | 9312 | I | Y Vilan |
| NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)- | 7221 | I | N |

1H-indole-3-carboxylate)

| N-Methyl-3-piperidyl benzilate | 7484 | I | N JB 336 |
|---|---|---|---|
| Noracymethadol | 9633 | I | Y |
| Norlevorphanol | 9634 | I | Y |
| Normethadone | 9635 | I | Y Phenyldimazone |
| Normorphine | 9313 | I | Y |
| Norpipanone | 9636 | I | Y |
| N-Piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- | 9761 | I | Y Etonitazepipne |

(2-(piperidin-1-yl)ethyl-1H-benzimidazole)

N-Pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1- 9758 I Y Etonitazepyne (2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)

Ocfentanil 9838 I Y N-(2-Fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4- yl)acetamide

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

O-Desmethyltramadol 9667 I Y O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol

ortho-Chlorofentanyl (N-(2-chlorophenyl)-N-(1- 9828 I Y phenethylpiperidin-4-yl)propionamide)

ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- 9852 I Y phenethylpiperidin-4-yl)acrylamide)

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9846 I Y phenethylpiperidin-4-yl)butyramide; also known as 2- fluorobutyryl fentanyl)

ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1- 9863 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- 9853 I Y phenethylpiperidin-4-yl)isobutyramide)

ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- 9848 I Y phenethylpiperidin-4-yl)acetamide; also known as 2- methyl acetylfentanyl)

ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- 9820 I Y 2-Methyl methoxyacetyl fentanyl methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide)

ortho-Methylcyclopropylfentanyl (N-(2-methylphenyl)-N- 9849 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

para-Chlorofentanyl (N-(4-chlorophenyl)-N-(1- 9818 I Y phenethylpiperidin-4-yl)propionamide)

para-Chloroisobutyryl fentanyl 9826 I Y N-(4-Chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide

para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- 9854 I Y phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1- 9870 I Y phenethylpiperidin-4-yl)pentanamide)

para-Fluorobutyryl fentanyl 9823 I Y N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide

| para-Fluorofentanyl | 9812 | I | Y China White; fentanyl |
|---|---|---|---|
| Parahexyl | 7374 | I | N Synhexyl |
| para-Methoxybutyryl fentanyl | 9837 | I | Y N-(4-Methoxyphenyl)-N-(1-phenethylpiperidin-4- |

yl)butyramide

para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N- 9859 I Y (1-phenethylpiperidin-4-yl)furan-2-carboxamide)

para-Methoxymethamphetamine (PMMA); 1-(4- 1245 I N (Positional isomer: methoxyphenamine (OMMA)) methoxyphenyl)-N-methylpropan-2-amine

para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N- 9865 I Y (1-phenethylpiperidin-4-yl)cyclopropanecarboxamide)

para-Methylfentanyl (N-(4-methylphenyl)-N-(1- 9817 I Y phenethylpiperidin-4-yl)propionamide; also known as 4- methylfentanyl)

| PB-22 (quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) | 7222 | I | N QUPIC; PB-22 |
|---|---|---|---|
| Pentedrone (α-methylaminovalerophenone) | 1246 | I | N 2-(Methylamino)-1-phenylpentan-1-one |

(Positional Isomers: 3-methylethcathinone (3-MEC), 4- ethylmethcathinone (4-EMC), 4-methylbuphedrone (4- MeMABP;4-MeBP), 3,4-dimethylmethcathinone (3,4- DMMC),N-ethylbuphedrone (NEB),N-ethyl-N-methylcathinone(EMC))

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Pentylone 7542 I N bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2- (methylamino)pentan-1-one

(Positional Isomers: dibutylone (bk-DMBDB) and propylone (3',4'-methylenedioxy-N-propylaminocathinone; 1-(benzo[d][1,3]dioxol-5-yl)-2-(propylamino)propan-1-one); 2,3-methylenedioxy-α-ethylaminobutiophenone)

| Peyote | 7415 | I | N Cactus which contains mescaline |
|---|---|---|---|
| Phenadoxone | 9637 | I | Y |
| Phenampromide | 9638 | I | Y |
| Phenomorphan | 9647 | I | Y |
| Phenoperidine | 9641 | I | Y Operidine; Lealgin |
| Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9841 | I | Y |

phenylbenzamide; also known as benzoyl fentanyl)

| Pholcodine | 9314 | I | Y Copholco; Adaphol; Codisol; Lantuss; Pholcolin |
|---|---|---|---|
| Piritramide | 9642 | I | Y Piridolan |
| Proheptazine | 9643 | I | Y |
| Properidine | 9644 | I | Y |
| Propiram | 9649 | I | Y Algeril |
| Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- | 9759 | I | Y |

propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)

| Psilocybin | 7437 | I | N Constituent of "Magic mushrooms" |
|---|---|---|---|
| Psilocyn | 7438 | I | N Psilocin, constituent of "Magic mushrooms" |

(Positional Isomers: 6-hydroxy DMT; 7-hydroxy DMT)

| Racemoramide | 9645 | I | Y |
|---|---|---|---|
| SR-18 (1-cyclohexylethyl-3-(2-methoxyphenylacetyl) | 7000 | I | N RCS-8 |
| indole) | Prior drug code 7008 under Synthetic Drug Abuse |  |  |

Prevention Act; consolidated to 7000 under 91 FR 2297

SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) 7000 I N RCS-4 Prior drug code 7104 under Synthetic Drug Abuse Prevention Act; consolidated to 7000 under 91 FR 2297

| Tetrahydrocannabinols | 7370 | I | N THC; Delta-8 THC; Delta-9 THC; dronabinol and others |
|---|---|---|---|
| Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin- | 9869 | I | Y Tetrahydrothiophene fentanyl |

4-yl)-N-phenyltetrahydrothiophene-2-carboxamide)

| Thebacon | 9315 | I | Y Acetylhydrocodone; Acedicon; Thebacetyl |
|---|---|---|---|
| Thiofentanyl | 9835 | I | Y Chine white; fentanyl |
| Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- | 9839 | I | Y |

phenylthiophene-2-carboxamide; also known as 2- thiofuranyl fentanyl; thiophene fentanyl)

THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I N yl](naphthalen-1-yl)methanone)

| Tilidine | 9750 | I | Y Tilidate; Valoron; Kitadol; Lak; Tilsa |
|---|---|---|---|
| Trimeperidine | 9646 | I | Y Promedolum |
| U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]- | 9547 | I | Y |

N-methylbenzamide)

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I N tetramethylcyclopropyl)metanone

| Valeryl fentanyl | 9840 | I | Y N-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide |
|---|---|---|---|
| Zipeprol (1-methoxy-3[-4-(2-methoxy-2- | 9873 | I | Y |

phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol)

α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- 7551 I N α-PiHP; alpha-PiHP one)

| 1-Phenylcyclohexylamine | 7460 | II | N PCP precursor |
|---|---|---|---|
| 1-Piperidinocyclohexanecarbonitrile | 8603 | II | N PCC; PCP precursor |
| 4-Anilino-N-phenethyl-4-piperidine (ANPP) | 8333 | II | N ANPP; despropionyl fentanyl |
| Alfentanil | 9737 | II | Y Alfenta |
| Alphaprodine | 9010 | II | Y Nisentil |
| Amobarbital | 2125 | II | N Amytal; Tuinal |
| Amphetamine | 1100 | II | N Dexedrine; Adderall; Obetrol |
| Anileridine | 9020 | II | Y Leritine |
| Bezitramide | 9800 | II | Y Burgodin |
| Carfentanil | 9743 | II | Y Wildnil |
| Coca Leaves | 9040 | II | Y |
| Cocaine | 9041 | II | Y Methyl benzoylecgonine; Crack |
| Codeine | 9050 | II | Y Morphine methyl ester; methyl morphine |
| Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II | Y Propoxyphene |
| Dihydrocodeine | 9120 | II | Y Didrate; Parzone |
| Dihydroetorphine | 9334 | II | Y DHE |
| Diphenoxylate | 9170 | II | Y |
| Dronabinol in an oral solution in a drug product | 7365 | II | N Syndros |

approved for marketing by the U.S. Food and Drug Administration

| Ecgonine | 9180 | II | Y Cocaine precursor, in Coca leaves |
|---|---|---|---|
| Ethylmorphine | 9190 | II | Y Dionin |
| Etorphine HCl | 9059 | II | Y M 99 |
| Fentanyl | 9801 | II | Y Duragesic; Oralet; Actiq; Sublimaze; Innovar |
| Glutethimide | 2550 | II | N Doriden; Dorimide |
| Hydrocodone | 9193 | II | Y Dihydrocodeinone |
| Hydromorphone | 9150 | II | Y Dilaudid; dihydromorphinone |
| Isomethadone | 9226 | II | Y Isoamidone |
| Levo-alphacetylmethadol | 9648 | II | Y LAAM; long acting methadone; levomethadyl acetate |
| Levomethorphan | 9210 | II | Y |
| Levorphanol | 9220 | II | Y Levo-Dromoran |
| Lisdexamfetamine | 1205 | II | N Vyvanse |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Meperidine | 9230 | II | Y Demerol; Mepergan; pethidine |
|---|---|---|---|
| Meperidine intermediate-A | 9232 | II | Y Meperidine precursor |
| Meperidine intermediate-B | 9233 | II | Y Meperidine precursor; normeperidine |
| Meperidine intermediate-C | 9234 | II | Y Meperidine precursor |
| Metazocine | 9240 | II | Y |
| Methadone | 9250 | II | Y Dolophine; Methadose; Amidone |
| Methadone intermediate (4-cyano-2-dimethylamino-4,4- | 9254 | II | Y Methadone precursor |

diphenylbutane)

| Methamphetamine | 1105 | II | N Desoxyn; D-desoxyephedrine; ICE; Crank; Speed |
|---|---|---|---|
| Methylphenidate | 1724 | II | N Concerta; Ritalin; Methylin |
| Metopon | 9260 | II | Y |
| Moramide-intermediate | 9802 | II | Y |
| Morphine | 9300 | II | Y MS Contin; Roxanol; Oramorph; RMS; MSIR |
| Nabilone | 7379 | II | N Cesamet |
| Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) | 8366 | II | Y |
| Noroxymorphone | 9668 | II | Y |
| Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2- | 9245 | II | Y |

[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9- yl]ethyl{time} )amine fumarate)

| Opium extracts | 9610 | II | Y |
|---|---|---|---|
| Opium fluid extract | 9620 | II | Y |
| Opium poppy | 9650 | II | Y Papaver somniferum |
| Opium tincture | 9630 | II | Y Laudanum |
| Opium, granulated | 9640 | II | Y Granulated opium |
| Opium, powdered | 9639 | II | Y Powdered opium |
| Opium, raw | 9600 | II | Y Raw opium; gum opium |
| Oripavine | 9330 | II | Y |
| Oxycodone | 9143 | II | Y OxyContin; Percocet; Endocet; Roxicodone; Roxicet |
| Oxymorphone | 9652 | II | Y Numorphan |
| Pentobarbital | 2270 | II | N Nembutal |
| Phenazocine | 9715 | II | Y Narphen; Prinadol |
| Phencyclidine | 7471 | II | N PCP; Sernylan |
| Phenmetrazine | 1631 | II | N Preludin |
| Phenylacetone | 8501 | II | N P2P; phenyl-2-propanone; benzyl methyl ketone |
| Piminodine | 9730 | II | Y |
| Poppy Straw | 9650 | II | Y Opium poppy capsules; poppy heads |
| Poppy Straw Concentrate | 9670 | II | Y Concentrate of Poppy Straw, CPS |
| Racemethorphan | 9732 | II | Y |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Racemorphan | 9733 | II | Y Dromoran |
|---|---|---|---|
| Remifentanil | 9739 | II | Y Ultiva |
| Secobarbital | 2315 | II | N Seconal; Tuinal |
| Sufentanil | 9740 | II | Y Sufenta |
| Tapentadol | 9780 | II | Y |
| Thebaine | 9333 | II | Y Precursor of many narcotics |
| Thiafentanil | 9729 | II | Y Thianil |
| [3,2-c]-Furazan-5α-androstan-17β-ol | 4000 | III | N |
| [3,2-c]Pyrazole-androst-4-en-17β-ol | 4000 | III | N |
| 13β-Ethyl-17β-hydroxygon-4-en-3-one | 4000 | III | N |
| 17α-Methyl-3α,17β-dihydroxy-5α-androstane | 4000 | III | N |
| 17α-Methyl-3β,17β-dihydroxy-5α-androstane | 4000 | III | N |
| 17α-Methyl-3β,17β-dihydroxyandrost-4-ene | 4000 | III | N |
| 17α-Methyl-4-hydroxynandrolone (17α-methyl-4- | 4000 | III | N |

hydroxy-17β-hydroxyestr-4-en-3-one)

| 17α-Methyl-5α-androstan-17β-ol | 4000 | III | N |
|---|---|---|---|
| 17α-Methyl-androst-2-ene-3,17β-diol | 4000 | III | N |
| 17α-Methyl-androsta-1,4-diene-3,17β-diol | 4000 | III | N |
| 17α-Methyl-androstan-3-hydroxyimine-17β-ol | 4000 | III | N |
| 17α-Methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α- | 4000 | III | N 17α-Methyl-1-testosterone |

methyl-5α-androst-1-en-3-one)

| 17β-Hydroxy-androstano[2,3-d]isoxazole | 4000 | III | N |
|---|---|---|---|
| 17β-Hydroxy-androstano[3,2-c]isoxazole | 4000 | III | N |
| 18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one | 4000 | III | N |
| 19-Nor-4,9(10)-androstadienedione (estra-4,9(10)- | 4000 | III | N |

diene-3,17-dione)

| 19-Nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene) | 4000 | III | N |
|---|---|---|---|
| 19-Nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene) | 4000 | III | N |
| 19-Nor-4-androstenedione (estr-4-en-3,17-dione) | 4000 | III | N |
| 19-Nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) | 4000 | III | N |
| 19-Nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene) | 4000 | III | N |
| 19-Nor-5-androstenedione (estr-5-en-3,17-dione) | 4000 | III | N |
| 1-Androstenediol (3α,17β-dihydroxy-5α-androst-1-ene) | 4000 | III | N |
| 1-Androstenediol (3β,17β-dihydroxy-5α-androst-1-ene) | 4000 | III | N |
| 1-Androstenedione (5α-androst-1-en-3,17-dione) | 4000 | III | N |
| 2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one | 4000 | III | N |
| 2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol | 4000 | III | N |
| 3α,17β-Dihydroxy-5α-androstane | 4000 | III | N |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| 3β,17β-Dihydroxy-5α-androstane | 4000 | III | N |
|---|---|---|---|
| 3β-Hydroxy-estra-4,9,11-trien-17-one | 4000 | III | N |
| 4-Androstenediol (3β,17β-dihydroxy-androst-4-ene) | 4000 | III | N 4-AD |
| 4-Androstenedione (androst-4-en-3,17-dione) | 4000 | III | N |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one | 4000 | III | N |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11- | 4000 | III | N |

dione

| 4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol | 4000 | III | N |
|---|---|---|---|
| 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol | 4000 | III | N |
| 4-Dihydrotestosterone (17β-hydroxy-androstan-3-one) | 4000 | III | N Anabolex; Andractim; Pesomax; Stanolone |
| 4-Hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4- | 4000 | III | N |

en-3-one)

4-Hydroxy-androst-4-ene-3,17-dione 4000 III N Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- c]pyrazole-5α-androstan-17β-ol

4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- 4000 III N one)

| 5-Androstenediol (3β,17β-dihydroxy-androst-5-ene) | 4000 | III | N |
|---|---|---|---|
| 5-Androstenedione (androst-5-en-3,17-dione) | 4000 | III | N |
| 5α-Androstan-3,17-dione | 4000 | III | N Androstanedione |
| 5α-Androstan-3,6,17-trione | 4000 | III | N |
| 6-Bromo-androsta-1,4-diene-3,17-dione | 4000 | III | N |
| 6-Bromo-androstan-3,17-dione | 4000 | III | N |
| 6α-Methyl-androst-4-ene-3,17-dione | 4000 | III | N |
| Amobarbital & noncontrolled active ingred. | 2126 | III | N |
| Amobarbital suppository dosage form | 2126 | III | N |
| Anabolic steroids | 4000 | III | N Any substance meeting the definition of anabolic steroid |

as set forth in 21 CFR 1300.01

| Aprobarbital | 2100 | III | N Alurate |
|---|---|---|---|
| Barbituric acid derivative | 2100 | III | N Barbiturates not specifically listed |
| Benzphetamine | 1228 | III | N Didrex; Inapetyl |
| Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4- | 4000 | III | N |

en-3-one)

| Boldenone (17β-hydroxyandrost-1,4-diene-3-one) | 4000 | III | N Equipoise; Parenabol; Vebonol; dehydrotestosterone |
|---|---|---|---|
| Boldione (androsta-1,4-diene-3,17-dione) | 4000 | III | N |
| Buprenorphine | 9064 | III | Y Buprenex; Temgesic; Subutex; Suboxone |
| Butabarbital (secbutabarbital) | 2100 | III | N Butisol; Butibel |
| Butalbital | 2100 | III | N Fiorinal; Butalbital with aspirin |
| Butobarbital (butethal) | 2100 | III | N Soneryl (UK) |
| Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4- | 4000 | III | N Methosarb |

en-3-one)

Centanafadine 1641 III N

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Chlorhexadol | 2510 | III | N Mechloral; Mecoral; Medodorm; Chloralodol |
|---|---|---|---|
| Chlorphentermine | 1645 | III | N Pre-Sate; Lucofen; Apsedon; Desopimon |
| Clortermine | 1647 | III | N Voranil |
| Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one) | 4000 | III | N Alfa-Trofodermin; Clostene; 4-chlorotestosterone |
| Codeine & isoquinoline alkaloid 90 mg/du | 9803 | III | Y Codeine with papaverine or noscapine |
| Codeine combination product 90 mg/du | 9804 | III | Y Empirin; Fiorinal; Tylenol; ASA or APAP w/codeine |
| Dehydrochloromethyltestosterone (4-chloro-17β- | 4000 | III | N Oral-Turinabol |

hydroxy-17α-methyl-androst-1,4-dien-3-one)

Desoxymethyltestosterone (17α-methyl-5α-androst-2- 4000 III N Madol en-17β-ol)

| Dihydrocodeine combination product 90 mg/du | 9807 | III | Y Synalgos-DC; Compal |
|---|---|---|---|
| Dronabinol (synthetic) in sesame oil in soft gelatin | 7369 | III | N Marinol; synthetic THC in sesame oil/soft gelatin as |
| capsule as approved by FDA | approved by FDA |  |  |
| Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3- | 4000 | III | N Drolban; Masterid; Permastril |

one)

| Embutramide | 2020 | III | N Tributane |
|---|---|---|---|
| Estra-4,9,11-triene-3,17-dione | 4000 | III | N |
| Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene) | 4000 | III | N Maxibolin; Orabolin; Durabolin-O; Duraboral |
| Ethylmorphine combination product 15 mg/du | 9808 | III | Y |
| Fluoxymesterone (9-fluoro-17α-methyl-11β,17β- | 4000 | III | N Anadroid-F; Halotestin; Ora-Testryl |

dihydroxyandrost-4-en-3-one)

Formebolone (2-formyl-17α-methyl-11α,17β- 4000 III N Esiclene; Hubernol dihydroxyandrost-1,4-dien-3-one)

Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]- 4000 III N Frazalon; Miotolon; Qu Zhi Shu furazan)

| Gamma Hydroxybutyric Acid preparations | 2012 | III | N Xyrem |
|---|---|---|---|
| Ketamine | 7285 | III | N Ketaset; Ketalar; Special K; K |
| Lysergic acid | 7300 | III | N LSD precursor |
| Lysergic acid amide | 7310 | III | N LSD precursor |
| Marijuana extract, as defined in 21 CFR | 7353 | III | N |

1308.11(d)(58), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license

Marijuana, as defined in 21 U.S.C. 802(16), in a U.S. 7362 III N Food and Drug Administration approved product or subject to a state medical marijuana license

Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Assimil; Ermalone; Methybol; Tantarone one)

Mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- 4000 III N Androviron; Proviron; Testiwop one)

Methandienone (17α-methyl-17β-hydroxyandrost-1,4- 4000 III N Dianabol; Metabolina; Nerobol; Perbolin dien-3-one)

Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- 4000 III N Sinesex; Stenediol; Troformone ene)

| Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3- | 4000 | III | N Methasterone; 2α,17α-dimethyl-17β-hydroxy-5α-androstan- |
|---|---|---|---|
| one) | 3-one |  |  |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3- 4000 III N Primobolan; Primobolan Depot; Primobolan S one)

Methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)- 4000 III N dien-3-one)

Methyltestosterone (17α-methyl-17β-hydroxyandrost-4- 4000 III N Android; Oreton; Testred; Virilon en-3-one)

Methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11- 4000 III N Metribolone trien-3-one)

| Methyprylon | 2575 | III | N Noludar |
|---|---|---|---|
| Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3- | 4000 | III | N Cheque; Matenon |

one)

Morphine combination product/50 mg/(100 ml or 100 9810 III Y gm)

| Nalorphine | 9400 | III | Y Nalline |
|---|---|---|---|
| Nandrolone (17β-hydroxyestr-4-en-3-one) | 4000 | III | N Deca-Durabolin; Durabolin; Durabolin-50 |
| Naturally derived delta-9-tetrahydrocannabinols in a | 7386 | III | N (i) Naturally derived delta-9-tetrahydrocannabinols means |
| U.S. Food and Drug Administration approved product | those delta-9-tetrahydrocannabinols, except as in |  |  |
| or in marijuana subject to a state medical marijuana | paragraphs 21 CFR 1308.13(g)(2) and (3), that are |  |  |
| license | naturally contained in a plant of the genus Cannabis |  |  |

(cannabis plant) (ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o (iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C 802(16)(B)(ii)

Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3- 4000 III N Genabol one)

| Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) | 4000 | III | N Anabol-4-19; Lentabol |
|---|---|---|---|
| Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3- | 4000 | III | N Nilevar; Pronabol; Solevar |

one)

Normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3- 4000 III N Lutenin; Matronal; Orgasteron one)

| Opium combination product 25 mg/du | 9809 | III | Y Paregoric, other combination products |
|---|---|---|---|
| Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α- | 4000 | III | N Anavar; Lonavar; Oxandrin; Provitar; Vasorome |

androstan-3-one)

Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4- 4000 III N Anamidol; Balnimax; Oranabol; Oranabol 10 en-3-one)

Oxymetholone (17α-methyl-2-hydroxymethylene-17β- 4000 III N Anadrol-50; Adroyd; Anapolon; Anasteron; Pardroyd hydroxy-5α-androstan-3-one)

| Pentobarbital & noncontrolled active ingred. | 2271 | III | N FP-3 |
|---|---|---|---|
| Pentobarbital suppository dosage form | 2271 | III | N WANS |
| Perampanel | 2261 | III | N Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2- |

dihydropyridin-3-yl) benzonitrile]

| Phendimetrazine | 1615 | III | N Plegine; Prelu-2; Bontril; Melfiat; Statobex |
|---|---|---|---|
| Prostanozol (17β-hydroxy-5α-androstano[3,2- | 4000 | III | N Prostanozol; [3,2-c]pyrazole-5α-androstan-17β-ol |

c]pyrazole)

Secobarbital & noncontrolled active ingred 2316 III N

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Secobarbital suppository dosage form | 2316 | III | N |
|---|---|---|---|
| Stanozolol (17α-methyl-17β-hydroxy-5α-androst-2- | 4000 | III | N Winstrol; Winstrol-V |

eno[3,2-c]-pyrazole)

Stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3- 4000 III N one)

| Stimulant compounds previously excepted | 1405 | III | N Mediatric |
|---|---|---|---|
| Sulfondiethylmethane | 2600 | III | N |
| Sulfonethylmethane | 2605 | III | N |
| Sulfonmethane | 2610 | III | N |
| Talbutal | 2100 | III | N Lotusate |
| Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta- | 4000 | III | N Teolit; Teslac |

1,4-dien-17-oic acid lactone)

| Testosterone (17β-hydroxyandrost-4-en-3-one) | 4000 | III | N Android-T; Androlan; Depotest; Delatestryl |
|---|---|---|---|
| Tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon- | 4000 | III | N THG |

4,9,11-trien-3-one)

| Thiamylal | 2100 | III | N Surital |
|---|---|---|---|
| Thiopental | 2100 | III | N Pentothal |
| Tiletamine & Zolazepam Combination Product | 7295 | III | N Telazol |
| Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) | 4000 | III | N Finaplix-S; Finajet; Parabolan |
| Vinbarbital | 2100 | III | N Delvinal; vinbarbitone |
| Δ1-Dihydrotestosterone (17β-hydroxy-5α-androst-1-en- | 4000 | III | N 1-Testosterone |

3-one)

| Alfaxalone | 2731 | IV | N Alfaxan; 5α-pregnan-3α-ol-11,20-dione |
|---|---|---|---|
| Alprazolam | 2882 | IV | N Xanax |
| Barbital | 2145 | IV | N Veronal; Plexonal; barbitone |
| Brexanolone (3α-hydroxy-5α-pregnan-20-one) | 2400 | IV | N Allopregnanolone |
| Bromazepam | 2748 | IV | N Lexotan; Lexatin; Lexotanil |
| Butorphanol | 9720 | IV | N Stadol; Stadol NS; Torbugesic; Torbutrol |
| Camazepam | 2749 | IV | N Albego; Limpidon; Paxor |
| Carisoprodol | 8192 | IV | N Soma |
| Cathine | 1230 | IV | N Constituent of "Khat" plant; (+)-norpseudoephedrine |
| Chloral betaine | 2460 | IV | N Beta Chlor |
| Chloral hydrate | 2465 | IV | N Noctec |
| Chlordiazepoxide | 2744 | IV | N Librium; Libritabs; Limbitrol; SK-Lygen |
| Cipepofol | 2139 | IV | N |
| Clobazam | 2751 | IV | N Urbadan; Urbanyl |
| Clonazepam | 2737 | IV | N Klonopin; Clonopin |
| Clorazepate | 2768 | IV | N Tranxene |
| Clotiazepam | 2752 | IV | N Trecalmo; Rize; Clozan; Veratran |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Cloxazolam | 2753 | IV | N Akton; Lubalix; Olcadil; Sepazon |
|---|---|---|---|
| Daridorexant ([(S)-2-(5-chloro-4-methyl- | 2410 | IV | N QUVIVIQ |

1H benzo[d]imidazol-2-yl)-2methylpyrrolidin-1-yl](5- methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone)

| Delorazepam | 2754 | IV | N |
|---|---|---|---|
| Dextropropoxyphene dosage forms | 9278 | IV | Y Darvon; propoxyphene; Darvocet; Propacet |
| Diazepam | 2765 | IV | N Valium; Diastat |
| Dichloralphenazone | 2467 | IV | N Midrin; dichloralantipyrine |
| Diethylpropion | 1610 | IV | N Tenuate; Tepanil |
| Difenoxin 1 mg/25 ug AtSO4/du | 9167 | IV | Y Motofen |
| Eluxadoline | 9725 | IV | N VIBERZI |
| Estazolam | 2756 | IV | N ProSom; Domnamid; Eurodin; Nuctalon |
| Ethchlorvynol | 2540 | IV | N Placidyl |
| Ethinamate | 2545 | IV | N Valmid; Valamin |
| Ethyl loflazepate | 2758 | IV | N |
| Fencamfamin | 1760 | IV | N Reactivan |
| Fenproporex | 1575 | IV | N Gacilin; Solvolip |
| Fludiazepam | 2759 | IV | N |
| Flunitrazepam | 2763 | IV | N Rohypnol; Narcozep; Darkene; Roipnol |
| Flurazepam | 2767 | IV | N Dalmane |
| Fospropofol | 2138 | IV | N Lusedra |
| Halazepam | 2762 | IV | N Paxipam |
| Haloxazolam | 2771 | IV | N |
| Ketazolam | 2772 | IV | N Anxon; Loftran; Solatran; Contamex |
| Lemborexant | 2245 | IV | N (1R,2S)-2-[(2,4-Dimethylpyrimidin-5-yl)oxymethyl]-2-(3- |

fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1- carboxamide

| Loprazolam | 2773 | IV | N |
|---|---|---|---|
| Lorazepam | 2885 | IV | N Ativan |
| Lorcaserin | 1625 | IV | N Belviq |
| Lormetazepam | 2774 | IV | N Noctamid |
| Mazindol | 1605 | IV | N Sanorex; Mazanor |
| Mebutamate | 2800 | IV | N Capla |
| Medazepam | 2836 | IV | N Nobrium |
| Mefenorex | 1580 | IV | N Anorexic; Amexate; Doracil; Pondinil |
| Meprobamate | 2820 | IV | N Miltown; Equanil; Micrainin; Equagesic; Meprospan |
| Methohexital | 2264 | IV | N Brevital |
| Methylphenobarbital (mephobarbital) | 2250 | IV | N Mebaral; mephobarbital |
| Midazolam | 2884 | IV | N Versed |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

| Modafinil | 1680 | IV | N Provigil |
|---|---|---|---|
| Nimetazepam | 2837 | IV | N Erimin |
| Nitrazepam | 2834 | IV | N Mogadon |
| Nordiazepam | 2838 | IV | N Nordazepam; Demadar; Madar |
| Oveporexton | 1775 | IV | N N-[(2S,3R)-2-[[3-(3,5-Difluorophenyl)-2- |

fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2- methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide; Orzeyful

| Oxazepam | 2835 | IV | N Serax; Serenid-D |
|---|---|---|---|
| Oxazolam | 2839 | IV | N Serenal; Convertal |
| Paraldehyde | 2585 | IV | N Paral |
| Pemoline | 1530 | IV | N Cylert |
| Pentazocine | 9709 | IV | N Talwin; Talwin NX; Talacen; Talwin Compound |
| Petrichloral | 2591 | IV | N Pentaerythritol chloral; Periclor |
| Phenobarbital | 2285 | IV | N Luminal; Bellergal-S |
| Phentermine | 1640 | IV | N Ionamin; Fastin; Adipex-P; Obe-Nix; Zantryl |
| Pinazepam | 2883 | IV | N Domar |
| Pipradrol | 1750 | IV | N Detari; Stimolag Fortis |
| Prazepam | 2764 | IV | N Centrax |
| Quazepam | 2881 | IV | N Doral |
| Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine- | 2846 | IV | N 8-Bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester, |
| 4-propionic acid) | benzenesulfonate (1:1); methyl 3-[(4S)-8-bromo-1-methyl- |  |  |

6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin- 4yl]propanoate benzenesulfonic acid

| Serdexmethylphenidate | 1729 | IV | N |
|---|---|---|---|
| Sibutramine | 1675 | IV | N Meridia |
| Solriamfetol (2-amino-3-phenylpropyl car-bamate; | 1650 | IV | N |

benzenepropanol, beta-amino-, carbamate (ester))

| SPA | 1635 | IV | N 1-Dimethylamino-1,2-diphenylethane; Lefetamine |
|---|---|---|---|
| Suvorexant | 2223 | IV | N MK-4305; [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl- |

1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2- yl)phenyl]methanone

| Temazepam | 2925 | IV | N Restoril |
|---|---|---|---|
| Tetrazepam | 2886 | IV | N Myolastan; Musaril |
| Tramadol (2-[(dimethylamino)methyl]-1-(3- | 9752 | IV | Y Tramadol |

methoxyphenyl)cyclohexanol)

| Triazolam | 2887 | IV | N Halcion |
|---|---|---|---|
| Zaleplon | 2781 | IV | N Sonata |
| Zolpidem | 2783 | IV | N Ambien; Ivadal; Stilnoct; Stilnox |
| Zopiclone | 2784 | IV | N Lunesta |
| Zuranolone | 2420 | IV | N ZURZUVAE |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

SUBSTANCE CSCN SCH NARC OTHER NAMES

Brivaracetam 2710 V N BRV; UCB-34714; Briviact; ((2S)-2-[(4R)-2-oxo-4- propylpyrrolidin-1-yl] butanamide)

| Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2- | 2720 | V | N 2H-Tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, |
|---|---|---|---|
| yl)ethyl]carbamate) | carbamate (ester), (alphaR)-; carbamic acid ®-(+)-1-(2- |  |  |

chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)

| Codeine preparations - 200 mg/(100 ml or 100 gm) | V | Y Cosanyl; Robitussin A-C; Cheracol; Cerose; Pediacof |  |
|---|---|---|---|
| Difenoxin preparations - 0.5 mg/25 ug AtSO4/du | V | Y Motofen |  |
| Dihydrocodeine preparations 100mg/(100 ml or 100 gm) | V | Y Cophene-S, various others |  |
| Diphenoxylate preparations 2.5 mg/25 ug AtSO4 | V | Y Lomotil; Logen |  |
| Ethylmorphine preparations 100 mg/(100 ml or 100 gm) | V | Y |  |
| Ezogabine | 2779 | V | N Potiga |
| Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one) | 2401 | V | N |
| Lacosamide | 2746 | V | N Vimpat |
| Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4- | 2790 | V | N Reyvow |

carbonyl)pyridine-2-yl-benzamide]

| Opium preparations - 100 mg/(100 ml or 100 gm) | V | Y Parepectolin; Kapectolin PG; Kaolin Pectin P.G. |  |
|---|---|---|---|
| Pregabalin | 2782 | V | N Lyrica |
| Pyrovalerone | 1485 | V | N Centroton; Thymergix |

Abbreviations: "NARC" = Narcotic, "CSA SCH" = CSA Schedule, "CSCN" = Controlled Substance Code Number

Controlled Substances - by CSA Schedule

List

I and List

## II

1. Alphabetical Order Regulated Chemicals 2. DEA Number 3. List Number 4. Illicit Uses and Threshold Quantities

## List I and II Regulated Chemicals

DEA CHEMICAL LIST EFFECTIVE CODE REGULATED CHEMICAL NUMBER CITATION DATE NUMBER

1-BOC-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) and its salts I 8336 87 FR 67550 11/9/2022 (Prior to 11/9/2022, 1-BOC-4-AP was a list I chemical as a carbamate of 4-AP with an effective date of 05/15/2020)

1-BOC-4-PIPERIDONE (tert-butyl 4-oxopiperidine-1-carboxylate) and its salts I 8331 90 FR 47563 10/2/2025 (Prior to 10/2/2025, 1-BOC-4-PIPERIDONE was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023)

4-ANILINOPIPERIDINE (N-phenylpiperidin-4-amine; N phenyl-4- I 8335 85 FR 20822 5/15/2020 piperidinamine; 4-AP) including its amides, its carbamates, its halides^, and its salts and any combination thereof, whenever the existence of such is possible. ^Halides designation specifically has an effective date of 11/30/2023 from a modification of the 4-anilinopiperidine listing. (See 88 FR 74352)

4-PIPERIDONE (piperidin-4-one) including its acetals, its amides, its I 8330 88 FR 21902 5/12/2023 carbamates, its salts, and salts of its acetals, its amides, and its carbamates, and any combination thereof, whenever the existence of such is possible

| ACETIC ANHYDRIDE | II | 8519 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| ACETONE | II | 6532 | Pub. L. 100-690 | 3/18/1989 |
| N-ACETYLANTHRANILIC ACID, salts & esters | I | 8522 | Pub. L. 100-690 | 3/18/1989 |
| ANTHRANILIC ACID, salts & esters | I | 8530 | Pub. L. 100-690 | 3/18/1989 |
| APAA (Alpha-phenylacetoacetamide) and its optical isomers (Effective | I | 8515 | 86 FR 24703 | 6/9/2021 |

06/09/2021)

APAAN (Alpha-phenylacetoacetoniltrile), salts, optical isomers, salts of I 8512 82 FR 32457 8/14/2017 optical isomers

| BENZALDEHYDE | I | 8256 | Pub. L. 103-200 | 4/17/1994 |
|---|---|---|---|---|
| BENZYL CHLORIDE | II | 8570 | Pub. L. 100-690 | 3/18/1989 |
| BENZYL CYANIDE | I | 8735 | Pub. L. 100-690 | 3/18/1989 |
| BENZYLFENTANYL (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), | I | 8334 | 85 FR 20822 | 5/15/2020 |

including its salts.

| gamma-BUTYROLACTONE | I | 2011 | Pub. L. 106-172 | 2/18/2000 |
|---|---|---|---|---|
| EPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8113 | Pub. L. 100-690 | 3/18/1989 |
| EPHEDRINE - remove exemption for OTC single entity drug product | I | 8113 | Pub. L. 103-200 | 4/17/1994 |
| EPHEDRINE-remove exemption for OTC combination products and establish | I | 8113 | Pub. L. 104-237 | 10/3/1996 |

a 24 g retail threshold. Threshold remains zero for single entity products. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, 1313

| ERGONOVINE or ERGOMETRINE & salts | I | 8675 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| ERGOCRISTINE | I | 8612 | 76 FR 17778 | 5/2/2011 |
| ERGOTAMINE & salts | I | 8676 | Pub. L. 100-690 | 3/18/1989 |
| ETHYLAMINE & salts | I | 8678 | Pub. L. 101-647 | 2/27/1991 |
| N-ETHYLEPHEDRINE - superseded by 1994 action | I | Pub. L. 101-647 | 2/27/1991 |  |
| N-ETHYLEPHEDRINE | REMOVED | Pub. L. 103-200 | 4/17/1994 |  |

### * Remain in Schedule III

List I and II Regulated Chemicals - Alphabetical Order

DEA CHEMICAL LIST EFFECTIVE CODE REGULATED CHEMICAL NUMBER CITATION DATE NUMBER

| ETHYL ETHER | II | 6584 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| N-ETHYLPSEUDOEPHEDRINE - superseded by 1994 action | I | Pub. L. 101-647 | 2/27/1991 |  |
| N-ETHYLPSEUDOEPHEDRINE | REMOVED | Pub. L. 103-200 | 4/17/1994 |  |
| HYDROCHLORIC ACID (including anhydrous hydrogen chloride) | II | 6545 | 57 FR 43614 | 10/22/1992 |
| HYDROCHLORIC GAS (anhydrous hydrogen chloride) | II | 6545 | Pub. L. 104-237 | 10/3/1996 |
| HYDRIODIC ACID - superseded by 1990 action | II | 6695 | Pub. L. 100-690 | 3/18/1989 |
| HYDRIODIC ACID | I | 6695 | Pub. L. 101-647 | 2/27/1991 |
| HYPOPHOSPHOROUS ACID, salts (Including ammonium hypophosphite, | I | 6797 | 66 FR 52670 | 11/16/2001 |

calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)

| IODINE - superseded by 2007 action | II | 6699 | Pub. L. 104-237 | 10/3/1996 |
|---|---|---|---|---|
| IODINE | I | 6699 | 72 FR 35920 | 8/1/2007 |
| ISOSAFROLE | I | 8704 | Pub. L. 101-647 | 2/27/1991 |
| D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers- | I | 7300 | Pub. L. 101-647 | 2/27/1991 |

superseded

| D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers* | REMOVED | 7300 | Pub. L. 103-200 | 4/17/1994 |
|---|---|---|---|---|
| METHYLAMINE and salts | I | 8520 | Pub. L. 101-647 | 2/27/1991 |
| METHYL ALPHA-PHENYLACETOACETATE (MAPA) | I | 8795 | 86 FR 64362 | 12/20/2021 |
| 3,4-METHYLENEDIOXYPHENYL-2-PROPANONE | I | 8502 | Pub. L. 100-690 | 3/18/1989 |
| N-METHYLEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8115 | Pub. L. 101-647 | 2/27/1991 |
| METHYL ETHYL KETONE (MEK) or 2-BUTANONE | II | 6714 | Pub. L. 100-690 | 3/18/1989 |
| METHYL ISOBUTYL KETONE (MIBK) | II | 6715 | 60 FR 19509 | 5/19/1995 |
| N-METHYLPSEUDOEPHEDRINE, salts, optical isomers, salts of optical | I | 8119 | Pub. L. 101-647 | 2/27/1991 |

isomers

| NITROETHANE | I | 6724 | Pub. L. 103-200 | 4/17/1994 |
|---|---|---|---|---|
| NORPSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8317 | Pub. L. 100-690 | 3/18/1989 |
| P2P METHYL GLYCIDIC ACID (2-methyl-3-phenyloxirane-2-carboxylic acid; | I | 8526 | 91 FR 16831 | 5/4/2026 |

BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible.

| N-PHENETHYL-4-PIPERIDONE (NPP) | I | 8332 | 73 FR 43355 | 4/23/2007 |
|---|---|---|---|---|
| PHENYLACETIC ACID, esters, and salts | I | 8791 | Pub. L. 100-690 | 3/18/1989 |
| PHENYLPROPANOLAMINE, salts, optical isomers, & salts of optical isomers | I | 1225 | Pub. L. 100-690 | 3/18/1989 |
| PHENYLPROPANOLAMINE-remove exemption for certain OTC transactions. | I | 1225 | Pub. L. 104-237 | 10/3/1997 |

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

| PIPERIDINE and salts | I | 2704 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| PIPERONAL | I | 8750 | Pub. L. 101-647 | 2/27/1991 |
| PMK GLYCIDATE (3,4-MDP-2-P METHYL GLYCIDATE) and its optical and | I | 8535 | 86 FR 24703 | 6/9/2021 |

geometric isomers (Effective 06/09/2021)

PMK GLYCIDIC ACID (3,4-MDP-2-P METHYL GLYCIDIC ACID) and its I 8525 86 FR 24703 6/9/2021 salts, optical and geometric isomers, and salts of isomers (Effective 06/09/2021)

List I and II Regulated Chemicals - Alphabetical Order

DEA CHEMICAL LIST EFFECTIVE CODE REGULATED CHEMICAL NUMBER CITATION DATE NUMBER

| POTASSIUM PERMANGANATE | II | 6579 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| PROPIONIC ANHYDRIDE | I | 8328 | Pub. L. 101-647 | 2/27/1991 |
| PROPIONYL CHLORIDE | I | 8337 | 91 FR 11450 | 4/9/2026 |
| PSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8112 | Pub. L. 100-690 | 3/18/1989 |
| PSEUDOEPHEDRINE -remove exemption for certain OTC transactions. | I | 8112 | Pub. L. 104-237 | 10/3/1997 |

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

| RED PHOSPHORUS | I | 6795 | 66 FR 52670 | 11/16/2001 |
|---|---|---|---|---|
| SAFROLE (includes sassafras oil) | I | 8323 | Pub. L. 101-647 | 2/27/1991 |
| SODIUM PERMANGANATE | II | 6588 | 71 FR 60823 | 12/18/2006 |
| SULFURIC ACID | II | 6552 | 57 FR 43614 | 10/22/1992 |
| TOLUENE | II | 6594 | Pub. L. 100-690 | 3/18/1989 |
| WHITE PHOSPHORUS (Other names: YELLOW PHOSPHORUS) | I | 6796 | 66 FR 52670 | 11/16/2001 |

List I and II Regulated Chemicals - Alphabetical Order

## - by DEA Chemical Code Number -

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

| N-ETHYLEPHEDRINE - superseded by 1994 action | I | Pub. L. 101-647 | 2/27/1991 |  |
|---|---|---|---|---|
| N-ETHYLEPHEDRINE | REMOVED | Pub. L. 103-200 | 4/17/1994 |  |
| N-ETHYLPSEUDOEPHEDRINE - superseded by 1994 action | I | Pub. L. 101-647 | 2/27/1991 |  |
| N-ETHYLPSEUDOEPHEDRINE | REMOVED | Pub. L. 103-200 | 4/17/1994 |  |
| PHENYLPROPANOLAMINE, salts, optical isomers, & salts of optical isomers | I | 1225 | Pub. L. 100-690 | 3/18/1989 |
| PHENYLPROPANOLAMINE-remove exemption for certain OTC transactions. | I | 1225 | Pub. L. 104-237 | 10/3/1997 |

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

| gamma-BUTYROLACTONE | I | 2011 | Pub. L. 106-172 | 2/18/2000 |
|---|---|---|---|---|
| PIPERIDINE and salts | I | 2704 | Pub. L. 100-690 | 3/18/1989 |
| ACETONE | II | 6532 | Pub. L. 100-690 | 3/18/1989 |
| HYDROCHLORIC ACID (including anhydrous hydrogen chloride) | II | 6545 | 57 FR 43614 | 10/22/1992 |
| HYDROCHLORIC GAS (anhydrous hydrogen chloride) | II | 6545 | Pub. L. 104-237 | 10/3/1996 |
| SULFURIC ACID | II | 6552 | 57 FR 43614 | 10/22/1992 |
| POTASSIUM PERMANGANATE | II | 6579 | Pub. L. 100-690 | 3/18/1989 |
| ETHYL ETHER | II | 6584 | Pub. L. 100-690 | 3/18/1989 |
| SODIUM PERMANGANATE | II | 6588 | 71 FR 60823 | 12/18/2006 |
| TOLUENE | II | 6594 | Pub. L. 100-690 | 3/18/1989 |
| HYDRIODIC ACID - superseded by 1990 action | II | 6695 | Pub. L. 100-690 | 3/18/1989 |
| HYDRIODIC ACID | I | 6695 | Pub. L. 101-647 | 2/27/1991 |
| IODINE - superseded by 2007 action | II | 6699 | Pub. L. 104-237 | 10/3/1996 |
| IODINE | I | 6699 | 72 FR 35920 | 8/1/2007 |
| METHYL ETHYL KETONE (MEK) or 2-BUTANONE | II | 6714 | Pub. L. 100-690 | 3/18/1989 |
| METHYL ISOBUTYL KETONE (MIBK) | II | 6715 | 60 FR 19509 | 5/19/1995 |
| NITROETHANE | I | 6724 | Pub. L. 103-200 | 4/17/1994 |
| RED PHOSPHORUS | I | 6795 | 66 FR 52670 | 11/16/2001 |
| WHITE PHOSPHORUS (Other names: YELLOW PHOSPHORUS) | I | 6796 | 66 FR 52670 | 11/16/2001 |
| HYPOPHOSPHOROUS ACID, salts (Including ammonium hypophosphite, | I | 6797 | 66 FR 52670 | 11/16/2001 |

calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)

D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers- I 7300 Pub. L. 101-647 2/27/1991 superseded

| D-LYSERGIC ACID, salts, optical isomers, & salts of optical isomers* | REMOVED | 7300 | Pub. L. 103-200 | 4/17/1994 |
|---|---|---|---|---|
| PSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8112 | Pub. L. 100-690 | 3/18/1989 |

### * Remain in Schedule III

List I and II Regulated Chemicals - by DEA Chemical Code Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

PSEUDOEPHEDRINE -remove exemption for certain OTC transactions. Retail I 8112 Pub. L. 104-237 10/3/1997 threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

| EPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8113 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| EPHEDRINE - remove exemption for OTC single entity drug product | I | 8113 | Pub. L. 103-200 | 4/17/1994 |
| EPHEDRINE-remove exemption for OTC combination products and establish | I | 8113 | Pub. L. 104-237 | 10/3/1996 |

a 24 g retail threshold. Threshold remains zero for single entity products. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, 1313

| N-METHYLEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8115 | Pub. L. 101-647 | 2/27/1991 |
|---|---|---|---|---|
| N-METHYLPSEUDOEPHEDRINE, salts, optical isomers, salts of optical | I | 8119 | Pub. L. 101-647 | 2/27/1991 |

isomers

| BENZALDEHYDE | I | 8256 | Pub. L. 103-200 | 4/17/1994 |
|---|---|---|---|---|
| NORPSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8317 | Pub. L. 100-690 | 3/18/1989 |
| SAFROLE (includes sassafras oil) | I | 8323 | Pub. L. 101-647 | 2/27/1991 |
| PROPIONIC ANHYDRIDE | I | 8328 | Pub. L. 101-647 | 2/27/1991 |
| 4-PIPERIDONE (piperidin-4-one) including its acetals, its amides, its | I | 8330 | 88 FR 21902 | 5/12/2023 |

carbamates, its salts, and salts of its acetals, its amides, and its carbamates, and any combination thereof, whenever the existence of such is possible

1-BOC-4-PIPERIDONE (tert-butyl 4-oxopiperidine-1-carboxylate) and its salts I 8331 90 FR 47563 10/2/2025 (Prior to 10/2/2025, 1-BOC-4-PIPERIDONE was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023)

| N-PHENETHYL-4-PIPERIDONE (NPP) | I | 8332 | 73 FR 43355 | 4/23/2007 |
|---|---|---|---|---|
| BENZYLFENTANYL (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), | I | 8334 | 85 FR 20822 | 5/15/2020 |

including its salts.

4-ANILINOPIPERIDINE (N-phenylpiperidin-4-amine; N phenyl-4- I 8335 85 FR 20822 5/15/2020 piperidinamine; 4-AP) including its amides, its carbamates, its halides^, and its salts and any combination thereof, whenever the existence of such is possible. ^Halides designation specifically has an effective date of 11/30/2023 from a modification of the 4-anilinopiperidine listing. (See 88 FR 74352)

1-BOC-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) and its salts I 8336 87 FR 67550 11/9/2022 (Prior to 11/9/2022, 1-BOC-4-AP was a list I chemical as a carbamate of 4-AP with an effective date of 05/15/2020)

| PROPIONYL CHLORIDE | I | 8337 | 91 FR 11450 | 4/9/2026 |
|---|---|---|---|---|
| 3,4-METHYLENEDIOXYPHENYL-2-PROPANONE | I | 8502 | Pub. L. 100-690 | 3/18/1989 |
| APAAN (Alpha-phenylacetoacetoniltrile), salts, optical isomers, salts of optical | I | 8512 | 82 FR 32457 | 8/14/2017 |

isomers

APAA (Alpha-phenylacetoacetamide) and its optical isomers (Effective I 8515 86 FR 24703 6/9/2021 06/09/2021)

| ACETIC ANHYDRIDE | II | 8519 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| METHYLAMINE and salts | I | 8520 | Pub. L. 101-647 | 2/27/1991 |
| N-ACETYLANTHRANILIC ACID, salts & esters | I | 8522 | Pub. L. 100-690 | 3/18/1989 |
| PMK GLYCIDIC ACID (3,4-MDP-2-P METHYL GLYCIDIC ACID) and its salts, | I | 8525 | 86 FR 24703 | 6/9/2021 |

optical and geometric isomers, and salts of isomers (Effective 06/09/2021)

P2P METHYL GLYCIDIC ACID (2-methyl-3-phenyloxirane-2-carboxylic acid; I 8526 91 FR 16831 5/4/2026 BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible.

List I and II Regulated Chemicals - by DEA Chemical Code Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

| ANTHRANILIC ACID, salts & esters | I | 8530 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| PMK GLYCIDATE (3,4-MDP-2-P METHYL GLYCIDATE) and its optical and | I | 8535 | 86 FR 24703 | 6/9/2021 |

geometric isomers (Effective 06/09/2021)

| BENZYL CHLORIDE | II | 8570 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| ERGOCRISTINE | I | 8612 | 76 FR 17778 | 5/2/2011 |
| ERGONOVINE or ERGOMETRINE & salts | I | 8675 | Pub. L. 100-690 | 3/18/1989 |
| ERGOTAMINE & salts | I | 8676 | Pub. L. 100-690 | 3/18/1989 |
| ETHYLAMINE & salts | I | 8678 | Pub. L. 101-647 | 2/27/1991 |
| ISOSAFROLE | I | 8704 | Pub. L. 101-647 | 2/27/1991 |
| BENZYL CYANIDE | I | 8735 | Pub. L. 100-690 | 3/18/1989 |
| PIPERONAL | I | 8750 | Pub. L. 101-647 | 2/27/1991 |
| PHENYLACETIC ACID, esters, and salts | I | 8791 | Pub. L. 100-690 | 3/18/1989 |
| METHYL ALPHA-PHENYLACETOACETATE (MAPA) | I | 8795 | 86 FR 64362 | 12/20/2021 |

List I and II Regulated Chemicals - by DEA Chemical Code Number

## - by List Number -

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

1-BOC-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) and its I 8336 87 FR 67550 5/15/2020 salts (Prior to 11/9/2022, 1-BOC-4-AP was a list I chemical as a carbamate of 4-AP with an effective date of 05/15/2020)

1-BOC-4-PIPERIDONE (tert-butyl 4-oxopiperidine-1-carboxylate) and its I 8331 90 FR 47563 10/2/2025 salts (Prior to 10/2/2025, 1-BOC-4-PIPERIDONE was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023) piperidone was a list I chemical as a carbamate of 4-piperidone with an effective date of 05/12/2023)

4-ANILINOPIPERIDINE (N-phenylpiperidin-4-amine; N phenyl-4- I 8335 85 FR 20822 5/15/2020 piperidinamine; 4-AP) including its amides, its carbamates, its halides^, and its salts and any combination thereof, whenever the existence of such is possible. ^Halides designation specifically has an effective date of 11/30/2023 from a modification of the 4-anilinopiperidine listing. (See 88 FR 74352)

4-PIPERIDONE (piperidin-4-one) including its acetals, its amides, its I 8330 88 FR 21902 5/12/2023 carbamates, its salts, and salts of its acetals, its amides, and its carbamates, and any combination thereof, whenever the existence of such is possible

| N-ACETYLANTHRANILIC ACID, salts & esters | I | 8522 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| ANTHRANILIC ACID, salts & esters | I | 8530 | Pub. L. 100-690 | 3/18/1989 |
| APAA (Alpha-phenylacetoacetamide) and its optical isomers (Effective | I | 8515 | 86 FR 24703 | 6/9/2021 |

06/09/2021)

APAAN (Alpha-phenylacetoacetonitrile), salts, optical isomers, & salts of I 8512 82 FR 32457 8/14/2017 optical isomer

| BENZALDEHYDE | I | 8256 | Pub. L. 103-200 | 4/17/1994 |
|---|---|---|---|---|
| BENZYL CYANIDE | I | 8735 | Pub. L. 100-690 | 3/18/1989 |
| BENZYLFENTANYL (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), | I | 8334 | 85 FR 20822 | 5/15/2020 |

including its salts.

| gamma-BUTYROLACTONE | I | 2011 | Pub. L. 106-172 | 2/18/2000 |
|---|---|---|---|---|
| EPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8113 | Pub. L. 100-690 | 3/18/1989 |
| EPHEDRINE - remove exemption for OTC single entity drug product | I | 8113 | Pub. L. 103-200 | 4/17/1994 |
| EPHEDRINE remove exemption for OTC ephedrine combination products | I | 8113 | Pub. L. 104-237 | 10/3/1996 |

and establish a 24 g retail threshold. Threshold remains zero for single entity products. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, 1313.

| ERGONOVINE or ERGOMETRINE & salts | I | 8675 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| ERGOCRISTINE and its salts | I | 8612 | 76 FR 17778 | 5/2/2011 |
| ERGOTAMINE & salts | I | 8676 | Pub. L. 100-690 | 3/18/1989 |
| ETHYLAMINE & salts | I | 8678 | Pub. L. 101-647 | 2/27/1991 |
| HYDRIODIC ACID | I | 6695 | Pub. L. 101-647 | 2/27/1991 |

List I and II Regulated Chemicals - by List Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

HYPOPHOSPHOROUS ACID, salts (Including ammonium hypophosphite, I 6797 66 FR 52670 11/16/2001 calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)

| IODINE | I | 6699 | 72 FR 35920 | 8/1/2007 |
|---|---|---|---|---|
| ISOSAFROLE | I | 8704 | Pub. L. 101-647 | 2/27/1991 |
| METHYLAMINE and salts | I | 8520 | Pub. L. 101-647 | 2/27/1991 |
| METHYL ALPHA-PHENYLACETOACETATE (MAPA) and its optical isomers | I | 8795 | 86 FR 64362 | 12/20/2021 |
| 3,4-METHYLENEDIOXYPHENYL-2-PROPANONE | I | 8502 | Pub. L. 100-690 | 3/18/1989 |
| N-METHYLEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8115 | Pub. L. 101-647 | 2/27/1991 |
| N-METHYLPSEUDOEPHEDRINE, salts, optical isomers, salts of optical | I | 8119 | Pub. L. 101-647 | 2/27/1991 |

isomers

| NITROETHANE | I | 6724 | Pub. L. 103-200 | 4/17/1994 |
|---|---|---|---|---|
| NORPSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8317 | Pub. L. 100-690 | 3/18/1989 |
| P2P methyl glycidic acid (2-methyl-3-phenyloxirane-2-carboxylic acid; BMK | I | 8526 | 91 FR 16831 | 5/4/2026 |

glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible.

| N-PHENETHYL-4-PIPERIDONE (NPP) | I | 8332 | 73 FR 43355 | 4/23/2007 |
|---|---|---|---|---|
| PHENYLACETIC ACID, esters, and salts | I | 8791 | Pub. L. 100-690 | 3/18/1989 |
| PHENYLPROPANOLAMINE, salts, optical isomers, & salts of optical isomers | I | 1225 | Pub. L. 100-690 | 3/18/1989 |
| PHENYLPROPANOLAMINE -remove exemption for certain OTC | I | 1225 | Pub. L. 104-237 | 10/3/1997 |

transactions. Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

| PIPERIDINE and salts | I | 2704 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| PIPERONAL | I | 8750 | Pub. L. 101-647 | 2/27/1991 |
| PMK GLYCIDATE (3,4-MDP-2-P METHYL GLYCIDATE) and its optical and | I | 8535 | 86 FR 24703 | 6/9/2021 |

geometric isomers (Effective 06/09/2021)

PMK GLYCIDIC ACID (3,4-MDP-2-P METHYL GLYCIDIC ACID) and its I 8525 86 FR 24703 6/9/2021 salts, optical and geometric isomers, and salts of isomers (Effective 06/09/2021)

| PROPIONIC ANHYDRIDE | I | 8328 | Pub. L. 101-647 | 2/27/1991 |
|---|---|---|---|---|
| PROPIONYL CHLORIDE | I | 8337 | 91 FR 11450 | 4/9/2026 |
| PSEUDOEPHEDRINE, salts, optical isomers, & salts of optical isomers | I | 8112 | Pub. L. 100-690 | 3/18/1989 |
| PSEUDOEPHEDRINE -remove exemption for certain OTC transactions. | I | 8112 | Pub. L. 104-237 | 10/3/1997 |

Retail threshold of 24 g established for products not distributed in blister packs. Mail order report requirements imposed. For more info, see 21 CFR Parts 1309, 1310, and 1313.

| RED PHOSPHORUS | I | 6795 | 66 FR 52670 | 11/16/2001 |
|---|---|---|---|---|
| SAFROLE (includes sassafras oil) | I | 8323 | Pub. L. 101-647 | 2/27/1991 |
| WHITE PHOSPHORUS (Other names: YELLOW PHOSPHORUS) | I | 6796 | 66 FR 52670 | 11/16/2001 |

List I and II Regulated Chemicals - by List Number

DEA CHEMICAL LIST CODE EFFECTIVE REGULATED CHEMICAL NUMBER NUMBER CITATION DATE

| ACETIC ANHYDRIDE | II | 8519 | Pub. L. 100-690 | 3/18/1989 |
|---|---|---|---|---|
| ACETONE | II | 6532 | Pub. L. 100-690 | 3/18/1989 |
| BENZYL CHLORIDE | II | 8570 | Pub. L. 100-690 | 3/18/1989 |
| ETHYL ETHER | II | 6584 | Pub. L. 100-690 | 3/18/1989 |
| HYDROCHLORIC ACID (including anhydrous hydrogen chloride) | II | 6545 | 57 FR 43614 | 10/22/1992 |
| HYDROCHLORIC GAS (anhydrous hydrogen chloride) | II | 6545 | Pub. L. 104-237 | 10/3/1996 |
| HYDRIODIC ACID - superseded by 1990 action | II | 6695 | Pub. L. 100-690 | 3/18/1989 |
| IODINE - superseded by 2007 action | II | 6699 | Pub. L. 104-237 | 10/3/1996 |
| METHYL ETHYL KETONE (MEK) or 2-BUTANONE | II | 6714 | Pub. L. 100-690 | 3/18/1989 |
| METHYL ISOBUTYL KETONE (MIBK) | II | 6715 | 60 FR 19509 | 5/19/1995 |
| POTASSIUM PERMANGANATE | II | 6579 | Pub. L. 100-690 | 3/18/1989 |
| SODIUM PERMANGANATE | II | 6588 | 71 FR 60823 | 12/18/2006 |
| SULFURIC ACID | II | 6552 | 57 FR 43614 | 10/22/1992 |
| TOLUENE | II | 6594 | Pub. L. 100-690 | 3/18/1989 |

List I and II Regulated Chemicals - by List Number

Listed Chemicals Regulated Under CONTROLLED SUBSTANCE PRODUCED

### the Controlled Substances Act

### See 21 C.F.R. §§ 1309, 1310, 1313 and 1314 for details

### DEA

### Reagent = 

### Chemical

### Last Update: Nov 12, 2026 Precursor = 

### Code

### Solvent = 

Number AmphetamineCocaineN,N-DimethylamphetamineEthylamphetamineFentanyl & analoguesGHBHeroinLSD MDA MDE MDMAMethamphetamineMethaqualoneMethcathinone4-MethylaminorexPhencyclidine (PCP)Phenyl-2-propanoneTHRESHOLDS

| 1. 1-Boc-4-AP¹ | 8336 |  | 0 | 0 |  |  |
|---|---|---|---|---|---|---|
| 2. 1-Boc-4-piperidone¹ | 8331 |  | 0 | 0 |  |  |
| 3. 4-Anilinopiperidine⁸ | 8335 |  | 0 | 0 |  |  |
| 4. 4-Piperidone¹² | 8330 |  | 0 | 0 |  |  |
| 5. N-Acetylanthranilic acid² | 8522 |  | 40 | 40 |  |  |
| 6. Alpha-Phenylacetoacetamide⁹(APAA) | 8515 |  |  |  | 0 | 0 |
| 7. Alpha-Phenylacetoacetonitrile³(APAAN) | 8512 |  |  |  | 0 | 0 |
| 8. Anthranilic acid² | 8530 |  | 30 | 30 |  |  |
| 9. Benzaldehyde | 8256 |  |  | 4 | 4 |  |
| 10. Benzyl cyanide | 8735 |  | 1 | 1 |  |  |
| 11. Benzylfentanyl¹ | 8334 |  | 0 | 0 |  |  |

3&7

| 12. Ephedrine | 8113 |  |  | 0 | 0 |  |
|---|---|---|---|---|---|---|
| 13. Ergocristine¹ | 8612 |  | 0 | 0 |  |  |
| 14. Ergonovine¹ | 8675 |  | 0.010 0.010 |  |  |  |
| 15. Ergotamine¹ | 8676 |  | 0.020 0.020 |  |  |  |
| 16. Ethylamine¹ | 8678 |  |  | 1 | 1 |  |
| 17. gamma-Butyrolactone (GBL) | 2011 |  | 0 | 0 |  |  |
| 18. Hydriodic acid | 6695 |  | 1.7 1.7 |  |  |  |
| 19. Hypophosphorous acid¹ | 6797 |  |  | 0 | 0 |  |
| 20. Iodine | 6699 |  |  | 0 | 0 |  |
| 21. Isosafrole | 8704 |    | 4 | 4 |  |  |
| LIST I22. Methyl alpha-phenylacetoacetate (MAPA)⁹ | 8795 |  |  |  | 0 | 0 |
| 23. Methylamine¹ | 8520 |   | 1 | 1 |  |  |
| 24. 3,4-Methylenedioxyphenyl-2-propanone | 8502 |    | 4 | 4 |  |  |
| 25. N-Methylephedrine³ | 8115 |  | 1 | 1 |  |  |
| 26. N-Methylpseudoephedrine³ | 8119 |  | 1 | 1 |  |  |
| 27. N-phenethyl-4-piperidone (NPP) | 8332 |  | 0 | 0 |  |  |
| 28. Nitroethane | 6724 |  |  |  | 2.5 2.5 |  |
| 29. Norpseudoephedrine³ | 8317 |  |  | 2.5 2.5 |  |  |
| 30. P2P methyl glycidic acid¹³ | 8526 |  |  |  | 0 | 0 |
| 31. Phenylacetic acid² | 8791 |  | 1 | 1 |  |  |

3&7

| 32. Phenylpropanolamine | 1225 |  |  | 0 | 0 |
|---|---|---|---|---|---|
| 33. Phosphorus (red) | 6795 |  |  | 0 | 0 |
| 34. Phosphorus (white or yellow) | 6796 |  |  | 0 | 0 |
| 35. Piperidine¹ | 2704 |  | 0.500 0.500 |  |  |
| 36. Piperonal (heliotropin) | 8750 |    | 4 | 4 |  |
| 37. PMK glycidate¹⁰ | 8535 |    | 0 | 0 |  |
| 38. PMK glycidic acid¹¹ | 8525 |    | 0 | 0 |  |
| 39. Propionic anhydride | 8328 |  | 0.001 0.001 |  |  |
| 40. Propionyl chloride | 8337 |  | 0 | 0 |  |

3&7

| 41. Pseudoephedrine | 8112 |  |  | 0 | 0 |
|---|---|---|---|---|---|
| 42. Safrole | 8323 |    | 4 | 4 |  |
| 43. Acetic anhydride | 8519 |  |  |  1,023 1,023 |  |
| 44. Acetone | 6532 |  |       | 150 1,500 |  |
| 45. Benzyl chloride | 8570 |  | 1 | 4 |  |
| 46. Ethyl ether | 6584 |   |  |         |   135.8 1,364 |

5&6

Hydrochloric acid 6545               N/C 222.3 47.

5&6

| Hydrogen chloride gas | 6545 |      |         |  | 0 | 27 |
|---|---|---|---|---|---|---|
| LIST II48.Methyl ethyl ketone (2-Butanone) | 6714 |  |  |   | ¹⁴⁵ 1,455 |  |
| 49. Methyl isobutyl ketone⁴ | 6715 |  |  |   |  | N/C 1,523 |
| 50. Potassium permanganate | 6579 |  | 55 500 |  |  |  |
| 51. Sodium permanganate | 6588 |  | 55 500 |  |  |  |

5&6

| 52. Sulfuric acid | 6552 |   |     |  N/C 347 |  |
|---|---|---|---|---|---|
| 53. Toluene | 6594 |  |  |  |   159 1,591 |

1 and its salts 2 and its salts and esters 3 and its salts, optical isomers, and salts of optical isomers 4 Exports only, to all Western Hemisphere except Canada 5 Exports to all South American countries & Panama - Domestic for HCI gas 6 Threshold for HCI acid and sulfuric acid is 50 gallons, the equivalent weight in kilograms is shown 7 For pseudoephedrine, phenylpropanolamine and ephedrine drug products, see 21 USC § 802(45)(A) and 21 C.F.R. Part 1314

### DOMESTICEXPORTS

8 IMPORTS & Including its amides, its carbamates, its halides, and its salts 9 and its optical isomers 10 and its optical and geometric isomers 11 and its salts, optical and geometric iosmers and salts of optical and geometric isomers

### KILOGRAMS

12 and its acetals, amides, carbamates, salts, and salts of acetals, amides, carbamates, and any combinaton thereof, whenever that existence of such is possible 13 and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible N/C = Not Controlled

---

Källa: https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf · Licens: se originalet. Omvandlad till Markdown för tillgänglighetens skull; originalet är den gällande versionen.

[Visa på webbplatsen](https://kmr.clearagency.ai/docs/orangebook) · [Alla dokument](https://kmr.clearagency.ai/docs.md) · [Site index for agents (llms.txt)](https://kmr.clearagency.ai/llms.txt)